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Abstract
Volumetric muscle loss (VML) is a traumatic injury in skeletal muscle resulting in the
bulk loss of more than 20% of the muscle’s volume. Included in the bulk loss of muscle is the
skeletal muscle niche comprised of nerve bundles, vasculature, local progenitor cells, basal
lamina, and muscle fibers, overwhelming innate repair mechanisms. The hallmark of VML
injury is the excessive accumulation of non-contractile, fibrotic tissue and permanent functional
deficits. Though predominant in the younger demographic, the elderly population is also
captured within VML injuries. There are many factors that change with aging in skeletal muscle
that may further hinder recovery and regeneration following VML. In an attempt to further our
understanding on how age affects VML treatments, comparisons between young and aged
animals following VML injury and repair were made. Presented in this dissertation is a summary
of the current state of the tissue engineering field in skeletal muscle and explores strategies for
repairing not only VML but also understanding what age-associated changes in skeletal muscle
preclude effective tissue repair. The future directions and potential approaches to further the
field’s understanding of VML repair in the aging microenvironment along with the remaining
challenges in skeletal muscle tissue engineering are presented within.
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Chapter 1
Introduction
A. Skeletal Muscle Review
Comprising approximately 40% of total body weight, skeletal muscle is one of the most
plastic and dynamic tissues in the human body. Additionally, it is seen as one of the biggest
reservoirs for amino acids, accounting for roughly 50-75% of all body proteins (Frontera &
Ochala, 2015). Mechanically, skeletal muscle has the main function of providing locomotor
movement as well as providing skeletal stability, preventing damage and misalignment at the
joints. Structurally, skeletal muscle is a highly organized, hierarchical tissue composed of tightly
apposed bundles of multi-nucleated fibers. Generally, skeletal muscle is comprised of bundles of
muscle fibers, resident muscle cells, nerve fibers, blood vessels, non-contractile tissue such as
fat, and the extracellular matrix (ECM).
Individual muscles are surrounded by a sheath of connective tissue called the epimysium.
Within those muscles are fibers that are arranged into bundles that are surround by their own
layer of connective tissue called the perimysium. Further down are single muscle fibers that are
surrounded by a cell membrane, or the sarcolemma. The bundle containing these connective
tissue sheaths and membranes are typically referred to as a fascicle and originate at proximally
located tendon plates and terminate at distal insertion points (Lieber & Friden, 2000). For the
purposes of this paper, the aforementioned connective tissues will be referred to as the ECM
unless noted otherwise.
Connecting the sarcolemma to the myofibrils is a complex of myofilament proteins,
referred to as a sarcomere, that is necessary for normal muscle function (Frontera & Ochala,
2015). The sarcomere is considered to be the basic contractile unit of skeletal muscle. The main
1

components of the sarcomere include the thin filament protein actin, thick filament protein
myosin, intermediate linking proteins providing mechanical stability such as dystrophin, titin,
and nebulin (Frontera & Ochala, 2015; Monroy et al., 2012; Ottenheijm & Granzier, 2010), and
the Z disk which functions as an anchor point for myofilaments within the sarcomere (Frontera
& Ochala, 2015). Any absence or dysfunction of one of these proteins are associated with
instability in muscle structure leading to sarcolemmal damage or muscle weakness. A common
example of this is the absence of dystrophin found in neuromuscular disorders such as Becker
and Duchenne muscular dystrophies (G. D. Thomas, 2013).
The basic mechanism of muscle contraction is known as the sliding filament theory
involving the transmission of forces generated by the actin-myosin cross-bridges within the
muscle fiber (A. F. Huxley & Niedergerke, 1954; H. Huxley & Hanson, 1954). Adenosine
triphosphate (ATP) is the main source of energy used in muscle action, which is produced by
muscle cells via the metabolism of carbohydrates and fats (Romijn et al., 1993). To describe
briefly, in the resting state myosin is tightly bound to actin at a 45º angle with respect to each
other. As ATP binds to myosin, it is dissociated from actin and proceeds to hydrolyze ATP into
ADP and a phosphate group. As a result, the head of the myosin molecule swings and weakly
binds to actin on a different binding site. Release of the phosphate group bound to the myosin
molecule initiates the power stroke of myosin, causing it to rotate on its hinge and pushing the
actin filament past it. At the end of the stroke, ADP is released from myosin causing it to resume
its previous tightly bound state on actin. The generated force is transmitted all the way down to
the z disk and movement is finally produced when the force reaches the myotendinous junction,
tendons, and finally the joints (Frontera & Ochala, 2015; A. F. Huxley & Niedergerke, 1954; H.
Huxley & Hanson, 1954).
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B. Muscle Injury and Repair
Following damage such as tears, contusions, and lacerations (Garrett, 1996; M. J.
Jarvinen & Lehto, 1993), skeletal muscle has the capacity to repair itself through a series of
critical events in the repair process. These events can broadly be categorized into the following
phases: degradation, inflammation, repair, remodeling, and maturation (Charge & Rudnicki,
2004; T. A. Jarvinen, Jarvinen, Kaariainen, Kalimo, & Jarvinen, 2005). Degradation occurs
immediately following injury as the sarcolemma (muscle cell plasma membrane) is ruptured
causing an influx of cytosolic calcium ions which activate calcium-dependent proteases, further
degrading the membrane (Fredsted, Gissel, Madsen, & Clausen, 2007; Tidball, 2011).
Additionally, as necrosis of damaged muscle fibers begin, a structure comprised of cytoskeletal
material referred to as the contraction band acts to seal the area off to localize the necrosis as
well as forming a protective barrier to allow for the repair of the damaged sarcolemma (T. A.
Jarvinen et al., 2005).
The inflammatory phase is initiated as activated satellite cells, fibroblasts, and the
damaged and necrotized ends of myofibers release host biomolecules that act as chemotractants
for immune cell extravasation via damaged blood vessels at the site of injury (Baoge et al., 2012;
T. A. Jarvinen et al., 2005; Tidball, 1995, 2011; Toumi & Best, 2003). During the acute phase of
inflammation, the first and most abundant cell population consist of polymorphonuclear
leukocytes such as neutrophils that act to debride the damaged site (Brickson, Hollander, Corr,
Ji, & Best, 2001; Brickson et al., 2003; Hurme, Kalimo, Lehto, & Jarvinen, 1991). Within 24
hours, the concentration of polymorphonuclear leukocytes rapidly decline and are replaced with
invading monocytes that ultimately transform into phagocytic macrophages, commonly referred
to as M1 macrophages, reaching peak concentrations at 48 hours post-injury (Ochoa et al., 2007;
3

St Pierre & Tidball, 1994; Tidball, 2011). M1 macrophages are considered to be proinflammatory, releasing cytokines such as interferon gamma (IFN-γ) and tumor necrosis factor
alpha (TNF-α) among others in order to further promote immune cell migration, activation of
inflammatory signaling via NF-κβ, and furthering muscle damage via increased nitric oxide
production (Nguyen & Tidball, 2003; Villalta, Nguyen, Deng, Gotoh, & Tidball, 2009).
Following M1 macrophages are their non-phagocytic, anti-inflammatory counterparts, the
M2 macrophages, which reach peak concentrations approximately 4 days post-injury
(Krippendorf & Riley, 1993; St Pierre & Tidball, 1994). M2 macrophages have been known
however to linger up to 2 weeks at the injury site, which also coincides with the terminal
differentiation of muscle satellite cells, suggesting a role of M2 macrophages in regulating
muscle repair and regeneration (St Pierre & Tidball, 1994). This is consistent with what was
reported in a macrophage depletion study using the loading/re-loading model in mice. The study
demonstrated that the depletion of macrophages during re-loading of muscle resulted in a
significant reduction in growth and differentiation as well as prevention of the repair of damaged
muscle cell membranes (Tidball & Wehling-Henricks, 2007).
Coinciding with shifts in the inflammatory response, the repair phase of regeneration
occurs, primarily involving the migration, proliferation, and differentiation myogenic progenitor
cells including satellite cells at sites of muscle injury. Satellite cells are widely accepted as the
main contributor to skeletal muscle regeneration (Zammit et al., 2002). Satellite cells normally
reside between the plasma and basement membrane of myofibers in a quiescent state, until they
are activated by muscle injury (Cossu & Biressi, 2005). A hallmark of satellite cells is their selfrenewal ability, which replenishes the remaining satellite cell population either by proliferation
or withdrawal from the cell cycle and returning to a quiescent state. Although satellite cells
4

account for only 1-5% of total myonuclei (Alameddine, Dehaupas, & Fardeau, 1989), they have
been demonstrated to be extremely competent in generating new myofibers following muscle
injury (Collins et al., 2005). Following injury, a mixture of wound healing cytokines released by
immune cells as well as mitogens from damaged muscle activate and induce the proliferation of
satellite cells as well as migration towards the injury site (Allen & Boxhorn, 1989; Bischoff,
1986). In addition, a family of muscle-specific transcription factors referred to as myogenic
regulatory factors (MRFs) regulate the proliferation and differentiation of satellite cells (Pavlath,
Dominov, Kegley, & Miller, 2003; Suelves, Lluis, Ruiz, Nebreda, & Munoz-Canoves, 2004).
Following injury, activated satellite cells are characterized by the high expression of MyoD and
Myf5, committing them to differentiation (Cooper et al., 1999; Pavlath et al., 2003; Smith,
Janney, & Allen, 1994; Yablonka-Reuveni & Rivera, 1994). Transient down-regulation of MyoD
and Myf5 give rise to increasing expression of myogenin (MyoG) and MRF4, characterizing the
terminal differentiation of myoblasts(Karalaki, Fili, Philippou, & Koutsilieris, 2009). Myogenin
has been associated with terminal differentiation and the fusion of myogenic precursor cells to
new or existing myofibers while MRF4 promotes early differentiation and myotube formation
(Launay et al., 2001).
Concurrent with the repair phase, the extracellular matrix at the site of injury is
remodeled and turned-over through the actions of metalloproteinases (MMPs) and their
antagonists, tissue inhibitors of metalloproteinases (TIMPs). The regulation of MMPs and
TIMPs are highly regulated throughout the muscle repair process as the balance of ECM
degradation and synthesis is vital to normal muscle regeneration (Casar et al., 2004; Velleman,
1999). The degradation of ECM into fragments and the growth factors that are released during
this process play an important role in the recruitment of a variety of cell types to the site of injury
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(K. Thomas, Engler, & Meyer, 2015). Among these cells, the resident myofibroblasts are the
main contributors to skeletal muscle ECM. They are responsible for the deposition of the two
predominant fibrous collagen types in interstitial connective tissue (type I and III) but have also
been shown to secrete collagens found in the basal lamina (type IV and VI) (Kuhl et al., 1984;
Zou, Zhang, Sabatelli, Chu, & Bonnemann, 2008).
In skeletal muscle, the two main MMPs during remodeling have been identified as MMP2 and MMP-9 and it has been proposed that these MMPs are differentially expressed transiently
throughout the regenerative process (Kherif et al., 1999). Specifically, MMP-2 is concomitantly
activated with de novo myofiber formation and MMP-9 is expressed in the early stages of
regeneration involving inflammation and satellite cell activation (Kherif et al., 1999).
Interestingly, activated satellite cells are capable of synthesizing and secreting MMP-2 and 9,
suggesting that satellite cells are involved in the degradation of their own niche, allowing them to
migrate to the site of injury (Kuhl et al., 1984; Zou et al., 2008).

C. Volumetric Muscle Loss
When extreme trauma occurs resulting in the bulk loss of tissue (<20% of muscle’s
mass), the regenerative capacity of muscle is overwhelmed leading to excessive scar tissue
deposition and permanent functional deficits (Garg, Ward, et al., 2015; Mase et al., 2010;
Terada, Takayama, Yamada, & Seki, 2001; Turner & Badylak, 2012). These injuries, referred to
as volumetric muscle loss (VML), can result from both military (Corona, Rivera, Owens, Wenke,
& Rathbone, 2015; B. D. Owens et al., 2008) and civilian trauma (Grogan, Hsu, & Skeletal
Trauma Research, 2011; MacKenzie et al., 2000). Though VML primarily occurs through initial
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trauma to the soft tissues, the condition can be further exacerbated as a consequence of excision
and debridement of necrotic muscle tissue in cases involving extremity compartment syndrome
from crush injuries. The absence of the contractile properties of the remaining muscle was
reviewed by Turner and Badylak in 2012 where they reported that due to a dense cap of scar
tissue forming between the damaged myofibers, denervation of the distal tissue occurs due to the
absence of neuromuscular junctions (Turner & Badylak, 2012). Aside from the permanent loss
of contractile tissue, the most challenging clinical problem is the multi-factorial nature of VML
resulting in the concomitant loss of the myogenic cell population as well as changes to the
muscle’s architecture and composition (Corona et al., 2018; Corona, Garg, et al., 2013; Corona,
Wu, et al., 2013).
With VML injuries, treating the injury itself may not be sufficient as there may be injuryassociated changes to the remaining musculature that may preclude effective repair. A study
highlighting the complexity of VML injuries was performed by Garg et al. found that the
magnitude of functional deficits from VML were dependent on joint angle and muscle length
(Garg, Ward, et al., 2015). Specifically, they reported that strength deficits were significantly
worse at joint angles where the muscle was in a shortened position (i.e. dorsiflexion of the TA
muscle). In addition, reductions in myofiber length, increased intramuscular collagen and
scarring, and reduction in range-of-motion were observed. “This study highlights the complexity
of VML injury: Not only the gross loss of muscle tissue but also architectural and histologic
adaptations of the remaining tissue underlie the persistent functional deficits” (Garg, Ward, et al.,
2015). Regeneration of de novo muscle fibers would be insufficient in restoring functional
capacity to muscle as demonstrated by this study and would “require therapies that maximize the
functional capacity of the remaining muscle tissue, promote de novo regeneration of muscle
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tissue, and integrate these tissues to re-establish the intrinsic properties of the original muscle”
(Garg, Ward, et al., 2015; Mase et al., 2010; J. G. Owens et al., 2011).
The current surgical standard of care for VML is the use of autologous muscle flap
transfers in addition to rehabilitative regiments (Greene & Beatty, 1988; Mase et al., 2010; J. G.
Owens et al., 2011). Flap transfer procedures have been used in various limbs including the
forearm (Fan et al., 2008), elbow (Vekris et al., 2008), and lower extremities (C. H. Lin, Lin,
Yeh, & Chen, 2007) following traumatic injuries requiring limb salvage. However, due to the
size of the tissue required, these complex procedures are often associated with significant donor
site morbidity. Moreover, the majority of flap transfers are non-functional and are mainly for
cosmetic purposes though functional free muscle transplantations have been explored with
limited success. Flap and free autografts are distinguished by flap autografts remaining attached
to the muscle origin to preserve systemic blood supply (Klebuc & Menn, 2013).

Muscle Flap Transfers
First performed experimentally in 1970 by Tamai et al. and clinically by Harii et al. in
1976, free muscle transplantation with microsurgical techniques became widely used for the
reconstruction of soft-tissue defects and functional replacement of damaged muscles (Harii,
Ohmori, & Torii, 1976; Tamai, Komatsu, Sakamoto, Sano, & Sasauchi, 1970). Muscle flap
transfer procedures have been explored for their advantages over local skin and fasciocutaneous
flaps for the treatment of complex soft tissue traumas. Muscle flaps demonstrate the ability to fill
in the dead space remaining in wound sites while the dense capillary network facilitates
reperfusion into the surrounding tissue via anastomosis (Klebuc & Menn, 2013). Additionally,
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muscle flaps have demonstrated rapid collagen deposition and allows for greater tissue ingrowth
when compared to skin or fasciocutaneous flaps (Calderon, Chang, & Mathes, 1986; Chang &
Mathes, 1982; Gosain, Chang, Mathes, Hunt, & Vasconez, 1990).
There have been many conflicting reports on the reinnervation of transplanted muscles
and their effects on functional recovery and muscle maintenance (Brunelli, Monini, & Brunelli,
1990; Chiu, Chen, Spielholtz, & Beasley, 1991; McNamara, Garrett, Seaber, & Goldner, 1987).
It was initially believed that the motor nerve was solely responsible for contractility and muscle
maintenance (TOWER, 1931, 1939). However, it was also suggested that the trophic influence
was a function of the sensory nerve fibers (FORBES & COBB, 1926). In 1945, Gutmann
experimentally showed that motor nerve repair promptly after denervation mitigated loss to
contractility and trophic maintenance of the affected muscle (Gutmann, 1945). Gutmann further
demonstrated that sensory muscle reinnervation by neurorrhaphy of a sensory nerve to a motor
nerve was insufficient to maintain muscle mass or contractility, supporting the claim that the
motor nerve is responsible for muscle maintenance and contractility (Gutmann, 1945). Later in
1970, Zalewski’s findings were in agreement with Gutmann when experiments showed that
reinnervation by sensory or symphathetic neurons could not preserve mass or contractility
(Zalewski, 1970). These studies were performed in an ideal setting with unaltered anatomic
position of the muscle as well as with an undisturbed vascular pedicle. The findings from
Gutmann and Zalewski prompted Thompson in 1971(Thompson, 1971a, 1971b) to explore the
effects of innervation of transplanted muscle which prompted other researchers in the area to
follow suit.
Interestingly, the previous findings supporting the motor nerve as the sole contributor to
muscle contractility and maintenance did not translate into muscle transplantation procedures as
9

was demonstrated by Harii et al. (Harii et al., 1976). Harii et al. used autologous gracilis muscle
transplantation to treat a patient with facial palsy and reported that despite prompt motor
reinnervation of the transplanted muscle, the muscle atrophied by approximately 50% following
8 months of recovery. Similarly, in a rat model of muscle transplantation used by Zhang et al.,
gracilis muscle flap transplantation was used to study the effects of reinnervation of transplanted
muscle using various microsurgical techniques including anastomosis and neurorrhaphy (Zhang
et al., 1997). They found that denervated gracilis muscle in situ and transplanted decreased to
28.4% and 31.6% of their initial masses, respectively. Interestingly, motor neurotization of
muscle in situ yielded bulk preservation of 83.2%, however, motor and sensory neurotization of
transplanted muscle resulted in only 38.5% and 38.4% preservation, respectively and not
significantly better than the denervated control flaps (Zhang et al., 1997). Though Zhang’s
findings demonstrated that motor nerves had better bulk preservation and trophic influence on
muscle, it was also the first study to experimentally show that sensory neurons could still
contribute to muscle maintenance, albeit to a lesser degree. These findings motivated further
studies into sensory neurotization as a potential therapeutic treatment for the bulk preservation of
denervated muscle.
Though sensory innervation was previously shown to be not as effective in muscle
preservation, it was not until the past decade where a clinically relevant procedure using sensory
nerves was developed. Termed ‘sensory protection’, the Bain group in 2001 first demonstrated
that sensory neurotization of denervated gastrocnemius and soleus muscles in rats resulted in
higher preservation of mass and superior histological appearance compared to non-protected
muscles (Bain, Veltri, Chamberlain, & Fahnestock, 2001). However, isometric force did not
improve but stayed constant, affirming previous observations by Gutmann suggesting that
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sensory neurons are incapable of forming functional neuromuscular junctions (Gutmann, 1945).
Despite this, Bain et al. reported that temporary sensory protection followed by motor
neurotization can significantly improve force production in muscle and the first clinical
application of this technique was reported in 2008 by the same group (Bain, Hason, Veltri,
Fahnestock, & Quartly, 2008). This technique is not without drawbacks as there are still
concerns regarding changes in the nerve microenvironment with the engraftment of sensory
neurons that may create a sub-optimal environment for axonogenesis and myelination (Sulaiman
et al., 2002). Furthermore, the bulk of the evidence for the preservation ability of sensory
neurons in muscle is provided by very few sources. Though a significant amount of progress has
been made in the field, there still remains a need for more rigorous clinical studies examining the
effects of sensory neurotization and its effect on facilitating reinnervation and mass
preserveration. As such, the use of muscle flap transfers for treating severe soft tissue traumas
such as VML will remain ineffective in restoring functional capacity.

Rehabilitation Therapy
In the military medical system, the main form of therapeutic strategy for VML
management is physical rehabilitation as most tissue engineering strategies being researched
have yet to be realized in the clinic (Mase et al., 2010; J. G. Owens et al., 2011). By using
aggressive rehabilitation programs as reported by Owens et al., all of the patients in the study
were able to return to weight lifting while 80% of the cohort were able to return to running
activities (J. G. Owens et al., 2011). Immediately after discharge from the hospital, patients
underwent strength training to develop the force-generating capacity that is required for sports
activities and then transitioned into plyometrics, agility, and run training as long as there was no
11

abnormal increase in pain with regimen progression (J. G. Owens et al., 2011). Even with the
wide variety of injuries from explosive devices, high-velocity gunshot wounds, and motor
vehicle collisions, the fact that the majority of the patients were able to return to sports activities
and re-deploy in a few of the cases lends clinical value to rehabilitation programs, especially if
they were to be used in conjunction with a tissue-engineered repair strategy.
There is no guarantee that general rehabilitation programs will impart beneficial effects in
terms of muscle recovery following VML and VML-like injuries. Though physical rehabilitation
has been investigated for the recovery of skeletal muscle damage due to conditions such as
age(Betik, Baker, Krause, McConkey, & Hepple, 2008; Seene & Kaasik, 2012) and metabolic
conditions like diabetes(Armstrong & Ianuzzo, 1977; Suga et al., 2014), there still remains a
need for such investigations specifically for VML. In a study performed by Aurora et al. in
2014, the response of VML injured muscle to physical activity was investigated in order to aid in
developing an appropriate rehabilitation regimen for VML injuries (Aurora, Garg, Corona, &
Walters, 2014). The primary findings from the study reported that voluntary wheel running male
adult Lewis rats following VML promoted approximately a 17% increase in maximal isometric
torque as well as a 13% increase in weight of the injured muscle compared to sedentary controls,
reflecting a 31% recovery of the functional deficit which is similar to force recovery following
decellularized ECM transplantation following VML (Aurora et al., 2014; Corona, Wu, et al.,
2013). However, no morphological changes were observed with regards to hypertrophy and
hyperplasia, which may have indicated that the observed functional improvements were due to
improved force transmission rather than force generation (Aurora et al., 2014). As demonstrated
by the group before in an earlier study (Corona, Wu, et al., 2013), ECM remodeling and
deposition at the defect site may be an adaptation for improved force transmission. The findings
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from the study provided valuable insight into the changes in VML injured muscle following
physical rehabilitation and brought attention to other important parameters to investigate such as
magnitude of physical activity in the form of resistance exercise and timing of the
implementation of the rehabilitation program following injury.

D. Tissue Engineered Strategies
Great strides have been made in the advancement of tissue engineering as a field in the
past couple of decades, but despite the extensive effort of researchers there are still many
obstacles in translating exploratory strategies to the clinic. Cell and scaffold-based strategies
have been extensively employed in the repair and regeneration of a variety of tissues including
cartilage, skin, cardiac, and bone in the clinic (Chambers, Rimington, Rajani, Hodson, &
Shabbo, 2007; Falanga & Sabolinski, 1999; Harding, Sumner, & Cardinal, 2013; Oryan, Alidadi,
Moshiri, & Maffulli, 2014; Song & Ott, 2011). However, there is a lack of therapies available for
the repair and regeneration of muscle following extensive musculoskeletal trauma, though there
are a number of research groups developing cell and scaffold-based technologies to address this
issue (Carosio et al., 2013; Mertens, Sugg, Lee, & Larkin, 2014; Tedesco & Cossu, 2012).
Similar to therapies in other tissues, skeletal muscle constructs must be biocompatible with the
host environment, promote cell adhesion, proliferation, and differentiation, and also be able to
deliver additional biomolecules such as growth factors. The challenge, however, comes when
examining the components of skeletal muscle that need to be recapitulated through therapy.
Repair constructs must be able to mimic the highly aligned architecture of native skeletal
muscle and be able to form functional tissue post-implantation (Turner & Badylak, 2012;
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Valentin, Turner, Gilbert, & Badylak, 2010). In pre-clinical animal models where engineered
skeletal muscle constructs were used, contractile function restoration was demonstrated via
remodeling of the construct and formation of functional fibrotic structures that retained
continuity in muscle architecture allowing for effective force transmission through the muscle
(Aarimaa et al., 2004; Corona, Wu, et al., 2013). Construct design must also accommodate
sufficient diffusion of oxygen and nutrients to the muscle if they are to provide a sustainable
environment for seeded cell viability (Cittadella Vigodarzere & Mantero, 2014). Lastly, due to
the permanent denervation of the distal fibers following VML and VML-like injuries, it is
essential for repair strategies to be able to regenerate not only de novo muscle tissue but new
motor endplates as well to restore functional capability in order to avoid atrophy (T. A. Jarvinen
et al., 2007; T. A. Jarvinen et al., 2005). The importance of neurogenesis during muscle
regeneration was investigated in the 1970s and 1980s, first by Benoit and Belt then by Foster and
Carlson in studies using bupivacaine to induce muscle necrosis while preserving satellite cells,
nerves, and vasculature (Benoit & Belt, 1970; Foster & Carlson, 1980). In the model, new
myofiber formation was observed 3 days after bupivacaine injection with presence of newly
forming motor endplates resulting in restoration of muscle function (Jirmanova & Thesleff,
1972). However, in a separate study where bupivacaine was injected in addition to denervation,
the regenerating muscle was devoid of any contractile function (B. M. Carlson & Faulkner, 1996,
1998). In addition to conferring control to new muscle, motor endplates have also been shown to
have chemotropic and stimulating effects influencing muscle fiber type, alignment, and size
(Donghui et al., 2010; Grubic, Komel, Walker, & Miranda, 1995; Lefeuvre, Crossin, FontainePerus, Bandman, & Gardahaut, 1996).
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Despite these challenges, the biological and synthetic scaffolds being used in pre-clinical
animal models have been demonstrated to be reliable platforms upon which regenerative
therapies can be developed. These strategies aim to improve muscle regeneration by not only
providing the mechanical/architectural cues absent following injuries, but they also act as a
substrate for host and transplanted cells to carry out their regenerative processes. Biological
scaffolds such as decellularized ECM scaffolds have been shown to promote muscle regeneration
and functional improvement in patients suffering from traumatic injuries (Porzionato et al., 2015;
Sicari et al., 2014). The combination of cells such as myogenic precursors, mesenchymal stem
cells, and muscle satellite cells with scaffolds have also shown great promise as they similarly
contribute to myogenesis, modulate the inflammatory response, and help maintain an
environment conducive for regeneration (Borselli, Cezar, Shvartsman, Vandenburgh, & Mooney,
2011; B. N. Brown, Valentin, Stewart-Akers, McCabe, & Badylak, 2009; Garg, Ward, Rathbone,
& Corona, 2014; Machingal et al., 2011). Synthetic scaffolds such as PGA (polyglycolic acid),
PLA (polylactic acid), and PLGA (poly(lactic-co-glycolic acid)) (Cronin et al., 2004; Hoque et
al., 2009; Lesman et al., 2011) are popular as they can be formed into constructs with specific
patterning or alignment in order to manipulate cell behavior (Guex, Birrer, Fortunato, Tevaearai,
& Giraud, 2013). Another benefit of synthetic constructs is that they can be easily engineered to
facilitate the controlled release of growth factors and drugs to aid in muscle regeneration
(Grasman, Do, Page, & Pins, 2015). However, the main disadvantage of synthetic scaffolds
compared to decellularized xenogeneic and autologous tissue scaffolds is that they have poorer
affinity for cellular binding, often requiring protein coatings to promote adhesion, and have
higher risk of a foreign body response due to degradation products or the polymer itself (Yang,
Jao, McNally, & Anderson, 2014).
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Decellularized ECM Scaffold Strategies
Decellularized tissue scaffolds for tissue repair in recent years has been of particular
interest due to the scaffolds sharing similar properties of the native tissue as well as being able to
facilitate remodeling of de novo tissue and host cell infiltration (Merritt et al., 2010; Turner et al.,
2010). Cellular antigens are recognized by the host system as foreign bodies and therefore induce
an immune response. However, components of the ECM are remarkably conserved across
species post-decellularization, which have made decellularized ECM scaffolds an attractive
option in the area of regenerative medicine. The challenge and goal of decellularization protocols
is to be able to retain the composition, bioactivity, and mechanical integrity of the remaining
ECM during the decellularization process (Gilbert, Sellaro, & Badylak, 2006). Other factors to
consider carefully are the host of origin of the tissue from which the ECM will be isolated and
the method of decellularization as these factors can affect composition and structure of the ECM
leading to changes in host response to the implanted scaffolds (Gilbert et al., 2006). The most
effective protocols incorporate a combination of physical, chemical, and enzymatic treatments in
order to lyse the cell membranes, separate the ECM from the cellular components, and solubilize
the components for removal with subsequent rinse and sterilization steps (Gilbert et al., 2006).
These biologic scaffolds have seen success in both pre-clinical animal studies and in
human clinical trial applications (S. F. Badylak, 2004; F. Chen, Yoo, & Atala, 1999; Dellgren,
Eriksson, Brodin, & Radegran, 1999; Kolker, Brown, Redstone, Scarpinato, & Wallack, 2005;
Wainwright, 1995). Based out of the University of Pittsburgh, Dr. Stephen Badylak and his
group were among the first researchers exploring the value of tissue-based scaffolds and grafts as
regenerative biomaterials in small and medium pre-clinical animal models. The focus of his work
has been on the use of decellularized porcine small intestinal submucosa (SIS) as a biomaterial
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(Stephen F. Badylak, 1993). Prior to his investigations into orthopedic soft tissue applications,
his investigations included the use of SIS in the repair of small and large diameter arteries (S. F.
Badylak, Lantz, Coffey, & Geddes, 1989; Lantz, Badylak, Coffey, Geddes, & Blevins, 1990),
veins (Sandusky, Badylak, Morff, Johnson, & Lantz, 1992), and skin (Stephen F. Badylak,
1993).
In one of the first studies exploring the feasibility of using SIS as a biomaterial to repair
localized orthopedic injuries, Badylak and colleagues evaluated the tissue reponse to SIS when it
was used to repair an Achilles tendon defect in a canine model (S. F. Badylak et al., 1995). In the
study, a 1.5cm long segment of Achilles tendon was excised from 20 dogs and the resulting
defect was filled with a cylindrical piece of SIS that was sutured into place. Animals were
sacrificed at 1, 2, 4, 8, 16, 24, and 48 weeks post-repair and neotendons were collected to
monitor mechanical, biochemical, and morphological parameters (S. F. Badylak et al., 1995).
Mechanically, the repaired tendons were observed to be stronger than both the musculotendinous
origin and boney insertion, bearing loads of at least 1000N before rupturing when compared to
the non-repaired group (S. F. Badylak et al., 1995). At one and two weeks post-repair, excised
tendon samples showed dense infiltration of immune cells as well as a “richly vascular
connective tissue matrix material” and was only observed within the anastomosis site and the
area immediately adjacent (S. F. Badylak et al., 1995). At the later timepoints, the connective
tissue appeared to have been remodeled into organized sheets that were aligned to the weightbearing load. Additionally, the absence of significant populations of lymphoid and plasma cells
was inconsistent with immune rejection of the SIS material, lending great value and potential of
the material to be investigated in other repair applications (S. F. Badylak et al., 1995). Most
importantly, the study found that the SIS material was degraded over time and allowed for host
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tissue integration making it an attractive option for development as it was not associated with
any of the complications normally associated with synthetic and other biomaterials.
Subsequent studies involving the use of the porcine SIS scaffold led to investigations in
the repair of urinary tract replacement procedures (Shalhav et al., 1999), meniscal regeneration
(Cook, Tomlinson, Kreeger, & Cook, 1999), and bone regeneration (Suckow, Voytik-Harbin,
Terril, & Badylak, 1999; Winkler, Swaim, Sartin, Henderson, & Welch, 2002). However, the
first use of porcine SIS in muscle repair was performed in 1995 by Prevel et al. in a rodent model
of abdominal wall defects (Prevel et al., 1995). A 2x2-cm full-thickness defect was excised from
the rodent abdominal wall. A patch of porcine SIS graft material was then sutured into the defect
and the animals were left to recover for 1 week, 2 weeks, 4 weeks, 2 months, and 3 months prior
to euthanization. To assess treatment efficacy, histological analysis was performed and it was
revealed that the SIS graft had integrated into the host tissue with minimal inflammation by 2
months. Similar to studies using SIS biomaterials, there was no evidence indicating a hostrejection response to the material (Prevel et al., 1995).
In the realm of VML repair, in 2012 the Badylak group developed a murine model of
VML in the quadriceps muscle and demonstrated the response to repair using a bioscaffoldbased approach (Sicari et al., 2012). In the study, female C57/BL/6 mice aged 6-8 weeks had a
4x3mm full thickness segment of their tensor fasciae latae muscle along with a portion of the
underlying rectus femoris muscle resected and then the defect was filled with a 4x4x3mm
porcine SIS-ECM sheet implant. Histological analysis at the repair site at 7 days post-surgery
showed dense populations of neutrophils and mononuclear cells around the defect site and the
outer edges of the scaffold. In addition, evidence of angiogenesis and neurogenesis was found in
the remodeling scaffold at day 7 and remained until the 56 day endpoint. After 28 days, host18

derived ECM was found to be integrating with the remodeled ECM implant and appeared to be
cellularized. At 56 days, the ECM was completely populated with cells including desminpositive skeletal muscle cells. On the contrary, the unrepaired group in the study exhibited
deposits of dense connective tissue consistent with scar tissue formation with a distinct layer of
host-derived neo-matrix at the margins of the defect site (Sicari et al., 2012). This study clearly
demonstrated the potential of decellularized matrix scaffolds as therapies for VML injuries as the
implanted scaffolds were able to integrate with the surrounding host tissue, promoted
constructive remodeling of the defect site, and allowed for the recruitment of immune and
progenitor cells to the site without illiciting an overt foreign body response.
Extending their previous research into VML repair in both mice and humans (Sicari et al.,
2014), the Badylak group conducted a clinical study using several different tissue-derived ECM
scaffolds of porcine origin to repair VML injuries in a 13-paitent cohort (Dziki et al., 2016). The
injured muscle compartment of each patient was identified wherein scar tissue debridement and
selective tenolysis was performed prior to the implantation of one of three ECM bioscaffolds:
porcine urinary bladder matrix (UBM, MatriStem, ACell, Columbia, MD, USA), porcine SIS
(BioDesign, Cook Medical, Bloomington, IN, USA) or porcine dermis (XenMatrix, C.R. Bard,
Warwick, RI, USA) (Dziki et al., 2016). All bioscaffolds were suture with contact to adjacent
native healthy tissue and secured under tension with suture. Tissue biopsies taken at 6-8 weeks,
10-12 weeks, and 24-28 weeks post-surgery showed progressive evidence of de novo muscle
formation and neovascularization verified by the presence of desmin+ cells with centrally located
nuclei and CD146+NG2+ perivascular stem cells. The presence of β-III tubulin+ nerve bundles
by 6 months after surgery within the repair site was suggestive of innervation and neurogenic
cell activity. Post-operative improvements in force production was measured via dynamometer
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ranging from 20-140% at 6 months post-surgery which was attributed to ECM implantation.
However, all patients underwent aggressive physical therapy programs pre-operatively and
during recovery from VML repair which may have had a positive impact on bioscaffold
remodeling leading to increased vascularization and innervation. These findings are supported by
previous studies investigating the effects of mechanical loading following VML repair with
ECM scaffolds (Ballotta, Driessen-Mol, Bouten, & Baaijens, 2014; Gentile et al., 2014; Gilbert
et al., 2007; Turner, Badylak, Weber, & Badylak, 2012). However, the improved functional
outcomes are likely attributed to improved force transduction via scar tissue remodeling as
documented by Aurora and Corona (Aurora, Roe, Corona, & Walters, 2015; Corona, Wu, et al.,
2013). Further, the use of acellular bioscaffolds such as the urinary bladder matrix used in this
study alone were demonstrated to be insufficient in generating an appreciable amount of de novo
skeletal muscle and was suggested that for significant muscle regeneration to occur, repair
strategies needed to incorporate progenitor cell populations and develop more effective
myoconductive scaffolds (Aurora et al., 2015).

Decellularized Muscle-Derived ECM Scaffold Strategies
Though decellularization of tissues has been shown to be non-immunogenic and
acellular, there may be benefits to using a scaffold derived from the target tissue of interest.
Specifically for muscle, the remnant structure following decellularization may facilitate the
integration of peripheral nerves due to the already existing neural pathways in the scaffold
(Borschel, Dennis, & Kuzon, 2004). Further, the remaining vascular system in acellular skeletal
muscle scaffolds could be used to perfuse the constructs allowing for improved growth and force
production as well as recellularizing the vascular bed (Borschel et al., 2004). Current trends in
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skeletal muscle tissue engineering have shown a favorable response to the use of skeletal musclederived ECM strategies for muscle regeneration with extensive work being performed assessing
their host bioactivity and histocompatibility (Borschel et al., 2004; Corona, Wu, et al., 2013;
DeQuach et al., 2012; Perniconi et al., 2011).
In a study by Borschel et al., the myogenic potential and force production capability of
acellular muscle scaffolds seeded with and without C2C12 myoblasts was explored (Borschel et
al., 2004). Acellular scaffolds were created from extensor digitorum longus muscles excised
from adult C57-BL6 mice. Repopulated and acellular scaffolds were cultured for a period of 3
days in growth medium and then for 3 weeks in differentiation medium. Force production in the
myoblast populated muscle scaffolds was substantially lower than normal EDL muscle output
but was enough to demonstrate that the seeded cells were able to proliferate and differentiate into
fused myofibers within the acellular muscle scaffolds. These findings were further substantiated
with histological analysis using toluidine blue staining to confirm cell proliferation and electron
micrograph imaging to examine microscale structures within the populated and non-populated
acellular scaffolds. The non-populated scaffolds were devoid of the key muscle cytoskeletal
elements actin and myosin as well as having a loosely organized matrix. However, with the
populated scaffolds, researchers found the existence of the filamentous proteins actin and myosin
and further observed that they had assembled into a sarcomeric pattern (Borschel et al., 2004).
Though tested in vitro, these findings were significant in that they addressed some of the major
hurdles facing the development of constructs that are to be clinically relevant.
While it was demonstrated previously to be feasible to produce highly complex organs
such as the rodent heart in vitro (Ott et al., 2008), an in vivo skeletal muscle transplantable had
yet to be developed. To that end, Perniconi et al. produced acellular scaffolds from tibialis
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anterior (TA) muscles of adult sex-matched BALB/C mice and transplanted them into syngeneic
hosts to be assessed for histocompatibility, bioactivity, and host integration in a murine model
(Perniconi et al., 2011). An incision was made in the hindlimb to expose the TA epimysium to
allow for the excision of the TA. The distal tendon and a fragment of the proximally inserted
muscle on the TA were left intact to anchor the scaffold. Mice were given 2 and 4 weeks to
recover after which the grafted materials were harvested for histological analysis.
Immunostaining revealed that at 2 weeks post-implantation there were signs overt inflammation
within and around the scaffold, which was further specified to be infiltration of CD45+ cells
comprised mostly of macrophages via flow cytometry, indicating that immune cell infiltration
was restricted to the implanted material. In 4 week grafted material, the degree of inflammation
appeared to be decreased to control levels. The presence of muscle interstitial stem cells was also
confirmed within grafted materials. Scattered nascent myofibers exhibiting centrally located
nuceli preferentially located in the mid-belly and distal regions of the scaffold demonstrated its
myogenic capability. These findings were further validated with protein expression of myosin
heavy chain and sarcoglycan and mRNA expression of muscle-specific late differentiation
markers (Ott et al., 2008). Taken with other studies that use ECM from other tissues to
regenerate muscle that morphologically and functionally mimic native tissue (Turner et al., 2010;
Valentin et al., 2010; Vindigni et al., 2004), ECM has consistently shown the ability to form de
novo tissue, in part due to contributions of the migration of tissue-resident progenitor cells to the
implant site. The added value of this study is that it demonstrates that muscle-derived ECM itself
has pro-myogenic qualities supporting an environment favorable for myofiber formation.
Findings from other researchers highlighting the impact of niche regulation on tissue-resident
stem cell function suggest that muscle-derived ECM may possess to some degree muscle niche
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properties that aid in its myogenic activity (Ferraro, Celso, & Scadden, 2010; Pelosi et al., 2007;
Vindigni et al., 2004).
The use of muscle-derived ECM scaffolds in VML repair has been of great interest to the
military due to the high incidence of extremity trauma in veterans returning from active war
zones and the lack of an effective treatment to restore functional tissue following reconstructive
surgery (Andersen et al., 2014; Mase et al., 2010; B. D. Owens et al., 2008; J. G. Owens et al.,
2011; Ramasamy, Harrisson, Clasper, & Stewart, 2008). However, trauma research at the U.S.
Army Institute of Surgical Research (USAISR) led by the Walters and Corona groups have made
great advancements in the development of VML repair strategies using muscle-derived ECM
scaffolds. The Walters group’s initial work in VML yielded a standardized rat model of VML
(Wu, Corona, Chen, & Walters, 2012) upon which various treatment strategies have been tested
(Aurora, Corona, & Walters, 2016; Corona, Garg, et al., 2013; Corona, Ward, Baker, Walters, &
Christ, 2014). Specifically, the model involves the creation of a VML defect (~20% of muscle’s
mass) in the tibialis anterior muscle of a rat. More importantly, there has been thorough
documentation of the response to VML injury itself and to the implantation of muscle ECM
scaffolds during VML repair (Aurora et al., 2015; Corona et al., 2014; Corona, Wu, et al., 2013;
Garg, Corona, & Walters, 2015). Wu et al. demonstrated in the standardized rat VML model that
following VML injury at 2 and 4 months, significant atrophy to the unrepaired muscles occurred
(22.7% and 19.5% reduction in mass compared to uninjured controls at 2 and 4 months) while
also being accompanied by a reduction in peak isometric torque of 28.4% and 32.5% at 2 and 4
months respectively (Wu et al., 2012). In addition, they observed the characteristic deposition of
scar tissue at the VML injury site as well as ongoing remodeling and repair as indicated by the
presence of centrally nucleated muscle fibers at the injury site (Wu et al., 2012). These results
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have been observed to be consistent across similar VML studies (Corona, Wu, et al., 2013;
Kasukonis, Kim, Washington, & Wolchok, 2016).
In terms of functional recovery following repair, scaffold-only repair has been incapable
of promoting an appreciable amount of muscle regeneration resulting in significant increases to
contractile function (Aurora et al., 2015; Corona et al., 2014). Despite reports of improved
functional outcomes following VML repair with muscle-derived ECM and other ECM scaffolds,
the force improvements are most likely attributed to a “bridging” of the defect site by scar tissue
deposition as demonstrated by Corona et al. (Corona, Wu, et al., 2013). In that study performed
by Corona et al., a VML defected created in the tibialis anterior muscle of a rat was left
untreated, repaired with muscle ECM, or repaired with muscle ECM with a delayed injection of
bone marrow stem cells (Corona, Wu, et al., 2013). Interestingly, it was found that untreated
VML injury resulted in extensive fiber damage and remodeling that visibly extended from the
defect site to the underlying musculature. However, repair with the muscle ECM (with and
without BMSC delivery) appeared to attenuate the damage to the remaining musculature which
was associated with the observed functional improvements at 2 and 4 months post-treatment. No
significant de novo myofiber formation was observed in this study, though there have been
varying reports on the degree of myofiber generation following scaffold-mediated repair ranging
from abundant and modest levels (Corona et al., 2012; Machingal et al., 2011; Merritt et al.,
2010) to low or non-existent levels (Conconi et al., 2005; Turner et al., 2010). However, the
characteristic deposition of mostly collagen I-enriched scar tissue at the VML repair site was
observed; findings that are consistent with the use of ECM scaffolds to repair similar complex
injuries (Gamba et al., 2002; Kim, Kasukonis, Brown, Washington, & Wolchok, 2016; Turner et
al., 2012).
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Cell-based Strategies
The use of cells in tissue-engineered therapies can have tremendous value compared to
acellular scaffolds when considering rejuvenating the native cell population in cases such as
VML injuries. Due to their multipotency, mesenchymal stem cells have the ability to aid in the
repopulation and subsequent proliferation and differentiation into target tissue cells once
implanted. In various studies, the delivery of quiescent muscle satellite cells have shown to
promote greater regeneration compared to culture-derived myoblasts (DiMario & Stockdale,
1995; Rossi et al., 2011). These studies, however, focused on the therapeutic effects that the
degree of maturation of immature cells (quiescent vs. activated cells) may have whereas the
therapeutic potential in delivering a construct in combination with active precursor cells has been
explored to a lesser extent. The greatest advantage of using a tissue-engineered scaffold in
conjunction with myogenic precursor cells is that such a strategy aids in recapitulating the
cellular and mechanical environment following VML injury. For instance, a study led by Corona
from the Christ research group from Wake Forest University is particularly interesting as it
combines both acellular scaffold and in vitro cultured myofbers and cells (Corona et al., 2012).
The treatment strategy included the use of a porcine urinary bladder matrix, which was seeded
with a mix of primary cells isolated from tibialis anterior and soleus muscle. The seeded
constructs were then pre-conditioned in a stretch bioreactor in order to proliferate and
differentiate the cells (Corona et al., 2012). The three separate constructs tested in the study
consisted of a single seeding of cells that were proliferated during pre-conditioning (TEMR1SP), a seeding of cells that were differentiated under pre-conditioning (TEMR-1SPD), and 2
seedings of cells that were proliferated and differentiated (TEMR-2SPD). Significant functional
recovery following 1 and 2 months post-implantation was detected for all groups compared to
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non-repaired controls with the TEMR-2SPD group exhibiting the highest force recovery. It was
also observed that both magnitude and time course of recovery was dependent on the TEMR
construct used with the TEMR-1SPD and TEMR-2SPD constructs providing a 62% and 110%
increase in peak force values when compared to non-repaired controls at 2 months post-injury.
Additionally, TEMR-1SPD and TEMR-2SPD groups exhibited a 39% and 28% improvement in
peak force between 1 and 2 months post-injury. Morphologically, TEMR-1SPD and TEMR2SPD repaired muscle samples appeared to have an increased cellular presence within the
scaffold area, an increase in muscle tissue formation at both the repair site and within the
scaffold, and a presence of vascular and neural structures at the tissue-construct interface
(Corona et al., 2012).
These findings are particularly interesting as they illustrate the unique benefits of a
hybrid construct containing both pre-conditioned proliferating and differentiating cell
populations. Specifically, Corona et al. found that actively proliferating cells contributed to
accelerated functional recovery while the presence of differentiated myotubes is critical in
maintaining continuous functional recovery (Corona et al., 2012). Compared to strategies using
acellular scaffolds to form de novo muscle tissue, it is plausible that hybrid constructs such as the
TEMR would require a shorter time to promote new tissue growth contributing to functional
recovery ((Corona et al., 2012)). An alternative to the delivery of stem or progenitor cells is the
use of autologous minced muscle grafts as a means of introducing not only muscle progenitor
cells but other muscle-native cells and native ECM to the VML site (Corona, Garg, et al., 2013;
Goldman & Corona, 2017; Goldman, Henderson, & Corona, 2017; Hurtgen et al., 2017; B.
Kasukonis et al., 2016).
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The first experiments detailing the regenerative capacity of minced muscle fragments
were performed by Studitsky (Studitsky, 1964) and Carlson (B. M. Carlson, 1968) in their
respective seminal publications. Studitsky’s most significant finding was that minced muscle
tissue was observed to enter a state of plasticity and thereby increased the survivability and
development of transplanted minced tissue in injury sites (Studitsky, 1964). Carlson’s study in
1968 confirmed Studitsky’s previous findings by implanting minced muscle to regenerate rat and
frog muscles following complete removal of the gastrocnemius muscle (B. M. Carlson, 1968).
Carlson confirmed the regeneration of muscle and restoration of anatomical organization in both
frog and rat specimens, though it was noted that regeneration appeared to occur at approximately
twice the rate in the rats compared to the frogs (B. M. Carlson, 1968). An important finding from
the study, however, was the observation of normal regeneration in the acute phases of healing
but then cycles of degeneration of newly formed myofibers within the tissue regenerates. At the
end of the study, it was reported that most of the muscle regenerates were reduced to “a
tendinous structure with only a few scattered muscle fibers…” (B. M. Carlson, 1968). This was
attributed in part to the lack of innervation in the late phases of regeneration as previous reports
have demonstrated in detail that early muscle differentiation can occur independent of
innervation but is necessary for the latter stages of differentiation (Striganova, 1958;
Zhenevskaya, 1962).
In recent reports, the delivery of satellite cells via transplantation of single muscle fibers
has been demonstrated to be a potent technique to not only produce myogenically competent
progeny but to increase satellite cell engraftment and survivability as well (Collins et al., 2005;
Hall, Banks, Chamberlain, & Olwin, 2010; Tateyama, Fujihara, Misu, & Itoyama, 2009).
However, the delivery of progenitor cells via minced muscle grafts may be more advantageous

27

due to the simplicity of the procedure compared to single myofiber isolation and lends itself to
facile integration with treatment strategies for use in the clinic. Corona et al. in 2013 first
explored the use of autologous minced muscle grafts for VML repair (Corona, Garg, et al.,
2013). Following VML defect creation in the TA muscle of Lewis rats, it was observed that
orthotopic transplantation of minced muscle autografts into the wound bed promoted myofiber
regeneration by 8 and 16 weeks post-repair. Interestingly, by 8 weeks the regenerated fibers
exhibited signs of innervation, which was further validated via a glycogen depletion study.
Fibers were also reported to have similar cross-sectional areas as uninjured muscle fibers when
compared to literature (Corona, Garg, et al., 2013). Functional capacity was restored to
approximately 55% of the functional deficit present in unrepaired TA muscles (Corona, Garg, et
al., 2013). In an earlier study that transplanted decellularized muscle-derived ECM to repair a
VML defect (Corona, Wu, et al., 2013), functional recovery at 16 weeks post-repair was reported
to be approximately 20%. It is clear that minced muscle autografts contribute to an increase in
functional tissue as evidenced by the two-fold increase in functional recovery over scaffold-alone
repair.
Building off the minced muscle graft approach for VML repair, Kasukonis et al.
demonstrated that the combinatorial therapy of minced muscle grafts and decellularized ECM
scaffolds was able to significantly improve functional outcomes as well as exert transcriptional
regulation over myogenesis following VML repair (B. Kasukonis et al., 2016). The use of a 25%
minced muscle graft in this study was motivated by previous work from Corona et al. exploring
minced muscle graft volume expansion approaches for the treatment of VML (Ward, Ji, &
Corona, 2015). In that study, Corona et al. observed that using approximately 50% of the VML
defect tissue as minced muscle in a hydrogel carrier was comparable in promoting functional
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recovery to that of a 100% minced muscle graft with hydrogel carrier (Ward et al., 2015). By
utilizing a <50% minced muscle graft, Kasukonis et al. hoped to evaluate whether a
decellularized skeletal muscle scaffold (DSM) could improve the regenerative abilities of the
sub-optimal amount of minced muscle graft used in the study. Not only did DSM and 25%
minced muscle repair improve functional outcomes that were comparable to what was observed
with the use of 50% minced muscle by Corona et al. (~50% force recovery), significant
improvements in the restoration of muscle mass and upregulation of myogenic gene expression
were also observed (B. Kasukonis et al., 2016). These findings warrant further investigation into
the development of DSM scaffolds as carriers for minced muscle grafts. Specifically, it is of
great interest whether these scaffolds act merely as vehicles for the minced muscle or if there are
any significant matrix-minced muscle interactions that modulate satellite cell activity for the
benefit of myogenesis and VML repair.

Synthetic and Natural Polymer Strategies
The benefit in using natural and synthetic polymers in the development of engineered
skeletal muscle constructs is the ability to control the mechanical and spatial properties of the
material during fabrication. Another advantages of synthetic materials is the ability to
incorporate growth factors into the bulk structure of these polymers allowing for controlled
release of these factors into the site of injury (Niu, Feng, Wang, Guo, & Zheng, 2009;
Prabaharan & Jayakumar, 2009). Biomaterial development for skeletal muscle tissue engineering
has explored a large variety of materials ranging from synthetic polymers such as poly(glycolic
acid) (PGA) (Saxena, Marler, Benvenuto, Willital, & Vacanti, 1999; Saxena, Willital, & Vacanti,
2001), poly(lactic acid) (PLA) (Cronin et al., 2004), and poly-ɛ-caprolactone (PCL)(Choi, Lee,
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Christ, Atala, & Yoo, 2008); to natural polymers such as alginate (Borselli et al., 2010), collagen
(Hurd, Bhatti, Walker, Kasukonis, & Wolchok, 2015; Kroehne et al., 2008), and fibrin
(Marcinczyk et al., 2018; Page et al., 2011).
The spatial patterning of constructs, especially highly aligned patterns of electrospun
nanofibers mimicking the native architecture of muscle, provides control over cellular behavior,
which can be of great benefit in terms of being able to enhance certain phases of myogenesis. In
vitro studies exploring spatially patterned constructs for musculoskeletal engineering
applications have demonstrated that highly aligned cultures of myoblasts seeded onto aligned
nanofiber scaffolds have increased proliferation and more readily fuse into multi-nucleated
myofibers (Choi et al., 2008; Guex et al., 2013; Zatti et al., 2012) than cultures using randomlyoriented fibers. These effects are augmented when additional scaffold properties are
incorporated, as was the case with Chen et al. who fabricated electrically conductive
PCL/polyaniline (PCL/PANi) nanofiber scaffolds to evaluate their potential use in engineering
regenerative strategies for skeletal muscle (M. C. Chen, Sun, & Chen, 2013). Chen et al.
observed synergistic effects of topographical and electrical cues on myotube formation with
significant increases in myotube formation and maturation (15% and 18% increases,
respectively) when compared with non-conductive or randomly oriented conductive scaffolds.
Similar electrically conductive scaffolds have been demonstrated to increase differentiation and
myogenic gene expression in myoblasts (Jun, Jeong, & Shin, 2009), increase alignment and
proliferation in osteoblasts (Shao et al., 2011), and increase adhesion and proliferation of cardiac
myoblasts (Bidez et al., 2006). Synthetic constructs that provide multiple environmental cues
will be indispensable in the further development of tissue engineering strategies due to the
immensely complex nature of the in vivo environment.
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Despite imparting beneficial effects on functional outcomes, synthetic biomaterials are
limited due to their poor bioactivity, often requiring the addition of coatings to promote cell
adhesion or incorporation of natural polymers to attenuate the host immune response (Choi et al.,
2008; Wolf et al., 2014). An interesting approach exploring the development of a more bioactive
scaffold leveraged the porous architecture of polyurethane (PU) foams to act as a sacrificial
template for the deposition of ECM from rat myoblasts (Hurd et al., 2015). Myoblasts were
cultured on fibronectin coated PU foams for 4 weeks after which the foams were dissolved in
solvent to isolate the resulting ECM material. Collagen I, collagen IV, and laminin were all
detected to be present in the resulting material, all of which are present in the basement
membrane of skeletal muscle (Gillies & Lieber, 2011). Materials such as these are uniquely
suited to be used in the repair of VML and VML-like injuries as they can provide the bioactive
signaling cues that are missing due to the disruption to the basement membrane following VML
injury. However, Hurd et al. reported the mechanical strength of the foam template ECM to be
approximately one-third of decellularized muscle ECM, which may lack the structural support to
withstand mechanical loading during regeneration (Hurd et al., 2015).
Unlike their synthetic counterparts, natural polymers intrinsically possess bioactivity as
well as the ability to form molecules such as proteoglycans which enhance cell migration,
proliferation, and differentiation via binding of growth factors (Bidarra, Barrias, & Granja, 2014;
A. C. Brown & Barker, 2014; Walters & Stegemann, 2014). Among these biopolymers, alginate
(Hill, Boontheekul, & Mooney, 2006b; Liu et al., 2013), collagen (Chevallay & Herbage, 2000;
Rhim et al., 2007), and fibrin (Heher et al., 2015; Marcinczyk et al., 2018; Matsumoto et al.,
2007) have been predominantly explored in muscle regenerative applications.
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Initial exploration into the applications of alginate-based biomaterials were to utilize
them as encapsulating agents for the delivery of proteins in order to mimic paracrine signaling
between cells (Edelman, Mathiowitz, Langer, & Klagsbrun, 1991; Sugamori & Sefton, 1989).
Due to its ability to maintain steady release profiles of desired proteins and its tunable
mechanical properties (Boontheekul, Kong, & Mooney, 2005; Drury, Boontheekul, & Mooney,
2005), it remains as an ideal candidate for controlled delivery systems for various tissue
engineering applications such as the delivery of pancreatic islet cells (Opara, Mirmalek-Sani,
Khanna, Moya, & Brey, 2010), to promote osteogenesis via mesenchymal stem cell delivery
(Zhou & Xu, 2011), and revascularization of various tissues (Drewa, Adamowicz, & Sharma,
2012; Iwasa, Engebretsen, Shima, & Ochi, 2009; Macchiarini et al., 2008). Within skeletal
muscle regeneration, in vitro investigations found that the stiffness of the gels (~45 kPa)
significantly increased myoblast proliferation and differentiation (Boontheekul, Hill, Kong, &
Mooney, 2007). As a delivery vehicle, alginate has been demonstrated to be able to transport and
release various growth factors crucial to muscle regeneration including VEGF (Shvartsman et al.,
2014; Wang et al., 2014), IGF-1 (Borselli et al., 2010), and HGF and FGF-2 (Hill, Boontheekul,
& Mooney, 2006a; Hill et al., 2006b). In vivo, the combined delivery of VEGF and IGF-1 in an
alginate gel carrier was observed to improve host progenitor cell survival and vascularization in
the acute phases of regeneration (Borselli et al., 2010; Shvartsman et al., 2014). Further, delivery
of both VEGF and IGF-1 increased force production approximately 4-5 fold compared to blank
control gels (Borselli et al., 2010). However, this study used a less severe injury model than a
VML with ischemia induced muscle injury. Additionally, alginate gels have only, thus far, been
implanted on the surface of injury sites (Borselli et al., 2011) and even though they have been
proven effective in improving vascularization and myoblast proliferation and differentiation, no
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conclusions can be drawn on their efficacy when presented with a more complex in vivo
environment as in VML cases.
In skeletal muscle, collagen I gels have been used as cell delivery vehicles for myoblasts
which have been shown to promote cell migration out of the porous gels to the ends of existing
myofibers (Carnio et al., 2011). Without modifications to collagen assembly within gels, the
result of implantation following injury is a suboptimal healing response characterized by
increased immune cell infiltration into the site and an absence of myogenesis (van Wachem,
Brouwer, & van Luyn, 1999). However, collagen constructs with tunable internal structures such
as the parallel pore collagen sponge developed by Korehne et al. can promote aligned myotube
growth and development in vitro, which can later be transplanted into an in vivo injury site
(Kroehne et al., 2008). In the study, 6mm x 3mm x 2.5mm collagen sponges were seeded with
C2C12 myoblasts which were allowed to proliferate for 1 day before switching to differentiation
medium for an additional 5-6 days, after which the cultured regenerates were sutured into the
muscle bed where the tibialis anterior muscle was located prior to excision. It was observed that
the implanted regenerates were able to integrate into the surrounding host tissue as well as
having the ability to contract under stimulation (Kroehne et al., 2008). These results suggest that
rather than the material itself, the alignment of the constructs used to repair large tissue defects
appear to impart greater effects to improve myogenesis compared to similar materials with no
alignment. In addition, with the absence of any significant regenerative outcomes resulting from
the implantation of collagen materials/scaffolds, their uses are limited to in vitro development of
partial tissue regenerates and acting as vehicles for the delivery of growth factors such as VEGF
(Frey, Jansen, Raschke, Meffert, & Ochman, 2012) or HGF, IGF-1, and FGF2, which have been
shown to promote satellite cell recruitment (Ju, Atala, Yoo, & Lee, 2014).
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Fibrin, a branched fibrillary polymer, is another attractive biopolymer material upon
which muscle regenerative strategies can be developed due to its role in vivo as the provisional
matrix that is deposited during wound healing as well as its inherent bioactivity (A. C. Brown &
Barker, 2014; Chiron et al., 2012; Clark, 2001). Though its biodegradation has been observed to
be approximately 3 weeks in vivo, its structural integrity can be augmented via incorporation of
polymers such as PLLA/PLGA or polyethylene glycol (PEG) to slow the degradation rate
(Lesman et al., 2011). Additionally, an alternative to hybridizing fibrin with synthetic polymers
is manipulating the degree of cross-linking (ultraviolet or chemically-induced) (Grasman,
Pumphrey, Dunphy, Perez-Rogers, & Pins, 2014). Several studies have demonstrated the ability
of myoblast seeded fibrin gels to improve myoblast survival post-transplantation and promote
differentiation into myofibers that are able to integrate into the uninjured host tissue (Beier,
Kneser, Stern-Strater, Stark, & Bach, 2004; Beier et al., 2006; Gerard, Forest, Beauregard, Skuk,
& Tremblay, 2012). Further, it was found that implanting a myoblast-loaded fibrin gel sheaths in
the proximity of native blood vessels increased vascular perfusion into the constructs (Borschel,
Dow, Dennis, & Brown, 2006). In addition, the resulting tissue explants isolated from the gel
sheaths were found to resemble functional muscle tissue capable of contraction while
maintaining their mechanical integrity through testing (Borschel et al., 2006). Despite these
findings, with the lack of in vivo functional measurements it is difficult to say whether the
amount of regeneration and angiogenesis resulting from treatment would be effective in treating
larger volumetric defects in muscle.
In a VML injury setting, fibrin has been utilized in many forms including microthreads
(Grasman, Page, & Pins, 2017), hydrogels (Gilbert-Honick, Iyer, et al., 2018), and microbeads
(Lalegul-Ulker, Seker, Elcin, & Elcin, 2019). The benefit of these materials is that they are able
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to deliver growth factors (Cornwell & Pins, 2010; Grasman et al., 2015) and cells (GilbertHonick, Ginn, et al., 2018; Page et al., 2011) to the site of injury to augment the regenerative
process. In a study that leveraged both the delivery capability and tunable structure of fibrin,
researchers were able to seed adult adipose stem cells (ASCs) onto fibrin microfiber bundles
prior to implantation into a VML defect in a murine model (Gilbert-Honick, Ginn, et al., 2018).
Interestingly, in vitro experiments assessing the pro-myogenic potential of the ASC seeded fibrin
microfiber bundles revealed that the seeded constructs were able to produce aligned and
elongated ASCs that expressed markers for skeletal muscle but failed to mimic native muscle
characteristics. When the bundles were implanted in place of both TA and EDL muscles in vivo,
a significant reduction in fibrosis at the implant site was observed (Gilbert-Honick, Ginn, et al.,
2018). Further, compared to acellular fiber bundles, seeded bundles exhibited increased markers
for embryonic myosin as well as the mature muscle marker myosin heavy chain. However, due
to the lack of functional muscle measurements as well as histological analysis of the regenerating
construct/tissue explants, no meaningful conclusions can be drawn from a clinically relevant
standpoint. As the majority of non-modified fibrin materials degrade in vivo within 3 weeks upon
implantation, the resulting de novo myofibers are often randomly oriented and disorganized
unlike the highly aligned surrounding host tissue, giving rise to poor functional outcomes and
regeneration. Despite this, the development of biopolymer scaffolds such as fibrin and those
mentioned previously still hold great value when thinking towards combinatorial tissue
engineering approaches to repair large tissue defects like VML.

35

E. Aging Skeletal Muscle
Closely associated with aging is the gradual decline of cellular activity ultimately leading
to physiological changes that contribute to the impairment of normal regenerative processes.
This has been documented in various tissues such as skin during wound healing (D. R. Thomas,
2001), angiogenesis in various tissues and organs (Edelberg & Reed, 2003; Lahteenvuo &
Rosenzweig, 2012), and remyelination of axons in the central nervous system (Franklin, Zhao, &
Sim, 2002; Sim, Zhao, Penderis, & Franklin, 2002). In skeletal muscle, the predominant change
with aging is the overall loss of muscle strength, muscle mass, and decline in regenerative
potential. Underlying the loss in strength is a reduction in the number of functional motor units,
particularly fast-fatigueable motor units (Kung et al., 2014; Larsson, 1995). The progressive loss
in muscle mass, often referred to as sarcopenia, and decline in regenerative capacity is largely
due in part to the reduced activity and numbers of satellite cells associated with aging (Brack &
Rando, 2007; Conboy & Rando, 2005; Snow, 1977). Specifically, a decrease in sensitivity to
signals initiating the activation, proliferation, and renewal capability of satellite cells has been
documented with aging (Brack & Rando, 2007; Gopinath & Rando, 2008; Kuang, Gillespie, &
Rudnicki, 2008). Also, associated with sarcopenia is the marked decrease in capillary density and
circulating levels of angiogenic factors that may have negative implications regarding
metabolism, endocrine function, and muscle contractility (Olfert, Baum, Hellsten, & Egginton,
2016). Though these major changes in aging skeletal muscle have implications regarding the
regenerative capacity of muscle, it is equally as important to understand the more subtle changes
in the host environment and satellite cell niche that also contribute to the reduction in
regenerative ability.
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Extracellular Matrix
One of the major changes in the extracellular matrix with aging is the significant increase
in interstitial connective tissue (Marshall, Williams, & Goldspink, 1989). According to Marshall
et al., there is approximately a two-fold increase in endomysial collagen when comparing mice
aged 3 weeks and 26 weeks (Marshall et al., 1989). Further, there is also a marked increase in the
fibrotic response during muscle regeneration (B. M. Carlson & Faulkner, 1989; Ullman, Ullman,
Sommerland, Skottner, & Oldfors, 1990). Concomitant with increased fibrosis is the thickening
of the external lamina surrounding satellite cells resulting in reduced satellite cell numbers
(Snow, 1977). This increased fibrogenesis in aging muscle has been attributed to increased Wnt
signaling and possibly to Wnt-like proteins present in the serum (Brack et al., 2007).
Specifically, Brack et al. exposed young and aged satellite cells to serum in a heterochronic
pairing. When aged cells were exposed to serum from young animals, there was a significant
reduction in the myogenic-to-fibrogenic conversion of the aged satellite cells. Assessing the
effects of Wnt signaling on myogenic cell fate, Wnt3A protein was added to young serum which
resulted in an increase in the fibrogenic conversion of young satellite cells while administration
of a Wnt inhibitor into aged serum decreased the fibrogenic conversion of aged progenitors in
vitro (Brack et al., 2007). Though it was discovered that age-related changes in the muscle
microenvironment were responsible for increased fibrosis and altered cell fate in aging muscle
progenitors, this study identified a potential therapeutic target to improve the regenerative
response while reducing fibrosis.
Aside from fibrosis, ECM and ECM-associated molecules also play a direct role in
communicating with the cells that interact with it in order to regulate the migration, proliferation,
and differentiation of myoblasts (Grounds, 1991; Grounds & Yablonka-Reuveni, 1993). These
37

include laminins that are associated with the external lamina (B. M. Carlson, 1995; Maley,
Davies, & Grounds, 1995), proteoglycans that are necessary for the binding of specific growth
factors to their receptors (Muramatsu, Muramatsu, & Kojima, 2006; Schultz & Wysocki, 2009),
and proteolytic fragments such as collagen I and IV, fibronectin, and elastin which induce
chemotaxis of inflammatory cells (Adair-Kirk & Senior, 2008). Changes in ECM composition
and remodeling activity also are affected with aging. It was found that due to the increased levels
of matrix metalloproteinases (MMP) and reduced basement membrane protein synthesis, there is
a thinning of the basement membrane (Callaghan & Wilhelm, 2008; Frantz, Stewart, & Weaver,
2010). Moreover, as a result of cellular senescence, fibroblasts in aged tissue are resistant to
apoptotic cues and typically express increased levels of ECM-associated proteins such as
fibronectin, MMPs, growth factors, and cytokines in addition to elevated levels of plasminogen
activator inhibitor (PAI)(Coppe, Desprez, Krtolica, & Campisi, 2010) and reactive oxygen
species (ROS)(Untergasser, Madersbacher, & Berger, 2005). Together, these factors result in a
chronic inflammatory environment in aging tissue which can further lead to elastin degradation
and a modified collagen network in the ECM resulting in aberrant cellular function (Callaghan &
Wilhelm, 2008; Freund, Orjalo, Desprez, & Campisi, 2010; Nomura, 2006; Sprenger, Plymate,
& Reed, 2008).

Innervation
Accompanying sarcopenia, myofiber atrophy, and reduction in muscle strength and
quality is the age-related deterioration of the neuromusculuar junction, decline in motor unit
numbers, and neuromuscular junction instability (Hepple & Rice, 2016). Gutmann and
Hanzlikova first demonstrated that there is indeed a morphological deterioration of
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neuromuscular junctions as was observed in aged rodents (Gutmann & Hanzlikova, 1966). Their
findings were later confirmed as the same changes were observed in eldery humans in a study
conducted by the Oda group (Oda, 1984). Specifically, in older subjects increased fragmentation
of end-plates and increased pre-terminal axon branching at the end-plates were observed, which
may explain the increased fatigability associated with aging skeletal muscle.
Closely associated with the progressive loss in muscle strength with aging is the decline
in the number of functional motor units. Previously, electrophysiological techniques were used to
estimate numbers of motor units in the tibaialis anterior muscle of three age cohorts: young
adults (~25 years) older adults (~65 years), and very old adults (~80 years) (McNeil, Doherty,
Stashuk, & Rice, 2005). When comparing motor unit estimates between young and older adults
which were separated by ~40 years, there was approximately a 40% decline in motor unit
numbers in the older adults. In the very old group, which represented a 15-year difference
compared to the older adult group, there were 33% fewer motor units. These results support the
notion that a rapid decline in muscle function and muscle mass follows the loss of motor units.
Interestingly, studies have found that a decline in muscle strength with aging occurs prior to
significant losses in muscle mass (Goodpaster et al., 2006). Goodpaster et al. observed that even
after significant muscle loss had occurred, the reduction in strength was far greater than what
could be accounted for solely from muscle atrophy (Goodpaster et al., 2006). Overall, these
observations implicate motor unit loss as the contributor to loss of muscle strength preceding the
loss of muscle mass.
Through much of the life span of an adult, muscle has been shown to undergo repeated
cycles of denervation and reinnervation leading to alterations in the neuromuscular junction. This
process involves a temporary decoupling of an individual myofiber from its motor neuron
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preceded by reinnervation by either the original motor neuron associated with the myofiber or
through axonal branching of an adjacent motor neuron (Hepple & Rice, 2016). At the cellular
level, this cycle of denervation-reinnervation result in significant changes in the components of
the neuromuscular junction, namely in the narrowing of terminal axons (Jang & Van Remmen,
2011), altered distribution of post-synaptic membrane proteins (Samuel, Valdez, Tapia,
Lichtman, & Sanes, 2012), and excessive sprouting of terminal axons (Balice-Gordon, 1997). An
interesting study of note, Deschenes et al. set out to determine whether myofiber atrophy was
secondary to age-related myofiber denervation and whether the activity level in muscle affected
its sensitivity to age-related denervation (Deschenes, Roby, Eason, & Harris, 2010). Muscles
from aged rats that were lightly recruited exhibited signs of denervation with no change in
myofiber size and composition while muscles that were heavily recruited showed no signs of
denervation nor changes in myofiber profile. The researchers were able to confirm that changes
in neuromuscular junction did indeed occur prior to myofiber atrophy and that increased activity
could possibly delay age-related denervation and atrophy (Deschenes et al., 2010). However, as
previous studies have demonstrated that the early phases of regeneration can progress
independent of innervation until the late differentiation and fusion phases, the effects of poor
innervation ostensibly should have little impact on the regenerative process but will pose a
challenge later in overall muscle maintenance and myofiber survival (B. M. Carlson, 1995;
McGeachie & Grounds, 1989).

Vasculature
Resulting from regions of impaired or altered hemodynamics as is observed in aging
skeletal muscle (Socha & Segal, 2018), atherosclerosis creates a pro-inflammatory environment
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and severely compromises endothelial cell (EC) and smooth muscle cell function (SMC) (Dai et
al., 2004). ECs in flow regions promoting atherosclerotic plaque development have been shown
to be more prone to apoptosis as well as upregulating the activation of inflammatory NF-κβ
signaling and preventing the expression of transcription factors (KLF4) acting in an
atheroprotective manner (Dai et al., 2004; Y. Z. Jiang et al., 2014). In advanced atherosclerosis,
SMCs exhibited low proliferation rates and increased senescence attributed to growth factor
insensitivity and increased expression of cell cycle inhibitors (Patel et al., 2001). Moreover,
senescent SMCs promote a pro-inflammatory environment via release of pro-inflammatory
cytokines and MMPs while depositing reduced amounts of ECM into the vessel walls (Gardner,
Humphry, Bennett, & Clarke, 2015). This inflammatory environment is especially detrimental to
regenerative signaling pathways in aging skeletal muscle. Specifically, high levels of TGF-ß and
its effector pSmad3 found in aging muscle was observed to increase the expression of several
cyclin dependent kinase inhibitors that lead to the reduced activation of aged satellite cells (M. E.
Carlson, Hsu, & Conboy, 2008). Additionally, endogenous TGF-ß/pSmad3 was found to have an
antagonistic relationship with Notch, a protein involved in molecular signaling regulating
satellite cell activity. The Notch signaling pathway and its role in regulating satellite cell activity
as well as changes in Notch signaling with advanced aging is discussed in further detail in the
following section.

Satellite Cells and Regeneration
The gradual decline in regenerative capacity with age in skeletal muscle can be attributed
to the decline in satellite cell activity as they are largely responsible for the regenerative potential
of skeletal muscle (Zammit et al., 2002). The view that satellite cell numbers are altered with age
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has produced many confounding reports ranging from a reduction in numbers (Bockhold,
Rosenblatt, & Partridge, 1998), to no change (Conboy, Conboy, Smythe, & Rando, 2003), and to
an increase in numbers (Gibson & Schultz, 1983). Regardless, there is a consensus that more
important than satellite cell numbers is the ability of satellite cells to produce fusion-competent
progeny that can contribute to muscle regeneration, which carries greater value than any
observed perturbations in the number of muscle satellite cells. The age-associated decline in
satellite cell function is thought to be caused by either intrinsic changes such as cellular
senescence leading to insensitivity to environmental signals or changes in the environmental cues
directing satellite cells down the myogenic program. One of the more well-documented
mechanisms by which satellite cell activity is regulated involves the Notch signaling pathway,
which has been shown to exert regulatory control over the cell cycle of many cells including
satellite cells (Charge & Rudnicki, 2004; Conboy et al., 2003; C. Jiang et al., 2014).
There are marked changes associated with aging in the Notch signaling pathway that may
account for the reduction in satellite cell activity in skeletal muscle. Under normal conditions
such as in younger muscle, there is an upregulation of both Notch and its ligand, Delta, following
muscle injury promoting satellite cell proliferation and inhibiting differentiation (Conboy &
Rando, 2002). Once a pool of proliferating satellite cells have formed, the Notch antagonist,
Numb, is upregulated while Notch is downregulated, causing satellite cells to exit the cell cycle
and commit to differentiation (Conboy & Rando, 2002). However, in response to injury in aged
skeletal muscle, it is reported that there is a failure to upregulate Delta leading to diminished
myogenic potential (Conboy et al., 2003). Additionally, there is a distinct difference in the levels
of Notch and Numb between young (high levels) and aged (low levels) muscles that highlight the
importance of Notch signaling in regulating satellite cell activity (Carey, Farnfield, Tarquinio, &
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Cameron-Smith, 2007; Conboy et al., 2003). In vitro forced activation of Notch was able to
restore the proliferative abilities of aged satellite cell leading to efficient tissue repair similar to
what was observed in young satellite cells. Similar results were observed when Notch was
activated ex vivo regardless of Delta ligand upregulation (Conboy et al., 2003). These findings
are significant as Conboy et al. demonstrate that the diminished regenerative potential in aging
skeletal muscle is not an irreversible process and they identify a potential target for therapeutic
strategies restoring regenerative potential in aging muscle.
Moreover, the previously reported results suggest that a decline in environmental cues
and not dysfunction intrinsic to the cell is responsible for the impaired regenerative potential in
aging muscle. These observations are in agreement with previous reports proposing the ageassociated decline in environmental cues as the cause of the decline in regenerative capacity in
old skeletal muscle (B. M. Carlson & Faulkner, 1989; Zacks & Sheff, 1982). In these studies,
muscles were transplanted heterochronically (old to young, young to old) and isochronically (old
to old, young to young) in order to identify whether intrinsic or extrinsic changes associated with
aging were the cause of declining regeneration in aging muscle. It was found that old muscles
grafted into young hosts recovered just as well as young muscles grafted into young hosts.
Further, skeletal muscle mass and strength were well preserved in aged muscles grafted into
young hosts similar to observations from young muscles grafted into young hosts (B. M. Carlson
& Faulkner, 1989). Conboy et al. utilized a similar heterochronic transplantation model in mice
to determine whether the young environment contains systemic factors that contribute to
myogenesis and if the aged-associated decline in satellite cell activity can be rescued by
exposure to factors found in the young environment (Conboy et al., 2005). Young mice (2-3
months) were transgenic for green fluorescent protein (GFP) in order to differentiate which
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host’s cells contributed to regeneration. The young host heterochronic and isochronic pairings
exhibited robust regeneration as demonstrated by the presence of centrally located nuclei and
embryonic myosin heavy chain (eMHC) expressing myofibers. The aged mice (19-26 months) in
isochronic pairings failed to form myotubes and contained large regions of fibrotic repair tissue.
However, in the aged heterochronic parabionts, regeneration was comparable to that of both
young heterochronic and isochronic pairings (Conboy et al., 2005). Notably, the improved
regeneration in the aged muscle was exclusively due to the contribution of the aged satellite cells
as only 0.1% of regenerated myotubes were GFP+. Further, an upregulation of Delta in aged
satellite cells from aged heterochronic parabionts was observed and were similar to Delta levels
in both young pairings, though a slight inhibition of Delta expression was observed in young
heterochronic parabionts. Together, the data suggests that there are factors in the young
environment that are able to restore molecular signaling pathways critical to muscle regeneration
in aging muscle and that the majority of the intrinsic regenerative capabilities of aged progenitors
are conserved but the systemic environment in which they reside prohibit efficient tissue repair
(Conboy et al., 2005).

Hormonal Changes
With increasing age, there is a decrease in the levels of circulating hormones and
anabolic stimuli such as testosterone (Harman et al., 2001), growth hormone, and IGF-1 (Abbasi,
Drinka, Mattson, & Rudman, 1993) that contribute to the loss of muscle mass and strength
possibly as a result of decreased satellite cell activity. Due to this, androgenic interventions have
been found to be attractive options to mitigate age-related decline in skeletal muscle. In a study
comparing the regenerative response to testosterone supplementation between 2-month and 2444

month old mice, various improvements in aging muscle regeneration was reported (Serra et al.,
2013). Researchers observed an increase in satellite cell activation and in the number of
proliferating satellite cells in the injured tibialis anterior muscles of castrated 2-month and 24month old mice as well as increased cross-sectional area in regenerating fibers (Serra et al.,
2013). The sham counterparts on the other hand exhibited significantly lower levels of satellite
cell activation and proliferation, which reduced/delayed the rate of regeneration in aged muscles.
Despite the fact that this investigation was limited to only the early stages of myogenesis, it
demonstrates the potential application of this type of treatment in augmenting the declining
regenerative response observed in aging skeletal muscle.
Testosterone has been shown to stimulate various molecular signaling pathways to
improve satellite cell activity and muscle mass maintenance. A report by Kovacheva et al.
demonstrated testosterone’s ability to stimulate Notch signaling while preventing apoptotic
signaling in muscle (Kovacheva, Hikim, Shen, Sinha, & Sinha-Hikim, 2010). One of the more
salient findings from this study was that testosterone administration in aging animals clearly
inhibited the activation of JNK signaling, which is responsible for inducing cell apoptosis
following injury or in aging (Braga et al., 2008; Sinha-Hikim, Braga, Shen, & Sinha Hikim,
2007). Additionally, there was an observed decrease in myostatin expression which antagonizes
Akt signaling-mediated skeletal muscle hypertrophy (Amirouche et al., 2009; Morissette et al.,
2006) and decreased 4-HNE expression which is a marker of oxidative stress that decreases
satellite cell life-span and proliferative capacity (Renault, Thornell, Butler-Browne, & Mouly,
2002). However, no effect on p38 MAPK signaling was found with testosterone in aging
animals, which is consistent with previous studies indicating that the regulation of cellular
homeostasis through p38 MAPK signaling is more complex and varies widely with age and
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target tissue (Hsieh, Rosenblatt, & Papaconstantinou, 2003; A. Lin & Dibling, 2002). Finally, an
increase in Notch 1 expression in aged muscle was observed with testosterone administration
with concomitant increases in proliferating cell nuclear antigen (PCNA) and myogenin
expression, indicating increased satellite cell proliferation and differentiation (Kovacheva et al.,
2010). Taken together, these results suggest that testosterone supplementation in aging muscle
could rescue the regenerative potential of satellite cells by stimulating molecular signaling
pathways that are akin to what would be found in a younger skeletal muscle microenvironment.
Testosterone derivatives such as nandrolone decanoate have also been shown to improve
muscle regeneration in low testosterone conditions. Following contusion injuries, nandrolone
decanoate was found to increase muscle twitch and tetanic force 2 weeks post-injury and
improved the growth of regenerating myofibers 25 days post-injury (Ferry et al., 1999). In
another study, nandrolone injection in castrated mice exhibited increased expression of IGF-1,
MyoD, and cyclin D1 following bupivacaine-induced muscle injury (White, Baltgalvis, Sato,
Wilson, & Carson, 2009). Based on these results, researchers suggested that nandrolone
improved muscle regeneration through an IGF-1-mediated mechanism. IGF-1 is known to
promote myoblast proliferation and differentiation (Coolican, Samuel, Ewton, McWade, &
Florini, 1997; Jacquemin, Butler-Browne, Furling, & Mouly, 2007) and its receptor in muscle
(IGF-1R) appears to be essential in mediating the effects of testosterone on progenitor cell
proliferation and differentiation (White et al., 2009). Notwithstanding the beneficial effects to
skeletal muscle regeneration, the main drawback of nandrolone is that it has potent anabolic
effects while its androgenic effects are weak and its use is associated with various side effects
including reducing native testosterone biosynthesis (Barone et al., 2017; Kicman, 2008; Nagata
et al., 1999; Pomara et al., 2016; Takahashi, Tatsugi, & Kohno, 2004).
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F. Objective
The goal of this research is to provide evidence to the following fundamental premise:
age-associated changes in skeletal muscle will negatively affect muscle recovery following VML
injury and the response to repair with tissue engineered strategies. The following investigations
were performed to explore our fundamental premise:
1) Examine the effect of age on the response to recovery following volumetric muscle loss.
Hypothesis: Age will increase the force loss following VML injury.
2) Examine how age affects the response to repair of VML injury using minced muscle
autografts co-delivered with DSM (DSM+MM).
Hypothesis: Age will decrease the amount of force recovered following VML repair.
3) Investigate the regenerative outcomes following VML repair with co-delivery of the anabolic
steroid nandrolone decanoate in aged animals.
Hypothesis: Nandrolone decanoate administration will reverse the decrements to force
recovery following VML repair in aged animals.
VML investigations thus far have utilized various young animal models in developing
tissue repair strategies. With what is known about the declining regenerative potential and
various deleterious changes in skeletal muscle associated with aging, it is a possibility that
treatment strategies that have proven successful in younger animal models will not be effective
in older animal models. As per this gap in knowledge, we saw an opportunity to address the
potential differences in recovery after VML injury and VML repair in the aging animal
population when compared to the young population.
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The use of the DSM+MM repair strategy has been demonstrated previously to increase
myogenic gene expression, reduce fibrosis during regeneration, and significantly improve
functional outcomes in a young rat model of VML. We hope to study the changes in the
microenvironment of aging animals and how they affect the response to VML injury and repair
in order to better inform future research in developing not only tissue engineering strategies for
VML repair but also the effects of aging on muscle regeneration in VML. Moreover, many
researchers have employed the use of testosterone and other hormone replacement therapies to
combat age-associated muscle wasting and functional decline. Testosterone has also been shown
to improve regenerative outcomes in aging animals, restoring the response to injury to levels
seen in younger animals. We will use this as an adjunct to our current DSM+MM therapy in
order to further improve regeneration in aging animals.
A brief outline of our approach is as follows:


Develop an aged model of VML injury and investigate differences in VML recovery between
young and aged animals.



Investigate differences in the regenerative and functional outcomes following VML repair
using DSM co-delivered with MM autografts between young and aged animals.



The final study will use the anabolic steroid nandrolone decanoate as an adjunctive treatment
to DSM+MM repair and explore the effects on regenerative and functional outcomes
between young and aged animals.
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Highlights




Comparison between young and aged rats to volumetric muscle loss injury (VML).
Age does not exacerbate the post-VML functional response.
Age affects ECM composition and results in a more fibrotic post-VML environment.

Abstract
Termed volumetric muscle loss (VML), the bulk loss of skeletal muscle tissue either through
trauma or surgery overwhelms the capacity for repair, leading to the formation of non-contractile
scar tissue. The myogenic potential, along with other factors that influence wound repair are
known to decline with age. In order to develop effective treatment strategies for VML injuries
that are effective across a broad range of patient populations, it is necessary to understand how
the response to VML injury is affected by aging. Towards this end, this study was conducted to
compare the response of young and aged animal groups to a lower extremity VML injury.
Young (3 months, n=12) and aged (18 months, n=8) male Fischer 344 rats underwent surgical
VML injury of the tibialis anterior muscle. Three months after VML injury it was found that
young TA muscle was on average 16% heavier than aged muscle when no VML injury was
performed and 25% heavier when comparing VML treated young and aged animals (p<0.0001,
p<0.0001). Peak contractile force for both the young and aged groups was found to decrease
significantly following VML injury, producing 65% and 59% of the contralateral limbs’ peak
force, respectively (p<0.0001). However, there were no differences found for peak contractile
force based on age, suggesting that VML affects muscle’s ability to repair, regardless of age. In
this study, we used the ratio of collagen I to MyoD expression as a metric for fibrosis vs.
myogenesis. Decreasing fiber cross-sectional area with advancing age (p<0.005) coupled with
the ratio of collagen I to MyoD expression, which increased with age, supports the thought that
regeneration is impaired in the aged population in favor of fibrosis (p=0.0241). This impairment
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is also exacerbated by the contribution of VML injury, where a 77-fold increase in the ratio of
collagen I to MyoD was observed in the aged group (p<0.0002). The aged animal model
described in this study provides a tool for investigators exploring not only the development of
VML injury strategies but also the effect of aging on muscle regeneration.

Keywords: orthopedics, musculoskeletal, animal model, tibialis anterior, aging, VML
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A. Introduction
Our multidisciplinary team is exploring the development of implantable biomaterials
targeting the repair of damaged skeletal muscle (Hurd et al., 2015; B. Kasukonis, J. Kim, T.
Washington, & J. Wolchok, 2016). Towards that end we are particularly interested in
understanding the response of muscle to volumetric muscle loss injury (Corona et al., 2015;
Grogan, Hsu, & Skeletal Trauma Research, 2011b). In response to mild injuries like strains and
contusions, in which the myocytes are damaged but the underlying muscle structure and satellite
cell population is preserved, muscle has a strong capacity for regeneration (M. Hill et al., 2003;
Mauro, 1961). Muscle regeneration is characterized by progressive and coordinated
inflammation, repair, and remodeling phases (Charge & Rudnicki, 2004b; Mann et al., 2011b;
Turner & Badylak, 2012b). During the first hours and days after injury, phagocytic neutrophils
and macrophages are recruited to the wound site to clear the injury of dead cells and necrotic
tissue during what is termed the inflammatory phase. Transition from the inflammatory phase to
the repair phase, is characterized by a shift in the phenotype of the macrophages from the
inflammatory M1 phenotype, responsible for the digestion of necrotic tissues and promotion of
satellite cell proliferation, to tissue remodeling M2 macrophages responsible for myoblast
proliferation, growth and differentiation (Tidball, 2005a; Tidball & Villalta, 2010). During the
repair phase, satellite cells proliferate and differentiate into myoblasts that fuse with other
myoblasts or with existing fibers to form new skeletal muscle (Turner & Badylak, 2012b). The
remodeling phase is a continuation of the repair phase where myofibers mature and start to
adhere to both native and newly remodeled extracellular matrix (ECM). In muscle, the
regenerative process peaks anywhere from 7 to 30+ days depending on the type and severity of
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the injury (Benoit & Belt, 1970; Nikolaou, Macdonald, Glisson, Seaber, & Garrett, 1987; Warren
et al., 2007).
Alternatively, when significant skeletal muscle volume is lost (trauma or surgical
resection) the regenerative cues provided by the underlying ECM and satellite cell pool is
missing, and regeneration is poor. Termed volumetric muscle loss (VML), the bulk loss of
muscle tissue (>20% by mass) overwhelms the capacity for regeneration, leading to the
formation of non-contractile scar tissue at the defect site and functional impairment for the
patient (Grogan et al., 2011b; Terada et al., 2001). The poor clinical outcome following VML
injury combined with a lack of effective treatment options motivates our exploration of VML
regeneration. To better understand the sequence of events that follow VML injury and aid in the
development of effective treatment strategies, various pre-clinical animal models have been
developed (X. K. Chen & Walters, 2013; Hou, Gong, & Zhu, 2016; Turner et al., 2012; Wu,
Corona, Chen, & Walters, 2012b; J. Zhang et al., 2016). Among these, the hind limb muscles of
the rat are a reliable pre-clinical model that recapitulates healing with non-contractile scar tissue
observed in humans following VML injury (Wu et al., 2012b). In particular, the rat hind limb has
become a standard model for military research (Aurora et al., 2014; Aurora et al., 2015; Corona,
Garg, et al., 2013; Corona, Ward, Baker, Walters, & Christ, 2014a). This group of investigators
is seeking treatments for VML injuries caused by devastating battlefield trauma. With the active
military population in mind, the response to VML injury has typically been explored in young
(<50% of the median lifespan = 24 months) rat models. However, in addition to traumatic
injuries, the surgical removal of muscle as a treatment for soft tissue sarcoma is another
anticipated target for VML repair strategies (Fischer et al., 2015). This group of patients is
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typically older, and therefore an improved understanding of the response to VML injury in aged
muscle may provide unique insights that could guide future treatment strategies.
With increasing age, both animals and humans develop pathological changes to muscle
tissue which includes decreased muscle volume and increased adipose infiltration which reduces
muscle strength and can increase the risk of injury (Freemont & Hoyland, 2007). These agedassociated changes in muscle physiology can act as obstacles to muscle regeneration (Grounds,
1998a). We suspect that age related changes in muscle physiology might significantly influence
the response to VML injury. It is well established that muscle resident satellite cells account for
the majority of skeletal muscle’s regenerative capacity following injury (Conboy & Rando,
2005). However, aging leads to an overall decrease in myogenic capacity mostly in part due to
reduced satellite cell activity (Brack & Rando, 2007b; Conboy & Rando, 2005; Snow, 1977).
Specifically, it appears there is an age-related loss in satellite cell functionality, possibly
indicating that the “aging” of the satellite cells renders them less responsive to regenerative cues
(Brack & Rando, 2007a; Charge & Rudnicki, 2004b; Gopinath & Rando, 2008b). In addition, a
decreased responsiveness to the stimuli needed to induce activation and proliferation of satellite
cells has been observed with aging (Brack et al., 2007a; Gopinath & Rando, 2008b; Kuang et al.,
2008; Vinciguerra, Musaro, & and Rosenthal, 2010). When taken as a whole, the literature
supports the conclusion that aging diminishes the regenerative capacity of muscle.
While aging associated changes in muscle regeneration are known to exist, the effects of
aging on VML recovery has yet to be explored to our knowledge. With that gap in mind, an
aged animal model of VML injury was developed to investigate and compare the regenerative
response following VML injury of the hind limb tibialis anterior (TA) muscle. Two populations
of Fisher 344 rats aged 3 months and 18 months were used in this study. These ages are
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representative of adolescent (25% of mean lifespan) and early elderly (75% of mean lifespan) rat
lifespans. In order to assess the response to injury; muscle strength, mass, histology, and gene
expression profiles were measured for both aged and young animals three-months post VML
injury, a commonly explored VML recovery time point (Aurora et al., 2015; Corona, Garg, et al.,
2013; Corona et al., 2014b; Merritt, Cannon, et al., 2010b; Wu et al., 2012b). Overall, the study
was designed to compare the response between the two age groups and test the hypothesis that
aged animals recover differently from VML injury when compared to young animals as might be
evidenced by differences in myogenesis, contractile force, muscle atrophy, and tissue fibrosis.
Somewhat similar to VML in terms of functional outcomes, crush injuries result in similar
functional deficits in the muscle or in severe cases, complete amputation of the limb due to
inflammation, tissue swelling and necrosis, a condition known as acute compartment syndrome
(ACS) (Via, Oliva, Spoliti, & Maffulli, 2015). Although this may seem a worthwhile issue to
address, the effects of surgical VML don’t lead to other myopathies and conditions as ACS does.
Additionally, due to high mortality rates associated with ACS (Schwartz et al., 1989), it would
not be guaranteed that all animals used in the study would survive to the end of the study.
The results generated by this study not only provide some of the first insights into
recovery from VML injury in aged muscle, but also provide baseline recovery measures from
which to compare future VML injury strategies targeting aged patients.

86

B. Methods
Volumetric Muscle Loss Injury
In vivo VML injury studies were performed with young (3 month) and aged (18 months)
male Fisher 3 44 rats. All contralateral limbs to the VML injured limb served as internal controls
for comparison and are denoted as the normal groups in the study. The young rats (n=12) were
purchased commercially from Harlan Laboratories (Indianapolis, IN) and the aged rats (n=8)
were obtained through the National Institute on Aging (Bethesda, MD). Surgical procedures and
implant preparation methods were performed in accordance with protocols approved by the
University of Arkansas IACUC (Protocol #14044) and guided by published methods (Wu et al.,
2012b). Anesthesia was induced using isoflurane (1-3%) in oxygen. The implant site was
surgically exposed through a 1-2 cm incision running parallel to the tibia. The TA was identified
and a partial thickness VML defect (8mm diameter x 3mm deep) was created using a sterile
biopsy punch (Figure 1). Data that was previously collected correlated animal body weight to
TA mass for each animal group (Figure 2). From this relationship, the percentage of total TA
mass excised during surgery was calculated for each animal, to help insure consistent defect
creation across all animals. The average size of the VML defect was 18.7±0.6% and 19.5±0.6%
for the young and aged animal groups respectively (Corona et al., 2014a). The difference in
defect size between groups was not statistically significant (p=0.36). The contralateral limb was
left untreated to serve as an internal comparative control. The deeper periosteum and surface skin
layers were separately closed using an interrupted stich with a 5-0 absorbable suture (Vicryl,
Ethicon, Summerville, MA). Postoperative analgesia consisted of 0.1mg/kg buprenorphine
administered subcutaneously via injection (neck scruff) twice daily for two days. Animals also
received anti-inflammatory medication (Carprophan) via a dietary gel cup (Medigel CPF,
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ClearH2O, Westbrook, ME) added as needed to each cage out to 7 days. Following surgery,
animals were housed in standard-sized rat cages with unrestricted movement. The animals were
allowed to bear weight on the operative extremity as tolerated. All animals were housed for a 12week recovery period.

In-situ Contractile Force Measurement
Peak tetanic contraction produced by the TA muscle of both young (n=12) and aged (n=8)
rats were measured isometrically in vivo using similar procedures previously described18. After
rats were anesthetized (2-2.5% isoflurane), the left hindlimb was prepared for measurement. To
eliminate force contributions from the synergist muscle, distal tenotomies were performed on the
extensor digitorum longus (EDL) and extensor halluces longus (EHL). The knee was stabilized
in place using a custom mounting system and the knee and ankle were positioned at a right angle.
The foot was attached to a foot-plate with surgical tape, which was attached to the shaft of a
servomotor (Aurora Scientific, Inc., Mod. 305b) and was in turn controlled by a computer.
Percutaneous needle electrodes were inserted into the anterior compartment of the TA to
stimulate the peroneal nerve. Optimal voltage (2 – 5 V) was determined using a series of tetanic
contractions (150Hz, 0.1 ms pulse width, 400 ms train). Average peak tetanic force for each
animal was calculated from the average of 5 contractions. To minimize muscle fatigue, 1-minute
rest periods were taken between contraction cycles. Commercial muscle physiology software
(Aurora Scientific, Inc., Ontario, Canada) was used to collect contractile force versus time data.
At the conclusion of electrophysiological testing, all animals were euthanized through carbon
dioxide inhalation in accordance with guidelines provided by the 2013 AVMA Panel on
Euthanasia of Animals.
88

Tissue Histology and Image Analysis
VML treated TA muscles along with contralateral untreated TA muscles were harvested
from young (n=12) and aged (n=8) and trimmed to remove fascia and tendon, then weighed.
EDL muscles were also collected and weighed for comparison between groups. Muscles were
rinsed in sterile PBS, dabbed dry, and then weighed. Harvested muscles were flash frozen in
liquid nitrogen, and stored at -80°C for histological analysis. Tissue cross-sections were obtained
with the aid of a cryostat (Leica BioSystems) and maintained at a temperature between -25 to 20°C and thickness of 7 µm. Cross-sectional slices were taken from the top third of the TA
muscle, the region where the surgical VML injury was created. Prior to immunostaining, slides
were permeabilized in 0.1% 10X Triton then rinsed in phosphate-buffered solution (PBS, pH
7.4). Slides were then blocked in PBS containing 4% goat serum and 0.05% sodium azide for 1h
at room temperature prior to incubation in primary antibodies including mouse-anti-collagen I
IgG (1:500, Sigma Aldrich), rabbit polyclonal anti-collagen III (1:1000, Abcam), and mouseanti-myosin IgG2B (MF-20, 1:10, Developmental Studies Hybridoma Bank, Iowa City, IA) for 4h
at 4°C. Following PBS washes, slides were incubated in the appropriate corresponding Alexa
Fluor 488 and 596 (1:500, Life Technologies) labeled secondary antibodies for 30 minutes at
room temperature. Additional tissue sections were stained using commercially available
Hematoxylin and Eosin (H&E) and Masson’s Trichrome staining kits following manufacturers’
guidelines (Sigma). All sections were mounted onto microscope slides and digitally imaged.
Treated sections were evaluated for myofiber average cross-sectional area, formation, and
organization as well as the formation and extent of VML site repair tissue for comparison to
normal contralateral muscle tissue sections.
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Collagen type I and III accumulation, a potential indicator of diffuse muscle fibrosis, in
tissue regions away from the VML defect area was estimated using measures of collagen I
(Sigma Aldrich, St. Louis, MO) and collagen III (Abcam, Cambridge, MA) immunoreactivity
and guided by published methods (Bedair et al., 2007). Tissue immunoreactivity to collagen I
was calculated from fluorescent microscopic images (200X) using image analysis software
(Image J, NIH). All images were converted to 8-bit, gray scale, and uniformly thresholded across
all samples to isolate collagen type I and III positive tissue regions. From these images the
percent collagen type I and III positive tissue area was calculated for all tissue sections. Similar
image analysis methods were used to compute muscle fiber cross-sectional area from magnified
(200X) images. Images were converted to gray scale and thresholded to isolate individual muscle
fibers. Fiber cross sectional area (um2) for all fibers within an individual image (typically 50+
fibers) were calculated. Representative tissue sections collected from four animals per group
were used for all calculations. Within each section, three separate regions were imaged and
analyzed to calculate the average collagen type I and III percent area as well as average fiber
cross-sectional area for each sample. A total of twelve images were analyzed for each treatment
group. All image analysis was performed using a protocol with set parameters to process each
image under the same conditions as well as eliminating any user bias.
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Gene Expression
Real-time PCR was performed using the protocol reported by Washington et al
(Washington et al., 2013). In preparation for RT-PCR, samples of muscle from the defect site of
the right and left TA (n=4 animals/experimental group) were homogenized with Trizol (Ambion,
Carlsbad, CA)/choloroform (Sigma Aldrich, St. Louis, MO). Samples were treated with DNase
(Invitrogen, Carlsbad, CA) and then RNA was extracted using an RNAeasy kit (Invitrogen,
Carlsbad, CA). After quantification of RNA with a plate reader (BioTek, Winooski, VT), RNA
was converted to cDNA with a kit (Invitrogen, Carlsbad, CA). TAQMAN primers (Invitrogen,
Carlsbad, CA) for MyoD, Collagen I, Collagen III, ratios of Collagen I to MyoD and Collaen I to
Collagen III, and 18S rRNA housekeeping were used to quantify the expression of desired genes.
Experimental sample group expressions were normalized to 18S rRNA and then referenced to
the contralateral normal limb. Gene expression levels are reported as fold change using the 2(ΔΔCt)

method.

Data Analysis
All data is presented as the mean ± standard error and was tested for normality using the
Shapiro-Wilks Test. In addition, the data is also presented as mean ± standard deviation for
reference in Table 1. The key outcome measures, muscle mass, peak tetanic force, percent
collagen I / III areas, fiber cross-sectional area, and gene expression fold changes were analyzed
with two-way ANOVA. Post hoc comparison testing was performed using Tukey’s HSD test.
All statistical analyses were performed using commercial statistical analysis software (JMP 11
Pro). Animal growth and defect size comparisons were made using a two-sided Students t-test. A
standard p<0.05 level of significance was used for all statistical tests.
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C. Results
Animal Body Weight
Both aged and young animals tolerated the surgery well and there were no signs of postsurgical infection. At one week post-implantation, all animals were fully ambulatory with no
noticeable gait differences between groups. At the end of the study period, the young animals
increased in mass by an average of 36% (312±3 vs. 424±7 g, p<0.0001) whereas the aged
animals showed no significant change in body weight (Figure 3). Also, by the end of the 12week study period the difference in average mass between the aged and young groups had
narrowed to 3%. The difference in mass between young and aged animals at the end of the study
period was not statistically significant (p=0.38). Over the study period, the young animals put on
mass at a growth rate of 9.3±0.4 g/week while the aged animals lost mass at a negative growth
rate of 2.3±0.9 g/week. Age (young vs. old) was shown to have a statistically significant effect
on animal growth rate (p<0.05).

TA Peak Tetanic Contractile Force
Tetanic contraction plots for all muscles were characterized by a sharp rise in force,
followed by a plateau at the peak force, and then a return to a no force resting state (Figure 4).
There was a main effect of treatment with VML injury to decrease peak contractile force,
regardless of age (p<0.0001). Based on age, peak contractile force showed a decreasing trend
moving from the young to the aged group (p=0.08). The young and aged VML groups produced
65% (2.16±0.07 N/kg vs. 1.39±0.11 N/kg, p<0.0001) and 59% (2.02±0.05 N/kg vs 1.19±0.12
N/kg, p<0.0001) of their respective contralateral normal muscles in response to VML injury
(Figure 4A).
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TA and EDL Muscle Mass
Upon gross examination the defect site was visible on TA muscle samples collected from
both young and aged VML treated animals. Morphologically, there is a drastic difference in
overall muscle appearance and size following VML injury (Figure 5). EDL muscles were not
surgically disrupted during the TA VML defect treatment. Superficially, the EDL muscles
associated with both the normal and VML treated TA muscles appeared normal, with the VML
side EDL appearing slightly larger in size than the normal EDL. However, treated muscles were
noticeably larger in size. There was a main effect of age and treatment to decrease TA muscle
mass normalized to body weight, but no interaction effect was observed (p<0.0001, p<0.0001,
Figure 5). Based on age, the young normal group compared to the aged normal group exhibited
a 16% increase in normalized TA weight (1.61±0.04 mg/g vs. 1.37±0.05 mg/g, p<0.0001). A
similar response to age was exhibited by the young VML group compared to the aged VML
group with a 25% increase in normalized TA weight (1.27±0.02 mg/g vs. 0.99±0.02 mg/g,
p<0.0001). In response to treatment within the young group, young normal TA mass was on
average 24% heavier than young VML TA muscle (1.61±0.04 mg/g vs. 1.27±0.04 mg/g,
p<0.0001, Figure 5). Similarly, within the aged group, aged normal TA mass on average was
32% heavier than aged VML TA muscle (1.37±0.05 mg/g vs 0.99±0.02 mg/g, p<0.0001, Figure
5).
Interestingly for the normalized EDL weights, the main effect of age decreased EDL
mass whereas treatment was found to have an effect to increase EDL mass (p<0.0001 and
p<0.008, respectively). However, an interaction effect was not observed. Based on age, the aged
normal group compared to the young normal group exhibited a 25% decrease in normalized EDL
weight (0.4±0.01 mg/g vs. 0.31±0.02 mg/g, p<0.0001, Figure 5). Similarly, the aged VML group
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compared to the young VML group exhibited a 20% decrease in normalized EDL weight
(0.43±0.01 mg/g vs. 0.35±0.02 mg/g, p<0.0001). Within the young group, there was an increase
of 7% in EDL mass in response to VML injury (0.4±0.01 mg/g vs. 0.43±0.01 mg/g, p<0.008).
Similarly, within the aged group in response to VML injury, there was an increase of 12% in
EDL weight (0.31±0.02 mg/g vs. 0.35±0.02 mg/g, p<0.008).

VML Site Histology
Normal TA muscle histology for both young and aged groups (Figure 6A/B, E/F) was
characterized by ordered circular bundles of MHC positive myofibers surrounded by collagen
positive perimysium extending completely out to the anterior surface of the muscle. Twelveweeks following VML injury, tissue sections prepared from young animals were characterized
by collagen-dense repair layer located at the muscle surface. For the young VML muscles, MHC
positive muscle fibers were observed up to the border of the repair layer, but did not extend into
the repair tissue itself (Figure 6C,D). A similar distinct layer of collagen enriched repair tissue
was not typically observed within the aged animal groups. Aged animal sections prepared from
VML site tissue samples were frequently characterized by a region of diffuse collagen I
deposition, as well as an overall appearance indicating increased MHC positive myofibers
disorganization in the repair region (Figure 6G,H). While MHC positive muscle fibers were
present they were generally less closely packed than in normal TA muscle sections.

Collagen Percent Area and Fiber Cross-sectional Area
Percent area positively stained for collagen I and III provided a quantitative measure of
collagen content in the TA muscle regions outside the defect area (Figure 7A,B). There were no
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changes in percent area stained for collagen I between young normal and VML muscles
(7.6±1.6% vs. 8.3±1.0%, Figure 7C). Similarly, aged normal and VML treated muscles showed
no changes in percent collagen I area (6.0±1.3% vs. 8.3±0.9%).
There was a main effect of VML injury to decrease collagen III percent area in the young
group and increase in the aged group (p=0.011, Figure 7D). Collagen III area decreased by 13%
(19.2%±0.2% and 16.8%±1.6%) for the young normal group compared to the young VML
group. Collagen III percent area increased by 10% (20.8%±1.6% and 23%±3.0%) in the aged
VML group compared to the aged normal group.
Similarly, age had a significant effect to decrease average TA fiber cross-sectional area
(p=0.0365, Figure 8C). Average cross-sectional area decreased by 17% (2299±154 µm2 and
1926±122 µm2) for the aged normal group compared to the young normal group. For the aged
VML group compared to the young VML group, fiber cross-sectional area decreased by 28%
(2123±100 µm2 and 1585±318 µm2).

Gene Expression
There was a main effect of VML injury to decrease MyoD gene expression regardless of
age in rat TA muscle (p=0.0231, Figure 9A). There was approximately a 13-fold decrease
(1±0.58 and 0.08±0.04) in MyoD expression for the young VML group compared to the young
normal group (Figure 9A). Comparing the aged VML group to the aged normal group, there
was a 10-fold decrease in MyoD expression (1±0.21 vs. 0.1±0.03). For collagen I an interaction
effect of age and VML injury was found to increase collagen I expression (p<0.003, Figure 9B).
There were no differences found in collagen I expression within the young group, however,
between the aged normal (1±0.33) and aged VML group (14±4), a 14-fold increase in collagen I
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expression was found (p<0.0009) exhibiting a treatment effect. Between the young VML
(1.55±0.14) and aged VML (14±4) groups, a 9-fold increase in collagen I expression in the aged
VML group compared to the young VML group was observed (p<0.0014, Figure 9B).
Regarding collagen III gene expression, there was an interaction effect of age and VML injury
on expression levels (p=0.0164, Figure 9C). Post-hoc comparison revealed that the young VML
group responded with a 2-fold increase in collagen III expression over the young normal group
to VML injury (1±0.14 vs. 2.14±0.25, p=0.034). While not exhibiting significance for VML
injury within the aged group, the aged VML group exhibited a significantly lower response
compared to the young VML group with a 3.5-fold decrease in collagen III expression
(2.14±0.25 vs. 0.61±0. 26, p=0.013, Figure 9C).
There was an interaction effect of age and treatment on the ratio of collagen I to MyoD
(p<0.011). Post-hoc comparison revealed that the aged VML group responded with a 77-fold
increase in the collagen I to MyoD ratio over the aged normal group to VML injury (0.95±0.25
vs 74.5±18.8, p<0.0002, Figure 9D). While not exhibiting significant differences for VML
injury, the young group did exhibit significantly lower ratios of collagen I to MyoD compared to
the aged VML group. Compared to the young VML group, the aged VML group exhibited a 2fold increase in collagen I to MyoD ratio over the young VML group exhibiting an age effect
(32.9±10.5 vs. 74.5±18.8, p=0.0241, Figure 9D).
Similarly, there was an interaction effect of age and VML injury on the ratio of collagen I
to collagen III gene expression. Post-hoc comparison revealed that the aged VML group
responded with an 8-fold increase in the collagen I to collagen III ratio over the aged normal
group to VML injury (3.33±2.18 vs 27.8±5.21, p<0.0001, Figure 9E). While not exhibiting
significant differences for VML injury, the young group did exhibit significantly lower ratios of
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collagen I to collagen III compared to the aged VML group. Compared to the young VML group,
the aged VML group exhibited a 38-fold increase in collagen I to collagen III ratio over the
young VML group exhibiting an age effect (0.736±0.044 vs. 27.8±5.2, p<0.0001, Figure 9D).

D. Discussion
Extracellular matrix (ECM) remodeling is a critical aspect of successful resolution of the
regenerative response in skeletal muscle. Skeletal muscle has a robust capacity to recover from
injury in which there is not a significant loss of muscle mass. However, when there is traumatic
muscle injury and more than 20% of the muscle is lost (VML), the regenerative process will not
resolve and there will be a functional deficit (Corona et al., 2015; Garg, Corona, & Walters,
2014; Grasman, Zayas, Page, & Pins, 2015; Grogan et al., 2011b). Indicative of such injuries, it
is expected for there to be nerve damage or even complete denervation of the muscle.
Interestingly, even with temporary denervation of the muscle, it has been reported that muscle
virtually recovers completely given that reinnervation is allowed to proceed unhindered (Lowrie,
Krishnan, & Vrbova, 1982). However, even if innervation is preserved, unless there is
transmission from the nerve to the muscle, degenerative changes have been observed in the
muscle (Drachman, 1974; Gordon, Perry, Tuffery, & Vrbova, 1974). Though VML itself has
been investigated, the response to VML in the aged population has yet to be explored. To our
knowledge this is the first study to investigate how aging modulates the response to VML. The
current study reports that aging muscle modifies the ECM response post-VML. The current
study reports that the ECM response post-VML is modified in muscle from aged rats. It is of
vital importance to understand how aged muscle response to VML so effective tissue
engineering treatment strategies can be developed for this population to aid in skeletal muscle
regeneration.
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Sarcopenia is associated with decreased muscle mass and force deficits (Blough &
Linderman, 2000; Carson, Lee, McClung, & Hand, 2002; Washington, Healey, Thompson,
Lowe, & Carson, 2014). Our data is consistent with the literature in that we demonstrate an ageddependent decrease in muscle mass in both the TA and the EDL. Additionally we demonstrate a
trend for an age-dependent decrease in peak tetanic force. VML is associated with incomplete
skeletal muscle regeneration. We are the first to demonstrate how aging affects skeletal muscle
post-VML. 3 months post-VML skeletal muscle mass had only returned to 75% of the
contralateral control limb regardless of age. Additionally, muscle force only returned to
approximately 60% of the contralateral control limb 3 months post-VML in young and aged rats.
Taken together, the similar muscle mass loss and force deficit between young and aged rats,
suggests age does not exacerbate the post-VML functional response.
Skeletal muscle regeneration is a complex process that is characterized by inflammation,
ECM remodeling, and myofiber growth (L. A. Brown et al., 2015; Washington et al., 2011).
Impairments to any one of these processes can lead to incomplete skeletal muscle regeneration
(Washington et al., 2011). The ECM plays an important role during skeletal muscle regeneration
and acts as a functional link between skeletal muscle and bone. In skeletal muscle, the ECM is
composed primarily of collagen I and collagen III (Kovanen, 2002). Previous research has
demonstrated that 28 days post-VML there is a larger induction of collagen III compared to
collagen I gene expression in young rats (Garg, Corona, et al., 2014). Our data is in agreement
with this observation. We demonstrate an increase in collagen III gene expression with no
change in collagen I gene expression 3 months post-VML. However, muscle from aged rats had
a different response to VML. In muscle from aged rats, there was an increase in collagen I gene
expression with no change in collagen III gene expression 3 months post-VML. The increased
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expression of collagen I gene expression may contribute to the impaired regenerative response
associated with aged muscle. The mdx mouse is a model for Duchenne muscular dystrophy
(DMD). DMD is a degenerative muscular disease associated with accumulation of ECM material
(Fadic, 2005). It has been demonstrated that collagen I is elevated during the lifespan in this
animal (McDonald, Hebert, Kunz, Ralles, & McLoon, 2015). Collagen I inhibits muscular
regeneration and supports the production of more collagen (Alexakis, Partridge, & Bou-Gharios,
2007). It has been demonstrated that type I collagen inhibits differentiation of C2C12 myoblasts
(Alexakis et al., 2007). Differentiation of C2C12 myoblasts and myotubes is associated with a
reduction in transcription of collagen I mRNA (Alexakis et al., 2007). The increased collagen I
gene expression in aged muscle post-VML could negatively affect the ability of myoblasts to
proliferate and differentiate and contribute to regeneration of aged skeletal muscle.
There was a difference in gene expression and protein expression, as determined by
immunofluorescence, of collagen I and III post-VML. The collagen constitutive rate of synthesis
is very low due to the long half-life (45-70 days) (Rucklidge, Milne, McGaw, Milne, & Robins,
1992). Therefore, changes in gene expression are a more accurate representation of the acute
effects of VML. Collagen I and collagen III are produced from 1-2 different genes and coalesce
into a triple-helix pro-collagen molecule. Further processing is done leading to the mature
collagen molecule. Collagen is degraded by a family of enzymes referred to as matrix
metalloproteinases (MMPs). There is evidence that muscle MMP expression differs as a function
of age (Dennis et al., 2008; Robert et al., 1997; Sharples et al., 2012). Therefore, several factors
can regulate collagen expression post-transcriptionally and explain the discrepancy between gene
expression and protein expression.
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In order to employ quantitative measures to assess myogenic capability and fibrosis, we
calculated two ratios: the ratios of collagen I to MyoD and collagen I to collagen III expression.
Due to MyoD’s role in regulating muscle differentiation and myogenesis, exploring the
proportion of a pro-regenerative marker to a fibrotic marker such as collagen I can assist in
assessing the degree of regeneration. Satellite cells/myoblasts are critical to optimal skeletal
muscle regeneration. Upon activation satellite cells proliferate and differentiate into myoblasts
and begin expressing myoD (Hawke & Garry, 2001). In aged animals, satellite cell number as
well as activation and proliferation are depressed (Barani, Durieux, Sabido, & Freyssenet, 2003;
Kadi, Charifi, Denis, & Lexell, 2004). This would reduce the inherent regenerative capacity of
aged skeletal muscle. VML was associated with an increase in the Collagen I to MyoD ratio
regardless of age. However, there was a much larger increase in this ratio in the aged VML
group. The increase is suggestive of a switch from myogenesis to fibrosis. There are numerous
studies that demonstrate increased collagen deposition and fibrosis following VML with limited
skeletal muscle regeneration (Corona et al., 2014a; Corona, Wu, et al., 2013; VanDusen,
Syverud, Williams, Lee, & Larkin, 2014). In addition, increased intermuscular adipose tissue
(IMAT) has been found to be related to decreased whole body glucose metabolism, particularly
in individuals who have experienced an injury resulting in loss of muscle function (Addison,
Marcus, Lastayo, & Ryan, 2014). However, the larger induction in the aged group suggests a
more of an accelerated and more robust fibrotic response.
The ratio of collagen I to collagen III gene expression can provide insight in post-VML
ECM composition changes. As skeletal muscle regeneration involves the migration of satellite
cells and inflammatory cells through the ECM to the site of injury, the composition of the ECM
is critical for an efficient regenerative response (Keely & Nain, 2015). Garg et. al. demonstrated
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an impaired ability of satellite cells to migrate into the VML site (Aurora et al., 2014). Collagen I
is a triple helix that polymerizes into fibrils that are stabilized by covalent cross-links
contributing to its high tensile strength. Collagen III forms a looser network and is ideal for
maintaining structural integrity and distensibility of the collagen network. Higher ratios of
collagen I to collagen III is indicative of a stiffer scar region due to the mechanical properties of
collagen I whereas a lower ratio could mean greater flexibility and a greater tensility during
recovery leading to a more well-defined tissue reformation. 3 months post-VML, muscle from
aged rats had an increased collagen I to collagen III ratio whereas in young rats there was no
difference. This increased ratio has been demonstrated in skin from aged individuals (Goldspink,
Fernandes, Williams, & Wells, 1994). Due to the long half-life of collagen molecules (45-70
days) this sustained response 3 months post-VML could lead to an altered collagen I and
collagen III protein expression at a later time point. This would suggest an altered ECM
composition that could ultimately affect the regenerative capacity of skeletal muscle. Aged tissue
is associated with accumulation of advanced glycation end products (AGEs) and their receptors
(RAGEs) (Odetti et al., 1998). AGEs have been demonstrated to induce expression of collagen I
and inhibit collagen III expression (Tang et al., 2008). AGEs and RAGE signaling have been
implicated in chronic inflammation which is a characteristic associated with aging (Chuah, Basir,
Talib, Tie, & Nordin, 2013; Goto et al., 2004; Kislinger et al., 2001). Taken together, AGEs and
chronic inflammation could alter the muscle microenvironment and contribute to the altered
collagen III to collagen I ratio observed post-VML in aging skeletal muscle. As the functional
outcome was similar between young and aged rats, the altered ECM response has implications
for treatment strategies. This data implies treatment strategies in a young animal may not be
effective in an older animal possibly due to the altered ECM composition post-VML.
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E. Conclusion
In summary, this study is the first to describe the response to VML in muscle from aged
rats. By characterizing and understanding the responses to VML by both young and aged muscle,
various VML injury strategies can target areas that have a direct impact on myogenesis. With the
age range of the young and aged rats being equivalent to the human age range of 9-18 years old
and 54-63 years old, our aged model is effective in discriminating young vs aged responses to
VML (Andreollo, Santos, Araujo, & Lopes, 2012). We clearly demonstrate an altered response
to VML between young and aged rats. The aged rats had a much different ECM response as
compared to the young rats. This would suggest that tissue engineering strategies aimed at
treating VML should account for the age of the host.
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Figure Legends

Figure 1. Surgical VMLs are gross defect creations in the left TA muscle of the rat. Surgical site
was cleaned and disinfected prior to a vertical incision that was made to expose underlying
muscle (A). An 8mm biopsy punch was used to create a defect to a depth of 2mm and the
amount of muscle removed is approximately equivalent to 20% of the TA weight (B). Surgical
defects were created in the rat left hindlimb and the contralateral limbs were untouched, serving
as internal controls. The surgical site was then sutured with 5-0 absorbable sutures (C).

Figure 2. Correlation of animal weight and TA weight. (A) Aged animal (n=8) terminal weight
vs TA weight. (B) Young animal (n=12) terminal weight vs TA weight. Linear regression
analysis performed for all cases provided information to approximate TA weight given animal
weight. From the TA weight, the size of the defect (20% of TA weight) can be determined.

Figure 3. Young and aged Fisher 344 rat weight (g) prior to surgery and at the end of the study
period. The younger animals experienced significant weight gain post-surgery, whereas the aged
animals lost weight. Values are mean+SEM. * represents p<0.05 Student’s t-test for the young
group.

Figure 4. Peak tetanic force measurements of Young and Aged rats via electrophysiology. (A)
Percutaneous needle electrodes were placed in the anterior compartment of the TA to stimulate
the peroneal nerve. The knee was stabilized and the foot was attached to a muscle lever system
for isometric measurements. (B) In order to account for normal growth over the 3-month period
post-surgery, contractile force measurements were normalized to body weight (N/kg). The
contralateral normal limbs for both age groups yielded similar values as well as showing a
similar decrease in force production after VML injury. Values are mean+SEM. * represents
p<0.05 two-way ANOVA for normal vs VML injury.

Figure 5. Comparison of TA and EDL muscle weight between normal and VML injury groups
between Young (n=12) and Aged (n=8) rats. Gross morphological images of young normal (A),
young VML (B), aged normal (C), and aged VML (D) TA muscles. At the end of the 3 month
study period, terminal weights for TA (E) and EDL (F) of both young and aged normal and VML
groups were measured. Values are mean+SEM. # represents p<0.05 two-way ANOVA for
young vs aged. * represents p<0.05 two-way ANOVA for normal vs VML injury.

Figure 6. Comparison of histological cross-sections of young normal (A, B) and VML (C, D),
aged normal (E, F) and VML (G, H) TA muscles. The inset depicting the TA shows from where
the histological cross-sections were taken. Masson’s trichrome stained sections imaged at 100X
magnification (A, C, E, G) depict collagen in blue/purple colored regions whereas muscle is
shown in red/pink. Sections stained for collagen I (green) and myosin heavy chain (MHC, red)
111

at 100X magnification (B, D, F, H). * indicates the collagen I rich scar region in the young
muscles treated with VML (D). ** indicates the VML region for the aged group which is
characterized by diffuse collagen I deposition and disorganized myofiber bundles compared to
the young VML group (H). Masson’s trichrome was stained using a commercially available kit.
Primary antibodies used were anti-collagen I mouse IgG (1:500) and anti-myosin mouse IgG2B
(1:10). Secondary antibodies used were goat anti-mouse IgG (H+L) Alexa Fluor 488 and goat
anti-mouse IgG2B Alexa Fluor 594.

Figure 7. Representative TA cross-sections immunostained for Collagen I (A, green) and
Collagen III (B, red). Stained images were then analyzed in ImageJ software to calculate % area
of the stains as a function of cross-sectional area. No difference was found for collagen I area
(C) but a decrease in collagen III area was found for the young group after VML injury (D). On
the contrary, the aged group had an increase in collagen III following VML. Primary antibody
stains used were anti-collagen I mouse IgG (1:500) and anti-collagen III rabbit polyclonal
(1:500). Secondary antibody stains used were goat anti-mouse IgG (H+L) Alexa Fluor 488 and
goat anti-rabbit IgG (H+L) Alexa Fluor 594. * represents p<0.05 two-way ANOVA for normal
vs VML injury.

Figure 8. Rat TA muscle cross-sections of young (A) and aged (B) rats stained with H&E and
imaged at 200X magnification. Average fiber cross-sectional areas were calculated using ImageJ
software for young normal, young VML, aged normal, and aged VML groups (n=3, C). It was
observed that fiber cross-sectional area decreases significantly with age, regardless of VML
injury. # represents p<0.05 two-way ANOVA for young vs aged.

Figure 9. Normal gene expression compared to expression in response to VML. Expression of
MyoD (A), Collagen I (B), Collagen III (C), ratio of Collagen I to MyoD (D), and ratio of
Collagen I to Collagen III (E) are presented as fold-changes obtained using RT-PCR. Except for
MyoD, which experienced only a treatment effect, interaction effects of age and treatment were
found for all other genes/ratios tested. Values are mean+SEM. * represents p<0.05 two-way
ANOVA for normal vs VML injury and # represents p<0.05 two-way ANOVA for young vs
aged. Post-hoc analysis was performed upon finding significant interaction effects.
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Abstract
In this study, the influence of age on effectiveness of regenerative repair for the treatment of
volumetric muscle loss (VML) injury was explored. Tibialis anterior (TA) VML injuries were
repaired in both 3-month and 18-month aged animal models (Fischer 344 rat) using allogeneic
decellularized skeletal muscle (DSM) scaffolds supplemented with autologous minced muscle
paste (MM). Within the 3-month animal group, TA peak contractile force was significantly
improved (79% of normal) in response to DSM+MM repair. However, within the 18-month
animal group, muscle force following repair (57% of normal) was not significantly different
from unrepaired VML controls (59% of normal). Within the 3-month animal group, repair with
DSM+MM generally reduced scarring at the site of VML repair, whereas scarring and a loss of
contractile tissue was notable at the site of repair within the 18-month group. Within 3-month
animals, expression of myogenic genes (MyoD, MyoG), ECM genes (Col I, Col III, TGF-ß), and
key wound healing genes (TNF-α and IL-1ß) were increased. Alternatively, expression was
unchanged across all genes examined within the 18-month animal group. The findings suggest
that a decline in regenerative capacity and increased fibrosis with age may present an obstacle to
regenerative medicine strategies targeting VML injury.
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Impact Statement
This study compared the recovery following VML injury repair using a combination of minced
muscle paste and decellularized muscle ECM carrier in both a younger (3 months) and older (18
months) rat population. Currently, VML repair research is being conducted with the young
patient population in mind but our group is the first to look at the effects of age on the efficacy of
VML repair. Our findings highlight the importance of considering age-related changes in
response to VML when developing repair strategies targeting an elderly patient population.
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A. Introduction
Volumetric muscle loss (VML) injury is commonly characterized as the bulk loss (>20%)
of muscle tissue resulting in incomplete or aberrant muscle regeneration. Current soft tissue
repair techniques and traditional rehabilitation have not been able to reverse the pathological
changes that occur following VML injury. To reverse the pathobiology of VML injury, the use
of regenerative medicine strategies to recapitulate the cellular and structural cues during
regeneration have shown efficacy in animal models (Corona, Henderson, Ward, & Greising,
2017; Corona, Wu, et al., 2013; J. Dziki et al., 2016; Garg, Ward, et al., 2014; Goldman &
Corona, 2017; Goldman, Henderson, Walters, & Corona, 2018; Li, Willett, Uhrig, Guldberg, &
Warren, 2014; Nakayama et al., 2018). Among these strategies, our group has demonstrated that
the implantation of a decellularized skeletal muscle scaffold (DSM) co-delivered with a minced
muscle (MM) autograft paste is capable of recovering half of the contractile force lost to VML
injury (B. Kasukonis, J. Kim, L. Brown, et al., 2016).

Other groups have shown similar

improvements in muscle recovery using various combinations of scaffolds with and without
myogenic cell sources (Corona et al., 2012; Corona et al., 2014b; Dziki, Sicari, Wolf, Cramer, &
Badylak, 2016; Merritt, Cannon, et al., 2010a; Valentin et al., 2010). When taken as a whole, our
findings and others suggest that the use of regenerative medicine may have therapeutic potential
as a treatment for VML injury.
The examination of regenerative medicine strategies for VML repair has been limited
thus far to young animal models (Gilbert-Honick, Ginn, et al., 2018; Goldman et al., 2018;
Nakayama et al., 2018; Quarta et al., 2017). It remains unclear whether the VML findings
observed in these animal models will be predictive of clinical performance in the elderly. It is
reasonable to speculate that the age of the VML injured patient could influence the effectiveness
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of any VML treatment. Specifically, the decrease in myogenic capacity that occurs with age
could present a significant hurdle to muscle regeneration in an older patient population (Conboy
& Rando, 2005; Domingues-Faria, Vasson, Goncalves-Mendes, Boirie, & Walrand, 2016).
Traditionally, battlefield injuries to the extremities have been the primary clinical target
motivating the development of VML repair strategies (Mase et al., 2010; B. D. Owens et al.,
2008; J. G. Owens et al., 2011). Regarding civilian trauma, VML injuries are not as welldocumented or tracked due to the lack of a standard therapy (Corona, Wenke, & Ward, 2016).
Despite this fact, there are approximately 150,000 documented cases of open fractures (type III
open fracture) each year in the United States, with the majority of cases associated with the
concomitant loss of the surrounding soft tissues (Court-Brown & McBirnie, 1995). Moreover,
there is likely a high proportion of the VML-afflicted patient population (both civilian and
military) suffering from chronic pain and disability due to a lack of a standard of care for VML.
We suggest that an improved understanding of the relationship between age and VML treatment
performance would provide valuable insights that could help elucidate the appropriateness of
current VML repair strategies for a broader patient population.
As a first step towards reaching this level of understanding, our group has developed an
aged rat VML model and demonstrated that age impacts muscle healing following VML injury
(Kim et al., 2016). Specifically, our findings suggested that extracellular matrix (ECM) gene
expression and protein deposition is significantly altered following VML injury in an aged model
(18 months), resulting in a more fibrotic environment when compared to non-aged controls (3
months). While changes in muscle wound healing with age were identified and appeared
consistent with findings in humans (Parker et al., 2017), the study did not examine whether these
age-related differences in VML healing would in turn influence the response to regenerative
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repair. The purpose of this study was to examine whether the improved functional outcomes that
have been observed following VML repair in non-aged models are sensitive to aging.
Specifically, this study was designed to test the hypothesis that age will dampen the beneficial
effects of regenerative treatment. This study presents those performance results along with
comparisons to non-aged animal model findings.

B. Methods
DSM Scaffold Preparation
To prepare DSM samples for implantation, whole tibialis anterior (TA) muscle was
decellularized using a previously reported (B. M. Kasukonis et al., 2016) infusion system
(Figure 1). TA muscles were harvested from rats (Sprague Dawley) that had been euthanized at
the completion of an unrelated study. The TA samples were infused overnight (approximately 12
hours) with 1% SDS at a flow rate of 5mL/hr. Following infusion, samples were incubated
overnight in a DNAse solution (1kU/ml DNAse in 10mM Tris-HCL buffer; 2.5mM MgCL2 +
0.5mM CaCl2) and then incubated (8 hours) in a 1X penicillin/streptomycin solution to reduce
the risk of infection. Samples were rinsed thoroughly (a total of six 24-hour wash steps) in PBS
between each preparation step. Following completion of decellularization, the DNA
concentration of representative DSM implants (n=4) was measured with the aid of a commercial
quantification kit (Qubit, Fisher Scientific). DSM implants were lyophilized and stored at -20⁰C
until utilized for implantation.
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Volumetric Muscle Loss Injury and Minced Muscle
In vivo VML studies were performed using male Fischer 344 rats with ages of either 3
months (20% of the median lifespan) or 18 months (75% of their median lifespan). The 3-month
rats were purchased commercially from Envigo (Indianapolis, IN) and the 18-month rats were
obtained through the National Institute on Aging (Bethesda, MD). Surgical procedures and
implant preparation methods were performed in accordance with protocols approved by the
University of Arkansas IACUC (protocol #14044) and as described previously (B. Kasukonis, J.
Kim, L. Brown, et al., 2016). Briefly, VML defects (8mmx3mm) were created in the tibialis
anterior using a biopsy punch (Figure 2A,B). 25% of the removed defect plugs were retained for
use as MM autografts following hand mincing of the removed muscle (Figure 2C). DSM
scaffolds were fully coated in the minced muscle paste and then implanted into the VML defect
site (Figure 2D-F).

Animals were randomly assigned to one of two treatment groups

(n=8/treatment group): unrepaired VML defect (VML), or VML defect repaired with DSM
scaffold supplemented with MM (DSM+MM). All contralateral limbs were left untreated to
serve as comparative controls. All animals were housed for a 12-week recovery period.

In vivo Contractile Torque Measurement
Peak tetanic contractions produced by the TA muscle were measured isometrically in
vivo using procedures as previously described by Corona and familiar to our group (Corona,
Garg, et al., 2013; B. Kasukonis, J. Kim, L. Brown, et al., 2016; Kim et al., 2016). Briefly, the
lower limb of the animals were stabilized at 90º of knee flexion via a custom alignment jig. The
foot was secured to the lever arm of a dual-mode lever system (Aurora Scientific). Prior to nerve
stimulation, distal tenotomies of the extensor digitorum longus (EDL) and extensor hallucis
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longus (EHL) was performed to isolate the force contribution of the TA muscle. Percutaneous
needle electrodes were inserted into the anterior compartment of the tibialis anterior muscle and
the peroneal nerve was stimulated via physiological stimulator (Grass; S88). Optimal voltage (25 V) was determined using a series of tetanic contractions (150Hz, 0.1 ms pulse width, 400ms
train (3-month animals) and 200ms train (18-month animals)). The mean isometric torque values
(N cm) were calculated from 5 consecutive contractions with 1 minute rest periods in between
each contraction. The weight normalized (N cm/kg) and contralateral untreated limb normalized
(% normal) force data is reported in the results section.

Tissue Histology
VML and DSM+MM treated TA muscles along with contralateral untreated TA muscles
were harvested and trimmed to remove fascia, rinsed in sterile PBS, dabbed dry, and then
weighed. Harvested muscles were flash frozen in isopentane (2-methylbutane) chilled in liquid
nitrogen, and stored at -80°C. Tissue cross-sections (8µm) of the repair site were obtained via
cryostat (Leica BioSystems) maintained at a temperature between -25 and -20°C. Prior to
immunostaining, slides were permeabilized in 0.1% 100X triton and then rinsed in phosphatebuffered solution (PBS, pH 7.4). Sections were blocked in PBS containing 4% goat serum and
0.05% sodium azide for 1h at room temperature prior to incubation in primary antibodies
including mouse-anti-collagen I IgG (1:500, Sigma-Aldrich), rabbit polyclonal anti-collagen III
(1:1000, Abcam), and mouse-anti-myosin IgG2B (MF-20, 1:10, Developmental Studies
Hybridoma Bank) for 2h at room temperature. Following PBS washes, slides were incubated in
the appropriate fluorescently labeled secondary antibodies (AlexaFluor, 1:500, Life
Technologies) for 30 minutes at room temperature. Additional tissue sections were stained using
a Masson’s Trichrome kit following the manufacturer’s guidelines (Sigma-Aldrich).
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Image Analysis
Collagen type I accumulation within VML injured and DSM+MM repaired muscle tissue
was quantified via immunostaining for collagen I (Sigma-Aldrich) with myosin heavy chain
(Developmental Studies Hybridoma Bank) as a counter stain. Representative tissue sections
collected from four animals per group were used for all calculations. A total of twelve sections (4
animals x 3 sections/animal, each section separated by approximately 500-700µm) were imaged
(100X) at the site of injury or repair. All images were converted to 8-bit greyscale and a uniform
threshold was applied to isolate collagen type I positive tissue regions within each section.
Tissue immunoreactivity to collagen I as a percentage of total tissue area (% Col I) was
calculated using image analysis software (ImageJ, NIH) using established techniques familiar to
our group (Kim et al., 2016). Similar image analysis methods were used to compute collagen III
percent area (% Col III) and fiber cross-sectional area (µm2) using magnified (100X) collagen III
images. Collagen III immunostained images were converted to greyscale and thresholded to
isolate the borders of individual muscle fibers (typically 300+ fibers / field of view).

Gene Expression
RT-PCR was performed using the protocol reported by Washington et al (Washington et
al., 2013). In prep for RT-PCR, TA muscle tissue (~30mg) was collected from the site of
injury/treatment

(n=4 animals/group) and homogenized with Trizol (Ambion)/choloroform

(Sigma Aldrich). Homogenized samples were treated with DNase (Invitrogen) and then RNA
was extracted using an RNeasy kit (Invitrogen). After quantification of RNA with UV
spectrophotometry (BioTek), cDNA was reverse transcribed from 1µg of total RNA (Invitrogen).
TAQMAN primers (Invitrogen) for Collagen I, Collagen III, TGF-β1, IGF-1, Pax7, MyoD,
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MyoG, IL-1β, TNF-α, and 18S rRNA housekeeping were used to quantify the expression of
desired genes. 18s rRNA expression was consistent between all groups. Experimental sample
group expressions were normalized to 18S rRNA and then referenced to the contralateral normal
limb. Gene expression levels are reported as fold change using the 2-(ΔΔCt) method.

Statistical Analysis
Data is presented as the mean ± standard deviation and was tested for normality using the
Shapiro-Wilks Test. All dependent variables (animal growth; TA and EDL muscle mass; peak
tetanic force, %Col I and %Col III, fiber cross-sectional area) were analyzed using a two-way
(age and treatment) ANOVA. Post-hoc comparisons were performed using Tukey’s test and if
present, interactions effects were reported. Pre-planned comparison between 3-month and 18month repair groups were conducted by Student’s t-test. Chi-square analysis was performed to
compare fiber area distributions. All analyses were performed using commercial statistical
analysis software (JMP 13). A standard p<0.05 level of significance was used for all statistical
tests.

C. Results
Animal Growth
All animals tolerated the surgery well and post-surgical complications requiring
euthanasia were absent. After one week post-implantation, all animals were ambulatory with no
discernable gait differences between treatment groups. There was a significant effect with age to
decrease animal growth (p<0.0001). On average, the 3-month animals gained 101±17g by the
completion of the 12-week study period. Alternatively, the 18-month animals lost an average of
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28±29g by the end of the study period. Although age significantly affected animal growth, we
did not detect a significant effect on growth with treatment. Both the 3-month VML
(8.8±1.7g/week) and DSM+MM (8.1±1.2g/week) groups gained weight at a similar rate.
Similarly the 18-month VML and DSM+MM groups lost weight at comparable rates of -2.6±2.9
g/week and -1.7±0.80 g/week respectively.

Tibialis Anterior Appearance and Mass
Compared to normal TA muscle morphology, untreated VML and DSM+MM repaired
muscles collected from both 3-month and 18-month aged groups appeared atrophied when
compared to contralateral normals and were characterized by a distinct defect visible at the site
of VML injury or repair (Figure 3A and B). An interaction effect of age and treatment (p=0.03)
was detected for TA mass. 18-month TA samples across both VML and DSM+MM groups were
on average 23% and 34% smaller than their 3-month counterparts, respectively. The 3-month
VML and DSM+MM muscle masses were 81.7±6.3% and 87.2±8.8% of their normal
contralateral TA mass respectively (Figure 3C) while their 18-month counterparts were
75.1±7.8% and 72.1±5.4% of the normal contralateral mass, respectively (Figure 3C). Within
the 3-month age group, DSM+MM repair lead to a 7% increase in muscle mass while repair in
the 18-month group resulted in a 5% decrease in muscle mass.

Peak Contractile Torque
In-situ muscle force recordings were characterized by a rapid rise in torque, followed by
a stable tetanic peak torque plateau, and a similarly sharp descent to a resting state. Similar to the
outcomes observed for muscle mass, a significant interaction between age and treatment was
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detected within the torque data (Figure 3D, p=0.02). Mean VML and DSM+MM peak torque
values (percent contralateral normal) for the 3-month age group were on average 20% (5.6±1.2
Ncm/kg vs. 4.6±1.1 Ncm/kg) and 47% greater (6.8±1.0 Ncm/kg vs. 4.2±0.6 Ncm/kg)
respectively when compared to their 18-month counterpart torque values. In addition, the peak
torque in response to DSM+MM repair within the 3-month age group was significantly increased
when compared to the 3-month VML group (6.8±1.0 Ncm/kg vs. 5.6±1.2 Ncm/kg). Specifically,
3-month mean peak torque values reached 79.9±11.2% of normal in response to DSM+MM
repair (6.8±1.0 Ncm/kg vs. 9.0±1.3 Ncm/kg); a 45% recovery in peak torque when compared to
3-month VML values (5.6±1.2 Ncm/kg vs. 9.0±1.3 Ncm/kg). Alternatively, within the 18-month
age group, DSM+MM repair had a negligible effect on peak torque (57±8.7% of normal, 4.2±0.6
Ncm/kg) when compared to VML values (58.6±14% of normal,4.6±1.1 Ncm/kg). However, a
significant decrease in peak torque was detected in both 18-month VML and repair groups when
compared to the 3-month DSM+MM repair group.

Weight Change and Peak Torque Correlation
When the relationship between peak TA torque and weight change (% of initial weight)
was examined within the 3-month age group, we did not detect a correlation (Figure 4B, r2=0.07). However, within the 18-month animal group there was a modest positive correlation
(Figure 4C, r2=0.49) between peak torque and body weight change. The findings suggest that
increased weight loss during the 12-week recovery period was associated with decreased peak
torque outcomes for the 18-month age group (Figure 4). The absence of a correlation between
weight change and peak torque in the 3-month age group possibly suggests that peak torque
becomes more sensitive to changes in body weight with age progression.
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Gene Expression
Among the transcription factors related to myogenesis (Figure 5), MyoD (p=0.006) and
MyoG (p=0.03) were expressed significantly higher in the 3-month repair group compared to the
18-month repair group by approximately 3-fold (4.52±1.43 fold change vs. 1.48±0.29 fold
change) and 8-fold (16.3±9.8 fold change vs. 2.0±1.6 fold change), respectively. No difference
was detected in Pax7 expression as both 3-month and 18-month groups exhibited muted
expression (1.9±1.1 fold change vs. 1.7±0.3 fold change).
Significantly higher levels of expression of collagen I (p=0.044) and collagen III
(p=0.047) were found in the 3-month repair group compared to the 18-month group. Collagen I
was expressed approximately 35-fold higher in the 3-month repair group compared to the 18month repair group (88.6±51.2 fold change vs. 2.5±1.9 fold change). Collagen III was expressed
600-fold higher in the 3-month repair group compared to 18-month repair (86.0±39.19 fold
change vs. 0.1±0.0). Notably when examining the ratio of collagen I to collagen III gene
expression, the 3-month repair group exhibited a significantly lower collagen I to collagen III
ratio (p=0.009) of 1.1±0.2 whereas the 18-month repair group responded with a ratio of
17.5±8.6. TGF-ß expression was also significantly higher in the 3-month group compared to the
18-month repair group (10.5±4.9 fold change vs. 1.4±0.4 fold change, p=0.01).
Significant differences were detected in the expression of IL-1ß and TNF-α between the
3-month and 18-month repair groups. The 3-month repair group was found to express IL-1ß at
levels 8.5-fold higher than its 18-month counterpart (9.7±5.9 fold change vs. 1.1±0.4 fold
change, p=0.02). TNF-α was expressed approximately 13-fold higher in the 3-month repair
group compared to the 18-month repair group (13.7±10.8 fold change vs. 1.2±1.2 fold change,
p=0.04). Expression of the growth factor IGF-1, though not significantly different between the
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two age groups (p=0.08), was expressed at elevated levels in the 3-month repair group compared
to the 18-month repair group (5.3±3.9 fold change vs. 1.3±0.5 fold change).

VML Site Histology
Both 3-month and 18-month normal TA histology was characterized by tightly apposed
bundles of MHC positive myofibers extending to the anterior surface of the muscle (Figure
6A,B “Normal”). When compared to normal muscle, both 3-month and 18-month VML wound
site tissue was characterized by a fibrotic surface region and elevated collagen staining extending
into the muscle body (Figure 6A,B “VML”). The repair site region was notably shallower than
the initial VML defect for both 3-month and 18-month groups, typically extending a few
hundred microns into the muscle, suggesting atrophy of the muscle at the injury site. Following
DSM+MM repair, 18-month animal muscle was similarly characterized by a collagen enriched
repair region, with the highest density near the anterior surface of the repair site (Figure 6B
“Repair”). Within the collagen dense region, there was diffuse and disorganized MHC positive
tissue with increasing fiber disorganization towards the surface of the muscle.

3-month

DSM+MM repair site tissue was notably devoid of collagen repair tissue and while the muscle as
a whole was atrophied, the collagen staining at the fiber and bundle level appeared qualitatively
similar to controls (Figure 6A “Repair”). There was no evidence of immature fibers with
centrally located nuclei for both 3-month and 18-month groups, suggesting either negligible new
fiber formation, or very likely, resolution and maturation of any new fiber by the 12-week time
point.
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Collagen I and III Area
A main effect of age (p=0.0009) was detected for collagen I % area. Within the 3-month
age group, collagen I % area measurements were similar across all treatment groups.
Specifically, 3-month normal, VML, and DSM+MM repair tissue contained collagen I % areas
of 6.2±2.0%, 6.5±1.6%, and 5.4±1.2%, respectively (Figure 7A-C,G). Alternatively, exhibiting
collagen I % area measurements of approximately 2-3 folds higher than their 3-month
counterparts, 18-month normal, VML, and DSM+MM repair tissues comprised on average
10.4±4.5%, 17.9±4.5%, and 17.6+9.3% of the total tissue area, respectively (Figure 7D-F,G).
In contrast to collagen I % area, a main effect of treatment was detected for collagen III
% area (p=0.0454). 3-month normal, VML, and DSM+MM repair groups were comprised of
collagen III % areas of 19.8±3.5%, 21.4±4.4%, and 16.9±1.2%, respectively (Figure 8C). 18month normal, VML, and DSM+MM groups were comprised of collagen III % areas of
17.7±1.9%, 22.2±1.5%, and 18.4±0.9%, respectively (Figure 8C). Within both 3-month and 18month age groups, a significant decrease in collagen III % area was detected between VML and
DSM+MM repair groups.

Fiber Cross-Sectional Area
The mean muscle fiber area at the site of injury (VML) or repair (DSM+MM) was not
significantly different for either the 3-month or 18-month age groups (Figure 9). No effect of
treatment was detected nor were fiber sizes significantly different between the age groups. Mean
fiber diameter for both 3-month (2085±245µm2) and 18-month (1993±400µm2) DSM+MM
repair tissue was within 10% of VML injured values for both 3-month (2123±200µm2) and 18month (2146±89µm2) groups. No differences were detected between the distribution of fiber
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sizes for 3-month and 18-month DSM+MM repair groups. A summary of the key outcome
measures (mean ± standard deviation) is provided in Table 1.

D. Discussion
In this in vivo study, we observed significant effects with age on the response to
regenerative repair of VML injury as well as significant interactions between age and repair.
Specifically, the repair of VML defects using a combination of decellularized skeletal muscle
scaffolds and minced muscle paste recovered approximately half (45%) of the force lost to VML
injury when examined in the 3-month old rat model (3 months = 12.5% of median lifespan), but
was ineffective (recovery=-1%) when tested in the 18 month old model (18 months = 75% of
median lifespan). The age-related decrease in regenerative therapy effectiveness is meaningful
when one considers the broad age range of patients that could benefit from VML treatment
strategies. Overall, the results of this study suggest that the successful translation of VML injury
treatment strategies to the clinic may be compromised by patient age.
Generally, a sustained inflammatory response has been associated with chronic
inflammatory myopathies and disorders such as muscular dystrophy and myositis, which have
been shown to lead to excessive fibrosis and stagnation of the normal regenerative program
(Loell & Lundberg, 2011; Porter et al., 2002). However, recent studies have also demonstrated
important roles for inflammatory cytokines such as TNF-α and IL-1ß in the regulation of the
regenerative process. TNF-α attracts satellite cells to the injury site as well as promotes satellite
cell proliferation and myoblast differentiation via activation of NF-κß and p38 MAPK signaling,
respectively (S. E. Chen, Jin, & Li, 2007; Peterson, Bakkar, & Guttridge, 2011). These findings
are consistent with our observations in functional recovery and gene expression data where there
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was significant upregulation of TNF-α and MyoD in the 3-month repair group as well as a
significant increase in peak torque values compared to the older 18-month repair group. The low
expression of TNF-α in the 18-month repair group could be suggestive of low- or in-activation of
p38 MAPK activity which has been demonstrated to downregulate the expression of muscle
differentiation markers such as MyoD and MyoG (S. E. Chen et al., 2007; Zhan, Jin, Chen,
Reecy, & Li, 2007). Similar to TNF-α, IL-1ß is able to stimulate migration, proliferation, and
differentiation of mybolasts, albeit indirectly, by stimulating the secretion of IL-6 from skeletal
muscle cells (Luo, Hershko, Robb, Wray, & Hasselgren, 2003; Munoz-Canoves, Scheele,
Pedersen, & Serrano, 2013; Porter et al., 2002). Gene expression in the 3-month repair group
compared to the 18-month group mirrors the observations of TNF-α expression and may speak to
the aberrant inflammatory response and muscle homeostatic maintenance of the older 18-month
rat group (Joe et al., 2010; Kami & Senba, 1998; C. Zhang et al., 2013).
In addition to an overall reduction in the pool of available satellite cells within aged
muscle there is also a phenotypic shift of satellite cells from a myogenic to fibrogenic lineage (B.
M. Carlson, 1995; Grounds, 1998b). This shift in lineage is attributed to dysfunction in satellite
cell proliferative capacity (Conboy et al., 2005) and divergence towards fibrogenicity (Brack et
al., 2007b), which is largely influenced by soluble factors in the aging tissue microenvironment.
The age-related shift in satellite cell behavior towards a pro-fibrotic phenotype is consistent with
our observed results. Histological and quantitative %NCT measurements revealed regions of
increased collagen deposition within and around the area of injury and repair when compared to
the non-aged model repair site. Additionally, the heightened pro-fibrotic response is capable of
further impairing muscle fiber regeneration and force recovery via deregulation of satellite cells
driven by interactions with fibrotic ECM (Alnaqeeb, Al Zaid, & Goldspink, 1984; Mann et al.,
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2011a; Serrano et al., 2011). Furthermore, it has been demonstrated that increased collagen
deposition can decrease growth factor diffusion within the repair site and hinder satellite cell
migration, leading to incomplete regeneration at the site of injury (Hindi, Shin, Ogura, Li, &
Kumar, 2013). The composition of the ECM at the site of repair can also have a negative effect
on muscle regeneration (Lehto, Sims, & Bailey, 1985). Within tissue collected at the site of
repair from the 18-month rats, the ratio of collagen I to collagen III gene expression was
markedly elevated with approximately a 17:1 ratio while tissue from the 3-month rats exhibited a
ratio closer to 1:1. Unusually high ratios of collagen I to collagen III have been associated with
hypertrophic scar formation in wound healing as well as decreased sensitivity to growth factors
(Garner, Karmiol, Rodriguez, Smith, & Phan, 1993).
The regenerative medicine strategy that was used as the test bed for the examination of
age sensitivity to VML repair was similar in concept to strategies under examination by other
groups. Specifically, we utilized a combination of allogeneic decellularized skeletal muscle
scaffolds and autologous minced muscle paste to restore the architectural and cellular cues lost to
VML injury. The regenerative capacity of minced muscle fragments has been demonstrated
previously by Studitsky and Carlson in their respective seminal reports (B. M. Carlson, 1968;
Studitsky, 1964) but not until recently has minced muscle been incorporated into tissue
engineering strategies aimed at VML repair (Corona, Garg, et al., 2013; Goldman et al., 2018; B.
Kasukonis, J. Kim, L. Brown, et al., 2016; Ward et al., 2015). Additionally, the effects of minced
muscle transplantation on regeneration are comparable in its overall goal compared to the
delivery of pure populations of progenitor cells explored by others (Merritt, Cannon, et al.,
2010a; Quarta et al., 2017). Similarly, the ECM scaffolds used in this study are comparable to
those which have been examined extensively by other groups (Corona et al., 2014b; Gentile et

139

al., 2014; Merritt, Cannon, et al., 2010a; Merritt, Hammers, et al., 2010; Sicari et al., 2012;
Turner et al., 2012; Urciuolo et al., 2018). This is likely due to the consistency of the
overwhelming inflammatory and fibrotic response to VML injury leading to functional deficits,
regardless of scaffold composition or host species of origin.

The broad similarities between our

test bed and others, provides confidence that the age-related differences we observed in this
study are relevant to more recent cell- and tissue-based regenerative medicine strategies under
investigation by research teams (Gilbert-Honick, Iyer, et al., 2018; Goldman et al., 2018; Qiu et
al., 2018; Quarta et al., 2017) and would suggest that similar age-related deficiencies would exist
for these strategies.
Lastly, a limitation to this study that deserves discussion is the lack of an early-post
implantation time point that would provide the data needed to identify specific wound healing
events responsible for the age-related differences in functional outcome. The 12-week endpoint
examined in this study, while appropriate for the examination of functional recovery, misses the
key pro-myogenic milestones that occur during the first few weeks of muscle healing (Tidball,
2005b, 2017). In particular, the examination of acute time points may reveal key age-sensitive
differences in cellular and soluble factor (cytokines and growth factors) responses that occur
following regenerative VML repair (Tidball, 1995, 2011). The gene expression results measured
in this study demonstrate that pro-myogenic transcription pathways and cytokines are elevated at
12 weeks in the non-aged animal model suggesting ongoing regenerative processes, but it
remains unclear whether the muted myogenic response observed at 12 weeks in the aged animal
was similarly muted during early healing. Early time points could reveal whether all or only
specific key myogenic milestones are impaired within the VML repair site of aging muscle, and
could provide valuable insights that would inform age-targeted therapeutic strategies.
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E. Conclusion
In summary, this study is the first to demonstrate an age-dependent response to repair of a
VML injury utilizing a tissue-engineered therapy. Notably, the repair of VML defects using a
combination of tissue scaffolds and minced muscle paste recovered approximately half of the
force lost to VML injury when examined in a 3-month rat model, but was ineffective when tested
in the 18-month model. The 18-month animal model was characterized by an increase in scarring
at the site of repair and a reduction in the expression of key myogenic genes. When taken
together the findings suggest that a decline in regenerative capacity with age may present an
obstacle to regenerative medicine strategies targeting VML injury.
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Figure Legends
Figure 1: Whole tibialis anterior (TA) muscles were decellularized using an infusion bioreactor.
During decellularization, SDS solution was delivered to the mid-belly region of the TA muscle
via a hypodermic needle and syringe pump (A). The bioreactor was designed to accommodate
four side-by-side decellularization units each capable of accommodating a single muscle tissue
sample (B). Representative whole TA muscle appearance prior to and following infusion
decellularization treatment (C left and right), illustrates the appearance of the DSM scaffolds
following removal of intracellular myoglobin. Infusion prepared DSM scaffolds, when viewed in
thin section (scale bar = 100um) with H&E staining, retained the aligned network structure of
native muscle ECM (D). (arrow = approximate direction of muscle contraction)

Figure 2: Surgical VML and repair procedure. The surgical site was cleaned and disinfected and
a 1-2 cm incision was made to expose the underlying TA muscle (A). A 8mm biopsy punch was
used to create a VML injury to a depth of 3mm. Approximately 20% of the TA muscle was
excised (B). MM autografts were prepared using 25% (by mass) of the removed muscle plug.
The muscle tissue was minced using a scalpel and scissors (C). The resulting MM paste was
used to coat a DSM scaffold prior to implantation into the defect site (D). The MM coated DSM
scaffold was packed into the defect with scaffold alignment oriented to direction of muscle
contraction (E). The surgical site was closed using both deep and surface sutures (F). The
uninjured contralateral limb served as a comparative control.

Figure 3: Gross morphology of 3-month (A) and 18-month (B) normal, VML, and DSM+MM
repaired TA muscles. Dashed circle indicates the approximate location and boundary of the
defect site. TA muscle wet weight (C) and peak torque (D) was normalized to animal weight
(Nmm/kg) and calculated relative to normal contralateral TA muscle values (%normal) for each
animal tested. Representative in-vivo TA torque recording (D inset). Relative muscle wet weight
and peak torque data are presented. Data is presented as group means + SD; n=7-8/group; *
denotes statistically significant (p<0.05) differences between groups.

Figure 4: Animal weight was recorded at the time of surgery (initial) and sacrifice (final) for
each age and treatment group. Animal weight change (% initial) was quantified using initial and
final animal weight values (A). Data is presented as group means + SD; n=7-8/group; * denotes
statistically significant (p<0.05) differences between groups. Scatter plots, least square method
linear correlation fits, and sample coefficients of determination (r2) for animal weight change
versus peak torque data are shown for both the 3-month (B) and 18-month DSM+MM repair
groups (C).

Figure 5: Comparison of relative gene expression for 3-month and 18-month DSM+MM repair
groups using RT-PCR. The expression of myogenic (Pax7, MyoD, MyoG), ECM (COL I and
COL III), ECM regulatory (TGFβ1), and inflammation genes (IGF1, IL-1β and TNFα) were
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measured using muscle tissue harvested from the DSM+MM repair site. Expression is presented
as fold change normalized to contralateral normal muscle expression. Group means + SD are
presented, n=4/group. * denotes statistically significant (p<0.05) differences between groups.

Figure 6: TA muscle cross-sections were stained with Masson’s Trichrome. Representative 3month (A) and 18-month (B) normal, VML, and DSM+MM repair groups are presented.
Representative whole TA cross-sections and magnified (100X) images are shown. Arrows
highlight regions and bands of fibrotic collagen accumulation. Inset indicates approximate
location of magnified image within the TA cross-section. Arrow indicates anterior direction.
Scale bar = 100µm unless noted.

Figure 7: TA tissue cross-sections were immunostained for collagen I (green) and
counterstained against MHC (red). Representative 3-month (A) and 18-month (B) normal, VML,
and DSM+MM repaired tissue images are shown. Inset indicates approximate location of
magnified (100X) image within TA tissue section. Arrow indicates anterior direction. Open
arrows highlight regions and bands of fibrotic collagen I accumulation. Scale bar = 100µm.
Cross-sections were quantified for area fraction of collagen type I (C). Group means + SD are
presented; n=4/group. * denotes statistically significant (p<0.05) differences between groups.

Figure 8: TA tissue cross-sections were immunostained for collagen III (red). Representative 3month (A) and 18-month (B) DSM+MM repair site images are shown. Inset indicates
approximate location of magnified (100X) image within TA tissue section. Arrow indicates
anterior direction. Scale bar = 100µm. Cross-sections were quantified for area fraction (%)
collagen type III (C). Group means + SD are presented; n=4/group. * denotes statistically
significant (p<0.05) differences between groups.

Figure 9: Individual myofiber areas were measured from Collagen III stained tissue crosssections. Group data for myofiber cross-sectional area (A) and area frequency distribution are
shown (B). Group means + SD are presented; n=4/group; ns = no significance (p>0.05).
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Abstract
It has been previously demonstrated that a combinatorial repair strategy for volumetric muscle
loss (VML) consisting of autologous minced muscle (MM) grafts co-delivered with a
decellularized muscle scaffold (DSM) was not able to promote a pro-myogenic environment
leading to effective tissue repair nor restore muscle contractile function in an 18-month aged
animal model (Fischer 344). In this study, the use of the anabolic steroid nandrolone decanoate
(ND) was explored as an adjunct to DSM+MM repair in an aged model of VML injury
(n=15/treatment group). We observed no significant improvements in peak isometric torque
between ND(+) (64.5±18.3% of uninjured contralateral muscle) and ND(-) (80.9±37.9%) repair
groups. Histological findings revealed a significant reduction in collagen dense repair tissue at
the site of injury. These findings were also reflected in collagen I area fraction (%)
measurements with both ND(+) uninjured (6.1+1.1%) and ND(+) repair (9.3+3.2%) groups
having significantly lower collagen I area fraction compared to the ND(-) repair (15.6+5.5%)
group. Gene expression data revealed no significant changes in myogenic gene expression with
ND injection but did upregulate collagen III expression. The expression of transcription factors
related to Notch (Notch1, Jag1) and insulin (TRIM72, FOXO1, IRS-1) signaling were found to
be downregulated by age, independent of ND treatment. These findings suggest that ND
treatment may not be an appropriate addition to existing VML repair strategies to enhance ageassociated decline in regenerative potential.
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A. Introduction
Volumetric muscle loss (VML) is a traumatic injury that overwhelms the regenerative
ability of skeletal muscle leading to permanent functional loss and excessive scarring. Currently,
surgical interventions for VML are limited to autologous muscle flap transfers which have been
known to cause donor site morbidity, further exacerbating the patient (Fan et al., 2008; Lin, Lin,
Yeh, & Chen, 2007; Vekris et al., 2008). However, the use of implantable biological scaffolds as
a regenerative medicine strategy have shown encouraging results in small animal models
(Corona et al., 2013; Corona, Ward, Baker, Walters, & Christ, 2014; Gentile et al., 2014;
Kasukonis, Kim, Washington, & Wolchok, 2016). VML injuries can result from both battlefield
(Corona, Rivera, Owens, Wenke, & Rathbone, 2015; Owens et al., 2008) and civilian trauma
(Grogan, Hsu, & Skeletal Trauma Research, 2011; MacKenzie et al., 2000), with the latter
encompassing a wide range of age groups. With current investigations into regenerative
medicine strategies for the repair of VML being conducted primarily in young animal models,
there still exists a need for investigations into how age affects regenerative outcomes following
VML treatment.
There are well-documented aging-related changes in muscle function and quality
including reduction in muscle mass, reduced metabolism, and increased fatty tissue infiltration
into the muscle (Blaauw, Schiaffino, & Reggiani, 2013; Collino et al., 2013; Fielding et al.,
2011; Gheller, Riddle, Lem, & Thalacker-Mercer, 2016). Factors contributing to these changes
have been shown to be a combination of intrinsic changes in muscle such as the deterioration of
skeletal muscle quality (fiber composition, muscle capillarization, mitochondrial dysfunction)
(Coggan et al., 1992; Conley, Jubrias, & Esselman, 2000; Croley et al., 2005; Miller, Robinson,
Bruss, Hellerstein, & Hamilton, 2012; Suetta et al., 2007) and extrinsic factors such as dietary
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intake and physical activity (Donini, Savina, & Cannella, 2003; Straight, Brady, & Evans, 2015;
Thalacker-Mercer, Fleet, Craig, & Campbell, 2010). Coupled with the multi-factorial nature of
VML injuries, regenerative medicine strategies have proven unsuccessful in eliciting a
significant regenerative response in aging skeletal muscle as previously demonstrated by our
group (J. Kim et al., 2019). A potential solution to combat the age-related changes in aging
skeletal muscle is the use of exogenous testosterone.
The use of testosterone and other anabolic stimuli in aging animal models has been
documented to improve muscle regeneration. Specifically, testosterone has been demonstrated in
several studies to induce muscle hypertrophy via increased protein accumulation and myonuclear
accretion in addition to rescuing aging muscle from wasting (Axell et al., 2006; Kadi, Bonnerud,
Eriksson, & Thornell, 2000; Kovacheva, Hikim, Shen, Sinha, & Sinha-Hikim, 2010; SinhaHikim et al., 2002; Sinha-Hikim, Cornford, Gaytan, Lee, & Bhasin, 2006). Results suggest that
androgens can stimulate the proliferation of satellite cells and ultimately differentiation and
fusion into myofibers. This is further supported by studies showing increased satellite cell
numbers following treatment in numerous species including humans (Sinha-Hikim et al., 2006;
Sinha-Hikim, Roth, Lee, & Bhasin, 2003), rodents(Joubert & Tobin, 1995), and chickens
(Allouh, Jarrar, Asfour, Said, & Shaqoura, 2017). Testosterone has also demonstrated the ability
to inhibit Notch signaling through its inhibitor, Numb, which has been shown to promote satellite
cell differentiation during myogenic development and repair (Conboy & Rando, 2002; Jory et al.,
2009; Zilian et al., 2001). These findings are likely attributed to the role of the androgen receptor
on muscle cell proliferation and differentiation in both in vitro and in vivo environments (Dalbo
et al., 2017; Diel, Baadners, Schlupmann, Velders, & Schwarz, 2008; Hughes et al., 2016; D. K.
Lee, 2002; Sinha-Hikim, Taylor, Gonzalez-Cadavid, Zheng, & Bhasin, 2004).
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There still remains the question of whether a reversal of aging-related pathologies via
testosterone treatment used in conjunction with ECM-based therapies to repair VML injuries will
create an environment that is conducive to muscle regeneration. To that end, an aged animal
model of VML developed by our group (Kim, Kasukonis, Brown, Washington, & Wolchok,
2016) was used to investigate the response to VML repair with and without anabolic steroid
supplementation. Fischer 344 rats aged 18 months were used in this study, which represent the
mature to early elderly rat lifespan (ref). The purpose of this study was to test the hypothesis that
testosterone supplementation in conjunction with our minced muscle and ECM-based VML
repair therapy will counteract age-related muscle wasting in addition to stimulating myogenic
activity, thus creating an environment more receptive to regenerative treatment. This study
presents the performance of our previously reported regenerative strategy (J. Kim et al., 2019),
with and without testosterone supplementation in an aged animal model.

B. Methods
Anabolic Steroid Administration
The anabolic steroid nandrolone decanoate (ND) (Steraloids, Inc, Newport, RI) was used
in this study due to its long half-life (6-12 days) and has been demonstrated to have potent
myotrophic effects in skeletal muscle (Carson, Lee, McClung, & Hand, 2002; Tsika, Herrick, &
Baldwin, 1987; Washington, Healey, Thompson, Lowe, & Carson, 2014). Sesame oil was used
as a carrier for ND and was administered intramuscularly into the vastus lateralis muscle at a
concentration of 9 mg/kg body weight once weekly. Animal weights were recorded prior to
injections to adjust ND dosages to be consistent with the 9 mg/kg body weight dose. ND(-)
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animal groups were administered depot injections of sesame oil intramuscularly. Both ND(+)
and ND(-) groups were administered either ND or depot injections at the time of surgical
treatment and once every 7 days following the date of injection.

hDSM Preparation
To prepare human DSM samples (hDSM) for implantation, whole human tibialis anterior
(TA) muscle was portioned into smaller fragments for decellularization. TA muscles were
donated from Science Care, Inc (Phoenix, AZ). The TA samples were incubated in 1% SDS for
approximately 2 weeks with a fresh exchange of SDS every 24 hrs. Following infusion
treatment, samples were incubated overnight in a DNAse solution (1kU/ml DNAse in a 10mM
Tris-HCL buffer; 2.5mM MgCL2 + 0.5mM CaCl2) and then incubated (8 hours) in a 1X
penicillin/streptomycin solution to reduce the risk of infection. Samples were rinsed thoroughly
(a total of six 24-hour wash steps) in PBS between each preparation step. Following completion
of the entire decellularization protocol, the hDSM implants were lyophilized and stored at -20⁰C.

Volumetric Muscle Loss Injury and Minced Muscle
In vivo VML studies were performed with aged (18 months) male Fisher 344 rats. The
aged rats were obtained through the National Institute on Aging (Bethesda, MD). Surgical
procedures and implant preparation methods were performed in accordance with protocols
approved by the University of Arkansas IACUC (protocol #18052) and guided by published
methods. Anesthesia was administered using isoflurane (1-3%) in oxygen. The implant site was
exposed via a parallel incision (1-2cm) along the tibia (Figure 1). The TA was then identified
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and a partial thickness VML defect (8mm diameter x 3mm deep) was created using a sterile
biopsy punch. Defect site tissue was then removed and weighed to ensure consistent defect mass
values (average defect weight = 93.4mg). Defect mass values (20% of TA mass) were based on
pilot study data measuring TA muscle mass (average TA mass = 470±17mg). The removed
defect plugs were retained for use as minced muscle (MM) autografts (25% of VML defect
mass). Animals were randomly assigned to one of two treatment groups (n=15/treatment group):
VML defect repaired with hDSM scaffold supplemented with MM autografts followed by
testosterone injection (ND(+)) or repair with no injection (ND(-)). All contralateral limbs to the
ND(+) and ND(-) only limbs served as internal controls for comparison and are denoted as the
normal group in the study.
A single infusion-prepared DSM scaffold was cut to size (average DSM mass =
4.9±0.7mg) using surgical scissors. Separately, 25% of the defect muscle plug was hand-minced
into a loose paste using a scalpel and scissors until MM fragments larger than ~1mm 3 could not
be visually detected. The DSM scaffolds were then manually rolled in the MM autograft paste
until all surfaces were visibly coated. DSM+MM constructs were implanted into the VML
defect. Care was taken to ensure DSM implant network alignment matched that of the
surrounding muscle. Unrepaired VML defects served as negative controls. To remain consistent
with previous MM repair techniques, the DSM scaffolds were sized to fill, but were not sutured
to the surrounding tissue.

The deep fascia and skin layers were separately closed using

interrupted stitches with a 5-0 adsorbable suture (Vicryl, Ethicon). Post-operative analgesia
consisted of 0.1mg/kg buprenorphine administered subcutaneously through injection twice daily
for 2 days. The anti-inflammatory medication Carprofen was readily available to the animals via
a dietary gel cup (MediGel CPF, ClearH20, Westbrook, ME), which was added to each animal’s
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cage after surgery. Animal consumption of the gel was voluntary and any uneaten gel was
removed from the cage at 1-week post-surgery. Following surgery, animals were house in
standard-sized rat cages with unrestricted movement and were allowed to bear weight on the
operated extremity as tolerated. All animals were housed for a 12-week recovery period.

In-vivo Contractile Force Measurement
Peak tetanic contractions produced by the TA muscle were measured isometrically in
vivo using procedures described by Corona and familiar to our group (Corona et al., 2013; B.
Kasukonis et al., 2016). Animals were anesthetized (isoflurane) and the lower limb was
stabilized at 90° of knee flexion (tibia parallel to the benchtop) using a custom made alignment
jig. The ankle was flexed to 90° and the foot was secured (surgical tape) to the lever arm of a
dual-mode muscle lever systems (Aurora Scientific, Ontario, Canada,). To isolate the
contribution of the TA during force measurement, distal tenotomies were performed on the
extensor digitorum longus (EDL) and extensor halluces longus (EHL). TA peak isometric tetanic
force was measured by stimulating the peroneal nerve with the aid of a physiological stimulator
(Grass; S88). Optimal voltage (2 – 5 V) was determined using a series of tetanic contractions
(150Hz, 0.1 ms pulse width, 200 ms train). Average peak tetanic force for each animal was
calculated from an average of 5 contractions. All contractions were separated by one minute of
rest. Raw peak tetanic contractile force (N) was recorded from both the treated and contralateral
control limb of each animal and normalized to animal weight (N/kg). The weight normalized
(N/kg) and contralateral limb normalized (% normal) force data is reported in the results section.
At the conclusion of electrophysiological testing, all animals were euthanized through carbon
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dioxide inhalation in accordance with guidelines provided by the 2013 AVMA Panel on
Euthanasia of Animals.

Gene Expression
RT-PCR was performed using the protocol reported by Washington et al (Washington et
al., 2013). In preparation for RT-PCR, samples of muscle from the defect site of the right and
left

TA

(n≤5

animals/group)

were

homogenized

with

Trizol

(Ambion,

Carlsbad,

CA)/choloroform (Sigma Aldrich, St. Louis, MO). Samples were treated with DNase
(Invitrogen, Carlsbad, CA) and then RNA was extracted using an RNAeasy kit (Invitrogen,
Carlsbad, CA). After quantification of RNA with a plate reader (BioTek, Winooski, VT), RNA
was converted to cDNA with a kit (Invitrogen, Carlsbad, CA). TAQMAN primers (Invitrogen,
Carlsbad, CA) for Collagen I, Collagen III, TGF-β, IGF-1, Pax7, MyoD, MyoG, IL-1β, TNF-α,
IFN-γ, TRIM72, IRS-1, FOXO1, Notch1, Jag1, and 18S rRNA housekeeping were used to
quantify the expression of desired genes. Experimental sample group expressions were
normalized to 18S rRNA and then referenced to the contralateral normal limb. Gene expression
levels are reported as fold change using the 2-(ΔΔCt) method.

Non-contractile Tissue and Fiber Cross-Sectional Area Measurements
Collagen type I accumulation was quantified within normal and treated muscle tissue
sections using measures of Collagen I (Sigma Aldrich, St. Louis, MO) immunoreactivity with
myosin heavy chain (Developmental Studies Hybridoma Bank, Iowa City, IA) as a counter stain.
Representative tissue sections were imaged (200X), converted to 8-bit greyscale, and a uniform
threshold was applied across all samples to isolate collagen type I positive tissue regions within
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each section. From each image, tissue immunoreactivity to collagen I as a percentage of total
tissue area was calculated with the aid of image analysis software (ImageJ, NIH) and is reported
in the results as percent non-contractile tissue (% NCT). Similar image analysis methods were
used to compute mean muscle fiber cross-sectional area (µm2) using magnified (200X) collagen
III immunoreactivity images. Collagen III immunostained images were similarly converted to
greyscale and thresholded to isolate the borders of individual muscle fibers (typically 50+ fibers
per image). Representative tissue sections collected from four animals per group were used for
all calculations. Three sections were imaged and analyzed to calculate the mean %NCT and fiber
cross-sectional area for each animal. A total of twelve images (4 animals X 3 sections/animal)
were analyzed for each treatment group. All image analysis was performed following a protocol
established by our group (Kim et al., 2016) with set parameters to minimize any user bias.

Serum Testosterone Analysis
The Ultra-Sensitive Mouse & Rat LH ELISA is an in-house method based on a
manuscript published by Steyn et al (Steyn et al., 2013). This assay allows for a LH
measurement in 2.5 – 5ul of serum, plasma or whole blood. The capture monoclonal antibody
(anti-bovine LH beta subunit, 518B7) is provided by Janet Roser, University of California. The
detection polyclonal antibody (rabbit LH antiserum, AFP240580Rb) is provided by the National
Hormone and Peptide Program (NHPP). HRP-conjugated polyclonal antibody (goat anti-rabbit)
is purchased from DakoCytomation (Glostrup, Denmark; D048701-2). Mouse LH reference prep
(AFP5306A; NHPP) is used as the assay standard. The Limit of Quantitation (Functional
Sensitivity) is defined as the lowest concentration that demonstrates accuracy within 20% of
expected values and intra-assay coefficient of variation (%CV) <20%, and was determined by
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serial dilutions of a defined sample pool. Intra-assay %CV is 2.2%. Inter-assay %CVs are 7.3%
(Low QC, 0.13 ng/ml), 5.0% (Medium QC, 0.8 ng/ml) and 6.5% (High QC, 2.3 ng/ml).
Functional sensitivity is 0.016 ng/ml.

Statistical Analysis
Data is presented as the mean ± standard deviation and was tested for normality using the
Shapiro-Wilks test. The following dependent variables were analyzed using a two-way ANOVA:
body weight; TA mass; gastrocnemius mass; EDL mass; peak isometric torque; non-contractile
tissue percentage, fiber cross-sectional area; myogenic, ECM, and inflammatory gene
expression. Post-hoc comparisons were performed using Tukey’s HSD test and if detected,
interaction effects were reported. Comparisons between 3-month ND(-) repair, 18-month ND(-)
repair, and 18-month ND(+) repair groups were conducted via one-way ANOVA with a Tukey’s
HSD post test. Comparison between ND(-) and ND(+) group means were conducted by
Student’s t-test. Chi-square analysis was performed to compare body weight curves, survival
curves, and fiber area frequency distributions. All analyses were performed using commercial
statistical analysis software (JMP 13). A standard p<0.05 level of significance was used for all
statistical tests.

C. Results
Animal Growth
Following VML injury repair, all animals appeared to tolerate surgery well and were
fully ambulatory within 1 week of the procedure. No surgical complications that required
euthanasia were observed. Over the 8-week study period, ND(-) repair animals on average lost a
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total of 18.1±25.2g while the ND(+) repair animals lost a total of 26.1±8.4g. ND(-) and ND(+)
repair groups lost weight at similar rates of -2.3±3.2g/wk and -3.3±1.2g/wk, respectively (Figure
2D). No statistical differences were found for both total weight loss and growth rate between the
two groups.
TA, EDL, and Gastrocnemius Muscle Mass
Compared to normal TA morphology, the repaired muscles for both the ND(-) and ND(+)
groups appeared significantly atrophied with a visible defect at the site of VML repair (Figure
3A). A main effect of treatment (p<0.0001) to reduce TA mass was detected. Post hoc analysis
revealed that within their respective treatment groups, normal TA mass for the ND(+) (1.34±0.10
g/kg, p<0.0001) and ND(-) (1.32±0.07 g/kg, p=0.0005) groups were significantly higher than
their ND(-) counterparts (1.07±0.08 g/kg and 1.12±0.09 g/kg)(Figure 3B). However, no
significant differences in TA mass were detected between the ND(+) and ND(-) groups.
In the gastrocnemius muscles, a main effect of treatment (p=0.0002) was detected to
increased gastrocnemius mass (Figure 3C). Specifically, ND(+) uninjured gastroc muscles
weighed significantly less compared to ND(+) repair muscles (4.14±0.08 vs. 4.52±0.08,
p=0.0074) while no significant differences were detected within the ND(-) group. For EDL
mass, an interaction effect between treatment and testosterone (p=0.0358) was detected to
decrease EDL mass (Figure 3D). Post hoc analysis revealed that EDL mass from the ND(-)
repair group was significantly higher than the ND(+) repair group (0.41±0.03 g/kg vs. 0.37±0.03
g/kg, p=0.0219).
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In vivo Peak Isometric Torque Measurements
In vivo torque readings were characterized by a rapid rise torque followed by a stable
plateau at the peak value and then concluding with a sharp descent to a normal resting state
(Figure 4A). Similar to our previous aging studies, there was a main effect of treatment to
decrease peak isometric torque (p<0.0001)(Figure 4B). Post hoc analysis indicated that the
ND(+) repair group TA produced significantly less force than its control counterpart (1.17±0.29
N/kg vs 1.87±0.38 N/kg, p<0.0006). Despite the absence of a significant difference in peak
torque between the ND(-) control and repair groups, a decreasing trend in force production was
observed with VML repair. These findings are consistent with previous findings utilizing this
aged animal model. Additionally, no difference was detected between % normal torque between
the ND(+) (64.5±18.3%) and ND(-) groups (80.9±37.9%)(Figure 4C).

Heart and Testes Mass
Heart mass measurements revealed that there was a significant increase in mass in the
ND(+) group compared to the ND(-) group (2.77±0.18 g/kg vs. 2.59±0.17 g/kg,
p=0.0068)(Figure 5A). Additionally, it was revealed that ND injections significantly decreased
testicular mass in the animals when compared to the ND(-) animal group (5.84±0.84g/kg BW vs.
9.34±3.53 g/kg BW, p=0.0018)(Figure 5B).
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Serum Testosterone
Interestingly, serum testosterone concentration was detected to be significantly higher in
the ND(-) group compared to the ND(+) repair group (p=0.0063)(Figure 5C). Specifically, the
ND(-) repair group’s serum testosterone concentration (93.1±30.7 ng/dL) was approximately
38% higher than the ND(+) repair group (63.5±11.4 ng/dL).

Histology
Masson’s trichrome staining revealed tightly apposed muscle fibers throughout both
ND(-) and ND(+) uninjured groups, with no sign of disorganized or abnormal tissue (Figure 6).
However, the respective repair groups were characterized with areas of dense collagen-rich scar
regions as well as diffuse non-contractile tissue infiltration extending medially from the anterior
surface of the muscle. By comparison, however, the ND(-) repair group had significantly more
scarring at the anterior surface than its ND(+) counterpart. Additionally, while the ND(+) repair
group maintained myofiber presence within and surrounding the repair site, the ND(-) repair
tissue was largely devoid of myofibers, suggesting a greater degree of atrophy compared to its
ND(+) counterpart.

Fiber Cross-sectional Area and Non-contractile Tissue Measurements
Regions immune-reactive to collagen I provided a semi-quantitative measure of scarring
or percentage non-contractile tissue (Figure 7A). Myofiber cross-sectional area distribution
histograms (Figure 7B) for all groups were characterized by a frequency peak at myofiber areas
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in the range of 1000-2000µm2. Though no significant differences were detected between fiber
area distributions for all groups, the greatest difference in fiber area frequency (~7%) was
observed in the 1000-2000µm2 range between the ND(+) repair (35.9%) and ND(+) uninjured
(28%) groups while ND(-) uninjured and repair groups exhibited similar fiber area frequencies
(32% vs. 32.4%). Following statistical analysis, an interaction effect of treatment and drug was
detected. Within the ND(-) group, a significant increase in percent non-contractile tissue was
measured in the repair TA compared to the uninjured TA (15.6±5.5% vs. 6.4±0.8%,
p<0.0001)(Figure 7C). Within the ND(+) however, no differences were detected between the
uninjured and repair groups. Post hoc analysis revealed that both the ND(+) uninjured and
ND(+) repair groups contained significantly less percentages of non-contractile tissue than the
ND(-) repair group (6.1±1.1% and 9.3±3.2% vs. 15.6±5.5%, p<0.0001 and p=0.0046
respectively). Interestingly, though no significant differences were detected in

No significant

differences in myofiber cross-sectional area was detected with all groups containing similar
mean cross-sectional areas ranging from 2100 µm2 to 2200 µm2 (Figure 7D).

Gene Expression
Myogenic gene expression (Pax7, MyoD, MyoG, IGF-1) within the ND(-) and ND(+)
was not found to be significantly different (Figure 8). However, though not significantly
different, MyoD expression had an elevated trend in the ND(+) control group compared to the
ND(+) repair group as well as their ND(-) counterparts. Overall, expression for myogenic genes
was similarly muted across all groups. Interestingly, among the inflammatory markers TNF-α,
IFN-γ, and IL-1ß, IL-1ß was the only gene to be expressed at detectable levels. An effect of
treatment was found to increase IL-1ß expression following repair in both non-ND (1.0±0.6 fold
176

change vs. 4.2±3.6 fold change) and ND (0.6±0.5 fold change vs. 2.8±1.1 fold change) groups
(p=0.0198).
Among ECM-related genes (Col I, Col III, TGF-ß), Col III was the only target to be
differentially expressed, exhibiting an effect of treatment to increase its expression (Figure 8).
Specifically, the ND(+) repair group (16.4±18.1 fold change) expressed Col III approximately
47-fold higher than the ND control group (0.4±0.01 fold change). TGF-ß expression was not
found to be significantly different across all groups, though there was a trend of increasing
expression following repair for both non-ND and ND groups. An interesting trend in expression
was found for Col I, though no significant differences were found. While treatment appeared to
result in lower expression in the non-ND repair group compared to the non-ND control group,
the opposite response was observed for the ND repair group compared to the ND control group
with the ND repair group trending towards higher Col I expression by approximately 4-fold.
While examining the expression of genes related to IGF-1 signaling and atrophy
(TRIM72, IRS-1, FOXO1), a main effect of age was detected to decrease the expression of IRS1 and FOXO1 (p<0.0001 and p<0.0001, respectively) in the 18-month ND(-) and ND(+) groups
compared to the 3-month ND(-) counterpart (Figure 9). Specifically, FOXO1 was expressed
approximately 33-fold and 50-fold lower in the 18-month non-ND (0.03±0.01 fold change,
p<0.0001) and ND (0.02±0.01 fold change, p<0.0001) groups, respectively than the 3-month
non-ND group (1.0±0.2 fold change). IRS-1 was expressed 100-fold lower in both the 18-month
non-ND (0.01±0.01 fold change, p<0.0001) and ND (0.01±0.004 fold change, p<0.0001) groups
compared to the 18-month non-ND group (1.0±0.1 fold change). No differences were found in
TRIM72 expression across the three groups, but there was a trend of higher expression in the 18-
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month non-ND and ND groups (1.6±0.9 fold change and 1.1±0.3 fold change, respectively)
compared to the 3-month non-ND counterpart (1.0±0.5 fold change).
Associated with satellite cell activity and myogenic regulation, the expression of the
Notch signaling receptor Notch1 and its ligand, Jag1, were measured between 3-month –ND, 18month –ND, and 18-month ND treatment groups (Figure 9). No significant differences were
detected between groups for both Notch1 and Jag1. However, an increasing trend of Notch1
expression was observed in the 18-month ND group (1.38±1.30 fold change) compared to both
18-month –ND (1.17±1.13 fold change) and 3-month –ND groups (1.00±0.56 fold change).
Interestingly, Jag1 expression in both 3-month -ND and 18-month ND groups were similarly
expressed at levels approximately 2.5 folds more than (1.00±0.27 vs. 0.94±0.92 fold change,
respectively) the 18-month –ND group (0.39±0.25 fold change).

D. Discussion
In this in vivo study we observed modest improvements in recovery following VML
repair with testosterone administration in 18-month rats. Specifically, there appeared to be
reduced scarring following VML repair in the ND treated animals compared to their -ND
counterparts. However, no significant changes were found in force production and force recovery
following VML repair as a result of ND administration. In addition, there were no observations
to indicate muscle hypertrophy as a result of ND administration. These findings are meaningful
when considering anabolic steroid supplementation to VML repair as they alone may not be able
to elicit a strong regenerative response and overcome the dysfunctional environment formed by
age-related changes in muscle as well as VML injury. The use of testosterone in less traumatic
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injury models in both young and aged animals have resulted in beneficial effects to myogenesis
but the results have varied from model to model (Beiner, Jokl, Cholewicki, & Panjabi, 1999;
Ferry et al., 1999; White, Baltgalvis, Sato, Wilson, & Carson, 2009). Overall, the results of this
study suggest that the treatment strategy used would prove more effective if used in conjunction
with rehabilitative strategies in order to improve muscle quality and create an environment that is
more receptive to treatment and recovery.
The use of ND has been explored extensively as a means to combat muscle wasting as a
result of various conditions including disuse atrophy (Camerino et al., 2015; Chen, Lin, Chen, &
Hsu, 2013), sarcopenia (Serra et al., 2013), and cachexia (Gold et al., 2006; Mulligan et al.,
2005). These studies demonstrated improvements to body weight and lean body mass with the
added benefit of improving physical activity in test subjects. However, we observed no such
improvements to body weight maintenance within this study nor any improvements to peak
tetanic contractions in the repaired TA muscles. Conflicting results across studies using ND as a
therapeutic to combat wasting can be attributed to differences in species used in the studies,
frequency of ND administration, and dosage, among other variables. Interestingly, it has also
been reported that chronic administration of ND had no effects on body weight and in some
cases decreased body weight (Oda & El-Ashmawy, 2012; Shahraki, Mirshekari, & Shahraki,
2015), which is in agreeance with our observations. Additionally, consistent with the use of
anabolic steroids, chronic ND use has also been reported to cause decreased bioavailable
testosterone (Nagata et al., 1999; Takahashi, Tatsugi, & Kohno, 2004), impaired
spermatogenesis, depletion of Leydig cells, and reduction in fertility (Svechnikov, Izzo, Landreh,
Weisser, & Soder, 2010).
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In both recreational and clinical use, testosterone has a well-documented effect of not
only inducing skeletal muscle hypertrophy but also increasing the number of satellite cells and
myonuclei in young and older subjects in a dose-dependent manner(Bouhlel, Joumaa, & Leoty,
2003; Kadi et al., 2000; Sinha-Hikim et al., 2002; Sinha-Hikim et al., 2006; Sinha-Hikim et al.,
2003). Bhasin et al (Serra et al., 2013) also reported increased fiber cross-sectional area after
treatment with testosterone, though fiber hypertrophy was limited to the early stages of myofiber
regeneration following cardiotoxin injury. The lack of peak tetanic contraction improvement
observed in this study may be attributable to a lack of myofiber hypertrophy as evidenced by an
absence of change in fiber cross-sectional area between treatment groups in the current study. It
is likely that any regenerating fibers fully developed and matured by the end of the 8-week study
endpoint. Non-contractile tissue percentages were observed to decrease following ND
administration, which is in agreement with previous studies investigating the use of anabolic
steroids in the clinic to aid in recovery following rotator cuff repair in sheep and rabbits (Gerber
et al., 2015; Gerber, Meyer, Nuss, & Farshad, 2011). Gerber et al. found that administration of
nandrolone decanoate immediately following rotator cuff tendon repair resulted in a significant
reduction in intramuscular fat accumulation during recovery as well as attenuation of muscle
atrophy. Taken together, these findings are confounding, given the ability of anabolic steroids to
increase muscle protein synthesis and hypertrophy primarily through the activation of the
mammalian target of rapamycin (mTOR) pathway (Basualto-Alarcon, Jorquera, Altamirano,
Jaimovich, & Estrada, 2013; Favier, Benoit, & Freyssenet, 2008).
Androgens and anabolic steroids have been shown to regulate Wnt and Notch signaling
pathways in skeletal muscle, which are crucial in determining myogenic stem cell fate and
regulating muscle satellite cell activation and proliferation (Brack, Conboy, Conboy, Shen, &
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Rando, 2008; Brack et al., 2007; Conboy & Rando, 2002; Cossu & Borello, 1999). Further,
Notch signaling is essential for the maintenance of satellite cell quiescence and renewal during
postnatal myogenesis (Bjornson et al., 2012; Fukada et al., 2011; Mourikis et al., 2012). Our
observations of Notch1 gene expression indicated no differences between the 3-month –ND, 18month –ND, and 18-month ND groups though there was an increasing trend of Notch1
expression following ND administration. In addition, Jag1 expression was similar between the 3month –ND and 18-month ND groups, with both groups following a decreasing trend in
expression. These results are in agreement with a study conducted by Carey et al. in which
reduced expression of Notch signaling genes was only observed in human skeletal muscle from
older individuals (60-75 years old) compared to muscle from younger men (18-25 years old)
(Carey, Farnfield, Tarquinio, & Cameron-Smith, 2007). This suggests that ND administration in
aging skeletal muscle following VML repair is able to stimulate Notch signaling. However, the
near basal levels of Pax7 expression in the 18-month ND group belie the observed Notch1
expression in the same group. Moreover, the absence of myofiber hypertrophy and de novo fiber
formation in both ND(-) and ND(+) treated groups suggests poor anabolic sensitivity in aging
muscle.
A previous investigation into elderly human subjects’ response to anabolic stimuli
revealed a reduced response of muscle protein synthesis to anabolic factors in addition to
dysfunction in the activation of translation factors contributing to protein metabolism (Guillet et
al., 2004). A similar resistant response to anabolic stimuli has been demonstrated in adult and old
rats (Baillie & Garlick, 1992; Dardevet, Sornet, Attaix, Baracos, & Grizard, 1994). Based on the
regulation of protein synthesis by insulin and amino acids (Shah, Anthony, Kimball, & Jefferson,
2000) and the trophic action of testosterone on IGF-1 (Ashton, Degnan, Daniel, & Francis,
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1995), it is possible that the absence of muscle protein accretion observed in this study is due to a
defect in the insulin signal transduction pathway. Dysfunction in insulin/IGF-1 signaling occurs
via degradation of the insulin receptor substrate-1 (IRS-1) due to its role as a critical node
through which subsequent activation of various signaling pathways occur. Aside from
insulin/IGF-1 signaling, IRS-1 is also responsible for activation of the PI3k/AKT/mTOR
pathway (Bodine et al., 2001; Bohni et al., 1999; Rommel et al., 2001). The mechanism of IRS-1
degradation is still widely debated though a common observation by researchers is that it occurs
through a negative feedback loop within the PI3K/AKT/mTOR signaling axis (Haruta et al.,
2000; A. V. Lee, Gooch, Oesterreich, Guler, & Yee, 2000; Tzatsos & Kandror, 2006; Zhande,
Mitchell, Wu, & Sun, 2002). An alternative mechanism of IRS-1 degradation involves the
muscle-specific mitsugumin 53 (MG53; also called TRIM72) marking IRS-1 for ubiquitination
(C. S. Lee et al., 2010; Song et al., 2013). The low expression of IRS-1 and increasing trend in
TRIM72 expression in the 18-month animals compared to their 3-month counterparts seems to
suggest that ubiquitin-mediated degradation of IRS-1 may be occurring and supports the lack of
animal growth and functional improvements observed in the study. These findings, however,
present a new set of challenges in developing VML repair techniques in the elderly population as
insulin/IGF-1 pathway dysfunction is closely associated with insulin resistance in metabolic
syndrome and type 2 diabetes (Eckel, Grundy, & Zimmet, 2005).
The results of this study would have benefitted from the addition of earlier time points in
order to investigate the mechanistic changes as a result of the VML repair treatment utilized. It
has been well-established that muscle satellite cell contribution during regeneration accounts for
the majority of the regenerative capacity of skeletal muscle (Conboy & Rando, 2005). During
muscle regeneration, the majority of the events take place within the first 7 days (Tidball, 2011)
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and as such, the effects of nandrolone on satellite cell activity as well as on myogenic cell cycle
regulatory factors such as MRFs (Lu, Jenster, & Epner, 2000) were not captured within this
study. An important factor of aging skeletal muscle that was not considered in this study is the
role of metabolism and how perturbations to aging skeletal muscle metabolism modulate muscle
stem cell function and homeostasis. Of particular interest is nutrition with a focus on calorie
restriction as it has been well-documented to be an effective strategy in increasing satellite cell
abundance in aging skeletal muscle as well as increasing mitochondrial abundance and inducing
conservation of metabolic and longevity regulators (Barger, Walford, & Weindruch, 2003;
Cerletti, Jang, Finley, Haigis, & Wagers, 2012; Shyh-Chang, Daley, & Cantley, 2013).

E. Conclusion
In summary, the present study is the first to assess the treatment outcomes from
administering nandrolone decanoate in conjunction with a minced muscle loaded decellularized
muscle ECM scaffold to repair VML in aging rats. VML repair followed by nandrolone injection
reduced collagen I accumulation at the defect site, which was reinforced with the downregulation
of the transcription factor for collagen I and upregulation of collagen III. Further,
downregulation of transcription factors related to Notch and insulin signaling independent of
nandrolone injection but sensitive to age suggested dysfunction within these pathways, which
may have caused abnormal cellular events resulting in sub-optimal regenerative conditions.
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Figure Legends
Figure 1: Surgical VML and repair procedure. The surgical site was cleaned and disinfected and
a 1-2 cm incision was made to expose the underlying TA muscle (A,B). An 8mm biopsy punch
was used to create a VML injury to a depth of 3mm (C). Approximately 20% of the TA muscle
was excised (D). MM autografts were prepared using 50% (by mass) of the removed muscle
plug and hand mincing with scissors and scalpel (E). The resulting MM paste was used to coat a
DSM scaffold prior to implantation into the defect site. The MM coated DSM scaffold was
packed into the defect with the scaffold oriented to the direction of muscle alignment (F). The
surgical site was closed using both deep and surface sutures (G). Depending on treatment group,
either ND or sesame oil depot injections were administered in the vastus lateralis muscle (H)
followed by subcutaneous injection of buprenorphine. The uninjured contralateral limb served as
a comparative control.
Figure 2: Animal body mass and survival analysis. Animal weights as a percentage of initial
weight was tracked throughout the study period (A). Survival curve for animals (n=15/group)
over the 8-week study period is presented (B). Growth rate (C) was calculated on a weekly basis
and final body weight at the end of 8 weeks was compared between all groups (D).
Figure 3: Gross morphology of ND(-) uninjured, ND(-) repair, ND(+) uninjured, and ND(+)
repair TA muscles. Dashed circle approximates the location of the defect site. TA (B),
gastrocnemius (C), and EDL (D) wet weights were normalized to animal body weight (g/kg) for
each group and presented as means + SD; n=7-13/group; * denotes statistically significant
differences between groups (p<0.05).
Figure 4: Representative in vivo peak force readings for each treatment group (A). Peak
isometric torque was normalized to animal body weight (Nmm/kg) for each group (B) and was
also calculated relative to uninjured contralateral TA muscle values (% normal) for each animal
tested (C). Data is presented as means + SD; n=7-13/group; * denotes statistically significant
differences between groups (p<0.05).
Figure 5: Animal heart (A) and testes (B) wet weights were normalized to body weight (g/kg).
Additionally, serum isolated from whole blood was analyzed for serum testosterone
concentrations for all animals tested (C). Data is presented as means + SD; n=7-13/group; *
denotes statistically significant differences (p<0.05).
Figure 6: TA muscle cross-sections stained with Masson’s Trichrome. Representative whole TA
sections and magnified (100X). TA cross-sections were also immunostained with myosin heavy
chain (red) and counterstained with collagen I (green). Open arrows highlight regions and bands
of fibrotic collagen accumulation. Arrow indicates anterior direction. Scale bar = 100µm.
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Figure 7: Myofiber cross-sectional area and non-contractile tissue (%) was measured from TA
muscle cross-sections immunostained for collagen I and collagen III (A). Images were acquired
at a magnification of 100X. Fiber area frequency distributions (B) and group data for noncontractile tissue (%)(C) and fiber cross-sectional area (D) are shown. Scale bar = 100µm. Data
is presented as group means + SD; n=4/group; * indicates significant differences based on
treatment and # indicates significant differences based on drug (ND) (p<0.05).
Figure 8: Comparison of relative gene expression for ND(-) uninjured, ND(-) repair, ND(+)
uninjured, and ND(+) repair groups using RT-PCR. The expression of myogenic (Pax7, MyoD,
MyoG), ECM and ECM regulatory (collagen I, collagen III, TGF-ß), and inflammatory genes
(IL-1ß, TNF-α, IGF-1) were measured using tissue harvested from the VML repair site.
Expression is presented as log2 fold change normalized to ND(-) uninjured muscle expression.
Data is presented as group means + SD; n=4/group; * indicates statistically significant
differences based on treatment (uninjured vs. repair) and # indicates significant differences based
on drug (ND(-) vs. ND(+)) (p<0.05).
Figure 9: Comparison of relative gene expression for 3-month ND(-) repair, 18-month ND(-)
repair, and 18-month ND(+) repair groups using RT-PCR. The expression of genes related to
satellite cell activity (Notch-1, Jag-1) and insulin signaling (TRIM72, FOXO1, IRS-1) were
measured using tissue harvested from the site of VML repair. Expressionis presented as log2 fold
change normalized to 3-month ND(-) repair muscle expression. Data is presented as groups
means + SD; n=4/group; * indicates statistically significant differences between groups (p<0.05).
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Chapter 5
Conclusion/Perspectives
A. Future Directions
Age-associated changes in skeletal muscle have been well-documented for many
decades, with the first studies focusing on morphological changes with aging (Fudel'-Osipova,
1963; Ingelmark & Gustafsson, 1957; Lohmann, Wielepp, & Nocker, 1957) and eventually
moving towards understanding the mechanisms of dysfunction in aging muscle that preclude
effective regeneration and function (Buliakova, 1987; Herrmann, 1987; Lewis & Schmalbruch,
1995; Sadeh, 1988; Snow, 1977; White & Esser, 1989). With a wealth of foundational research
available, it would be of great benefit to incorporate such mechanistic methodologies into aging
VML repair investigations. It would not be unreasonable to assume that that the aging VML
microenvironment would appear even more dysfunctional than in lesser injury models as VML
has been demonstrated to result in an overwhelmingly inflammatory and fibrotic response
resembling various pathological conditions such as muscle dystrophy (Greising et al., 2017;
Larouche, Greising, Corona, & Aguilar, 2018; Mann et al., 2011). As there is no current research
being pursued in age-associated changes in regeneration following VML injury and repair,
understanding the broad changes in aging skeletal muscle and how they affect the regenerative
process in a VML environment would be indispensable in the pursuit of developing effective
repair strategies for VML injuries in aging muscle.
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Cell-ECM Interaction
ECM, specifically skeletal muscle derived acellular scaffolds, has been previously
demonstrated to provide a pro-myogenic environment, exerting control over cell migration,
proliferation, and differentiation leading to constructive tissue remodeling and repair (Faulk,
Johnson, Zhang, & Badylak, 2014; Perniconi et al., 2011). The mechanical and compositional
characteristics of the ECM directly affect satellite cell activity as well as their self-renewal and
proliferative capacity (Gilbert et al., 2010; Montarras et al., 2005; Urciuolo et al., 2013).
Myogenic progenitors can also exert control over the local microenvironment (El Fahime,
Torrente, Caron, Bresolin, & Tremblay, 2000; Guerin & Holland, 1995) as well as their own cell
fate in a self-regulatory manner (Kuang, Gillespie, & Rudnicki, 2008). However, in an altered
microenvironment as is observed with aging, there are alterations in ECM composition that may
negatively affect cell behavior and function. ECM derived from senescent mesenchymal stem
cells (MSCs) was found to have an altered composition of proteins implicated in cell-ECM
interactions including laminin, collagens, TGF-ß, and LOXL-1 (Pohlers et al., 2009; Rodriguez,
Rodriguez-Sinovas, & Martinez-Gonzalez, 2008). As a result, the altered ECM has been
demonstrated to “re-program” gene expression patterns in cells such as fibroblasts and MSCs (H.
R. Choi et al., 2011; Choi, Kurtz, & Stamm, 2011). However, the exact mechanism of these
interactions are still unknown and warrant further investigation.

Hormonal and Secretory Alterations
There are distinct changes in the levels of circulating hormones associated with the
decline in regenerative potential with aging muscle (Thorley et al., 2015). This is due in part to
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alterations affecting several hormonal networks involved in inflammation, muscle regeneration,
and prtotein synthesis (Vitale, Cesari, & Mari, 2016). Significant reductions in the levels of
circulating factors such as testosterone, IL-6, growth hormone (GH), and IGF-1 have been
detected in serum samples from aged subjects (Gordon et al., 2014; Kojo et al., 2014; Sattler,
2013). Epidemiological studies have shown that decreased levels of GH secretion are correlated
with sarcopenia as well as other hallmarks of aging including increased adipose tissue
accumulation, osteopenia, etc. (Thorley et al., 2015; Veldhuis, 2008). GH has also been shown to
stimulate IGF-1, which can modulate myoblast proliferation (Brisson & Barton, 2012) and
differentiation (Matheny & Nindl, 2011) through the signaling of the MAPK and ERK1/2
pathways (Brisson & Barton, 2012; Troy et al., 2012). Also associated with IGF-1 is the
androgen, testosterone, which promotes anabolism and IGF-1 secretion in muscle while reducing
adipose-tissue formation (M. A. Gentile et al., 2010). In vitro treatment of C2C12 myoblasts
with androgen-induced secreted factors (IGF-1Ea and mechano growth factor (MGF)) led to
nuclear accumulation of ß-catenin, a pro-myogenic, anti-adipogenic stem cell regulatory factor
(M. A. Gentile et al., 2010). In addition to changes in levels of circulating hormones with aging,
the local muscle secretome is also affected, which may act on neighboring host cells in an
autocrine/paracrine manner (Thorley et al., 2015).

Stress Pathways
As satellite cells age they become more susceptible to apoptosis and senescence,
rendering them less resistant to cellular stresses that limit their ability to function properly
(Chakkalakal, Jones, Basson, & Brack, 2012; Sousa-Victor et al., 2014). Recently, multiple

208

groups have identified multiple molecular pathways associated with cellular stress including p38
MAPK (Kodama et al., 2013; Mandal, Blanpain, & Rossi, 2011), JAK-STAT3 (Park, Dahmer, &
Quasney, 2012), and p16INK4A (Ramsey & Sharpless, 2006). Increased signaling in these stress
pathways not only induce mitochondrial dysfunction and increase the production of reactive
oxygen species leading to DNA damage, they have been demonstrated to limit the proliferative
capacity of aged satellite cells as well as impairment of cell engraftment and myotube formation
(Cerletti, Jang, Finley, Haigis, & Wagers, 2012). Some of these deleterious effects can be
reversed, however, as was demonstrated in a study where introducing a p38 MAPK inhibitor to
satellite cell cultures in vitro restored their proliferative ability while improving satellite cell
engraftment and myotube formation when cells treated with the inhibitor were transplanted into
immunodeficient mice compared to control groups (Charville et al., 2015). These observations
provide a possible cause as to why DSM+MM treatment in a previous study presented in this
dissertation was not able to elicit a significant myogenic response as was detected by RT-PCR
and improve muscle force production. Nonetheless, pathways such as these that inhibit satellite
cell functional output provide future therapeutic targets that may help mitigate cellular stress and
rejuvenate their functional capabilities.

B. Evaluation of Myogenesis in the Aging Niche
The current criteria for assessing the success of VML treatment strategies currently rely
largely on functional measurements, histology, and the biomolecular profile of the treated
muscle. However, for evaluating success in an aging model, the previously mentioned factors
and mechanistic methodologies would prove useful in better understanding the response to VML
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treatment in aging animals. As demonstrated by the significant differences in treatment outcomes
presented in the studies in this dissertation, there is a need for investigating the source of
dysfunction in the aging animals that prevent successful VML repair. By incorporating some of
the techniques and molecular targets found in traditional gerontological and current VML
research into future aged VML studies, a more comprehensive understanding of age-associated
impedance to effective tissue repair can be obtained so that more effective treatment strategies
addressing the multi-factorial nature of not only VML but age-associated decline in regenerative
potential can be resolved.

Histology
Current histological protocols allow for the evaluation of myogenesis, fibrosis and
inflammation, angiogenesis, and innervation of skeletal muscle tissue. Immunofluorescence (IF)
staining of muscle-specific motor proteins such as sarcomeric myosin heavy chain (MHC),
embryonic myosin heavy chain (eMHC), and satellite cell related transcription factors such as
Pax7 and Ki67 provide researchers with the ability to assess the degree of myogenesis and
myofiber development and maturation while also providing information regarding satellite cell
activation and proliferation. Angiogenesis can also be assessed via IF staining of angiogenic
proteins such as vascular endothelial growth factor (VEGF), CD31, and anti-hypoxia-induced
factor-1α (HIF-1α). A quantitative measure of innervation can be obtained by the use of αbungarotoxin, a competitive antagonist to the acetylcholine receptors located at neuromuscular
junctions. Fibrosis can be assessed qualitatively via IF staining for collagen I or using dye based
staining protocols such as Masson’s Trichrome or hematoxylin and eosin staining. Semi-
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quantitative measures of fibrosis can be obtained using image analysis techniques to calculate the
percentage of the muscle area occupied by immunopositive regions of collagen I.
An interesting addition to current histological protocols would be the use of muscle fiber
typing as there have been documented changes to fiber type composition in response to external
stimuli (Miljkovic, Lim, Miljkovic, & Frontera, 2015). For instance, type I fibers are susceptible
to atrophy induced by disuse or denervation whereas type II fibers are affected by pathological
conditions such as cancer, diabetes, heart failure, and aging (Wang & Pessin, 2013). Based on
information from fiber typing, potential targets within the microenvironment and signaling
pathways involved in potentiating the compositional changes in aging muscle fibers can help
guide the development of more effective treatment strategies.

Biomolecular Analysis
There are a wide variety of quantitative methods available in the field of tissue
engineering and biology that provide information on the biomolecular response in tissues to
treatment strategies. In VML, one of the more commonly used analytical methods is RT-PCR for
examining gene expression relating to myogenesis, inflammation, angiogenesis, and innervation.
One disadvantage of PCR techniques, however, is that it only provides a single temporal
snapshot of the biomolecular changes initiated in response to treatment. Moreover, relative gene
expression at a certain time point may not account for potential post-transcriptional or posttranslational modifications following translocation of the factor to the nucleus. This raises the
issue of genotype vs. phenotype and the difficulty in discerning whether the phenotypical
changes observed in the tissue are a direct result of the measured transcriptional activity. This
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issue however can be resolved with the incorporation of multiple time points, especially short
time points, for an improved temporal understanding of the transcriptional response to treatment.
As stated previously, the terminal differentiation of myoblasts and myofiber formation culminate
at approximately 14 days post. Short time points would provide valuable information regarding
satellite cell-mediated regeneration and could provide indications of dysfunction within the
myogenic program.
Western blotting is another biomolecular analytical tool providing information on protein
expression captured at a single time point. With the ability to detect single proteins of interest,
the technique provides researchers with the ability to investigate cell signaling pathways, whose
activation or inhibition is paramount for maintaining tissue homeostasis and regulating cellular
function. The presence or absence of specific proteins involved signaling pathways will point to
dysfunction or inhibition of the pathway, often leading to aberrant changes that result in limited
cell functional output (e.g. reduced satellite cell activation, increased apoptosis, cellular
senescence) that translate to poor treatment outcomes at the tissue level.
To date, very few groups in the VML field have leveraged the power of whole
transcriptome sequencing techniques such as RNASeq (Aguilar et al., 2018). Though the
technique has been around for approximately a decade, it was not until recently that it was
applied in the field of skeletal muscle tissue engineering. The study performed by Aguilar et al.
sequenced minced muscle graft repair tissue and control tissue from 3, 7, 14, 28, 56 days postinjury, providing their group with a detailed and quantitative time course of tissue-level changes
in response to regenerative therapy (Aguilar et al., 2018). The one unique aspect of RNASeq that
will make it a ubiquitous technique used in research moving forward is the vast amount of data
acquired detailing the expression of every single transcript within samples, post-transcriptional
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modifications, gene fusion, mutations, temporal changes in gene expression, and differences in
expression between treatment groups (Maher et al., 2009). Such a powerful tool will be
indispensable in furthering our understanding of major changes occurring within the tissue
following VML repair and providing interesting targets for future therapies that may not be
captured with traditional biomolecular techniques.

Satellite Cell Engraftment
A question that remains with the aging VML repair studies presented in this dissertation
is whether the transplanted cells in the form of the minced muscle graft that is co-delivered with
DSM scaffolds actually contribute significantly to tissue repair. Studies have shown that the
maintenance of the satellite cell niche improves the survival and engraftment capabilities of
transplanted cells into a site of injury. Lesser injury models such as cryoinjury (Grounds &
Yablonka-Reuveni, 1993) or myotoxin-induced injury models (Harris, 2003) result in local cell
and myofiber death while preserving the satellite cell niche (basal lamina, nerves, vessels, etc.)
which in principle should preserve engraftment, survival, and proliferation of transplanted
satellite cells. A study performed by Boldrin et al. used genetically modified mice
overexpressing ß-galactosidase (ß-gal) in myonuclei and satellite cells in order to identify donor
cells within graft muscles (Boldrin, Neal, Zammit, Muntoni, & Morgan, 2012). The group
injured muscle through various methods including myotoxin-induced injury and irradiation and
found several interesting findings. If the grafted muscle’s host satellite cells survived the injury,
they were able to more effectively contribute to tissue regeneration compared to the transplanted
donor cells. Conversely, if the host cells were destroyed following injury, the transplanted cells
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were able to take over tissue repair and contributed to the regeneration of de novo muscle tissue.
They did observe, however, that if the engraftment of the transplanted cells were not prompt,
engraftment was observed to be extremely poor implying that the satellite cell niche comprised
of existing myofibers, ECM, and satellite cells are required to allow for donor cell engraftment
and subsequent regenerative events to occur (Boldrin et al., 2012). These results suggest that
transplanted cells in not only VML but the aging satellite cell niche would not be effective in
contributing to myogenesis due to the VML-associated bulk loss of tissue (muscle tissue, nerves,
vasculature, basal lamina, satellite cells) and age-associated perturbations to the niche as
mentioned previously. It would be interesting to definitively demonstrate the engraftment
capabilities of minced muscle grafts in aging VML models because it would provide specific
targets within the niche that could be modulated or enhanced in order to augment tissue repair.

Rehabilitation/Exercise
Exercise has been demonstrated in both rodents (Song, Kwak, & Lawler, 2006) and
humans (Melov, Tarnopolsky, Beckman, Felkey, & Hubbard, 2007) to reverse or mitigate
several age-associated changes in skeletal muscle. In both young(Carroll et al., 2015) and aged
(Gosselin, Adams, Cotter, McCormick, & Thomas, 1998) rats, exercise has been demonstrated to
reduce the amount of collagen cross-linking allowing for improved mechanical properties and
mechanotransduction to resident satellite cells (Garg & Boppart, 2016), improved metabolism
(Schultz et al., 2013), and increased satellite cell proliferation and differentiation (Smith &
Merry, 2012). Until now, there have been only three published clinical reports in which
decellularized ECM scaffolds were used to treat VML injuries combined with physical therapy
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pre- and post-repair (N. E. Gentile et al., 2014; Mase et al., 2010; Sicari et al., 2014). However,
these studies reported mixed results in improvements in contractile output in the affected
muscles. Interestingly, Corona et al. reported a significant increase (~100%) in the recovery of
TA functional output following minced muscle graft repair combined with running wheel
exercise when compared to minced graft repair only animals (Corona et al., 2013). However,
Aurora et al. reported contrasting results when using an acellular porcine urinary bladder matrix
in conjunction with rehabilitation therapy (Aurora, Roe, Corona, & Walters, 2015). Not only was
the scaffold found to be unsuitable for regenerative purposes, physical rehabilitation did not
improve functional response nor tissue remodeling (Aurora et al., 2015). Results from both
studies suggest that in order for physical activity/rehabilitation to improve muscle function, the
regenerative therapy used needs to be able to elicit a regenerative response resulting in the
formation of de novo myofibers so that they may contribute to overall force production in the
muscle.

C. Remaining Challenges in Aging Myogenesis
Androgen Insensitivity
Despite the fact that as a cohort aging men have lower levels of serum testosterone, many
older men have normal to low-normal levels of testosterone, suggesting they are insensitive to
the anabolic effects of testosterone (Kuhne, Mikulas, Paul, & Weidinger, 1989). This may be due
in part to the observed reduction in androgen receptor numbers and weak affinity for the receptor
associated with aging rats (Bhasin & Bremner, 1997; Haji, Kato, Nawata, & Ibayashi, 1981). In
stark contrast in aging human males, there is an increased sensitivity to androgen (Greenstein,
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1979). In the last of the VML studies presented in this dissertation, the potent anabolic steroid
nandrolone decanoate (ND) was administered in combination with DSM+MM for VML repair.
The results from this study are consistent with what has been seen in aging rats and their
insensitivity to androgens. There was no improvement in muscle functional output nor
maintenance of body mass compared to control groups not receiving ND. However, there were
improvements in animal survival rates and reduced fibrosis at the site of VML injury associated
with the ND receiving repair groups. This could suggest that an aged rat model of VML may not
be the appropriate model for exploring the regenerative effects of androgen/anabolic steroid
therapy as there is an inherent bias towards insensitivity. Another possibility is that the anabolic
steroid that was used in the study was not appropriate as chronic ND abused has been shown to
reduce bioavailable testosterone in vivo (Barone et al., 2017). Further investigations exploring
the intrinsic and extrinsic (environmental) changes in response to androgen/anabolic
supplementation needs to be conducted to determine whether this form of therapy can be
meaningful in long-term VML recovery and enhance regeneration in aging skeletal muscle.

Innervation
One of the biggest challenges in skeletal muscle tissue engineering, especially in VML
and aging VML research, is the permanent denervation of distal myofibers due to the bulk loss of
the local muscle niche as well as excessive fibrotic deposition in the injury site. Though
decellularlized scaffolds have the porous structure needed to accommodate proper cell migration
and vascularization to occur, re-innervation can be a challenge if the distance between the ends
of the transected nerves is too large or if there is lack of available neighboring nerve bundles to
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attach to (Kuiken, Barlow, Hargrove, & Dumanian, 2017). Complicating neurogenesis with age
are a confluence of changes that lead to poor innervation. These include decrease nerve
conduction velocity, sensory discrimination, and decline in the amount of trophic and tropic
factors secreted by Schwann cells (Verdu, Ceballos, Vilches, & Navarro, 2000). Perhaps one of
the major changes affecting nerve regeneration in aging muscle is metabolism. The progressive
reduction in neural blood supply (Kihara, Nickander, & Low, 1991) leads to low availability of
nutrients supporting mitochondrial ATP production which is needed for axonal transport and
polymerization of microtubules and neurofilaments (Brunetti, Miscena, Salviati, & Gaiti, 1987;
Frolkis, Tanin, Marcinko, Kulchitsky, & Yasechko, 1985; McQuarrie, Brady, & Lasek, 1989).
Secondary effects are decreased membrane excitability and action potential propagation, which
may explain decrease in muscle output associated with aging (Adinolfi, Yamuy, Morales, &
Chase, 1991).
Fortunately, a number of these adverse changes in the aging environment can be
attenuated through the use of physical activity as previously mentioned. However, the use of
rehabilitation/physical therapy regimens have yet to be explored in aging VML studies but these
treatments have been demonstrated to be effective in young VML models (Quarta et al., 2018;
Quarta et al., 2017). By pursuing an aggressive exercise regimen along with their repair strategy,
Quarta et al. observed enhanced maturation of innervation and force production at 30 days
following VML treatment. Further, the group also observed increased vascularization and
reduced fibrosis in de novo tissue generated from repair (Quarta et al., 2017). The discrepancy
between Quarta et al. and other groups that may have not observed such improvements may lie
in the treatment methodologies used. Quarta et al. used multi-cellular (freshly isolated satellite
cells and other muscle resident cells) tubular ECM-based hydrogels whereas the previously
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mentioned studies either used pure cell-based (minced muscle graft) or scaffold based
(decellularized ECM) for treatment. Regardless, Quarta et al.’s results demonstrate the
synergistic effects of physical exercise and regenerative therapy in VML repair and presents a
very promising therapeutic strategy that has the possibility to be translated into the clinic fairly
easily. Moreover, these results provide an additional treatment methodology that can be easily
incorporated into future aging VML repair research that has the capability of addressing many of
the factors, not just innervation, in the aging microenvironment that preclude effective
regeneration.

Clinical Designation of Volumetric Muscle Loss
Due to the lack of a clinical standard of care for volumetric muscle loss injuries, the
majority of extremity traumas involving massive soft tissue loss go undocumented as VML
injuries and are categorized rather as varying degrees of open fractures (Lin, Lin, Yeh, & Chen,
2007), compartment syndrome (Badge & Hemmady, 2011), or general limb injury (Dziki et al.,
2016). Current emphasis in the clinic for severe extremity trauma is addressing bone healing,
despite the fact that upon successful limb salvage following bone repair there exists soft-tissue
associated functional deficits leading to chronic disability. This lack of VML documentation and
limited number of relevant clinical case studies act as hindrances in the development of clinically
relevant treatments for the future. Due to the disconnect between clinicians and academic
researchers, a shared database where clinical case studies can be shared between the two groups
may prove invaluable in identifying real-world VML trauma and provide researchers with new
insights that may impact future development of therapies and treatments targeting such traumas.
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